# EDGAR Filing Document

**Accession Number:** 0000096664
**File Stem:** 0001079973-26-000309
**Filing Date:** 2026-3
**Character Count:** 396435
**Document Hash:** d589f0ed5ac636ce58011d604d0d3809
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001079973-26-000309.hdr.sgml**: 20260316

**ACCESSION NUMBER**: 0001079973-26-000309

**CONFORMED SUBMISSION TYPE**: 10-12G

**PUBLIC DOCUMENT COUNT**: 54

**FILED AS OF DATE**: 20260316

**DATE AS OF CHANGE**: 20260316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Renewal Fuels, Inc.
- **CENTRAL INDEX KEY:** 0000096664
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 221436279
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-00000
- **FILM NUMBER:** 26757734

**BUSINESS ADDRESS:**
- **STREET 1:** 401 N CARROLL AVE., STE. 192
- **CITY:** SOUTHLAKE
- **STATE:** TX
- **ZIP:** 76092
- **BUSINESS PHONE:** 480-788-7420

**MAIL ADDRESS:**
- **STREET 1:** 401 N CARROLL AVE., STE. 192
- **CITY:** SOUTHLAKE
- **STATE:** TX
- **ZIP:** 76092

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TECH LABORATORIES INC
- **DATE OF NAME CHANGE:** 19990706

**As filed with the Securities and Exchange Commission on March 16, 2026.**

**Registration No. 000-XXXXX**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10**

**GENERAL FORM FOR REGISTRATION OF SECURITIES**

**Pursuant to Section 12(b) or (g) of**

**the Securities Exchange Act of 1934**

**Renewal Fuels, Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Texas** | **22-1436279** |
| **(State or other jurisdiction<br> of incorporation or organization)** | **(I.R.S. Employer<br> Identification No.)** |
| **401 N Carroll Ave., Ste. 192**<br> **Southlake, TX 76092** | **19901** |
| **(Address of principal executive office)** | **(Zip Code)** |
| **(480) 788-7420**<br> **(Registrant's telephone number)** | **(480) 788-7420**<br> **(Registrant's telephone number)** |

---

Securities to be registered pursuant to Section 12(b) of the Act: **Not Applicable** 

Securities to be registered pursuant to Section 12(g) of the Act: **Common stock, par value $0.001 per share**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer,"- "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| PART I |  |  |
| Item 1. | [Business](#a_001) | 1 |
| Item 1A. | [Risk Factors](#a_002) | 4 |
| Item 1B. | [Unresolved Staff Comments](#a_003) | 10 |
| Item 1C | [Cybersecurity](#a_004) | 10 |
| Item 2. | [Properties](#a_005) | 10 |
| Item 3. | [Legal Proceedings](#a_006) | 11 |
| Item 4. | [Mine Safety Disclosures](#a_007) | 11 |
| PART II |  |  |
| Item 5. | [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](#a_008) | 12 |
| Item 6. | [[Reserved](#a_009)] | 13 |
| Item 7. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_010) | 13 |
| Item 7A. | [Quantitative and Qualitative Disclosures About Market Risk](#a_011) | 14 |
| Item 8. | [Financial Statements and Supplementary Data](#a_012) | 14 |
| Item 9. | [Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](#a_013) | 14 |
| Item 9A. | [Controls and Procedures](#a_014) | 14 |
| Item 9B. | [Other Information](#a_015) | 15 |
| Item 9C. | [Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#a_016) | 15 |
| PART III |  |  |
| Item 10. | [Directors, Executive Officers and Corporate Governance](#a_017) | 16 |
| Item 11. | [Executive Compensation](#a_018) | 19 |
| Item 12. | [Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#a_019) | 20 |
| Item 13. | [Certain Relationships and Related Transactions, and Director Independence](#a_020) | 21 |
| Item 14. | [Principal Accounting Fees and Services](#a_021) | 22 |
| PART IV |  |  |
| Item 15. | [Exhibits and Financial Statement Schedules](#a_022) | 23 |

---

i

**PART I**

**Cautionary Note on Forward-Looking Statements**

This registration statement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on our current expectations, assumptions, estimates, and projections about future events and are subject to risks, uncertainties, and other factors, many of which are beyond our control. Forward-looking statements are based on our current expectations, assumptions, estimates, and projections about future events and are subject to risks, uncertainties, and other factors, many of which are beyond our control. Forward-looking statements often include words such as "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," "ongoing," "forecast," "strategy," or similar expressions, or the negatives of these terms.

Forward-looking statements include, but are not limited to, statements concerning:

* our
business plans and strategy;

* projected
profitability, performance, or cash flows;

* future
capital expenditures;

* growth
strategy, including organic growth and mergers and acquisitions;

* anticipated
financing needs;

* business
trends;

* capital
allocation strategy;

* liquidity
and capital management; and

* other
information that is not historical in nature.

These statements are subject to known and unknown risks, uncertainties, and other important factors that may cause our actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Such risks are described in "Item 1A. Risk Factors" and elsewhere in this registration statement. All forward-looking statements are expressly qualified in their entirety by these cautionary statements.

The forward-looking statements in this registration statement are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements.

Unless the context otherwise requires, all references in this registration statement to "Renewal Fuels," "we," "us," "our," the "Company," American Fusion, Inc., or similar terms refer to Renewal Fuels, Inc. and its directly and indirectly owned subsidiaries on a consolidated basis.

ii

The foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or risk factors that we are faced with. A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances. You should not place undue reliance on the forward-looking statements. Except as required by law, we undertake no obligation to update or revise any of the forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Unless the context requires otherwise, references in this Report to "we," "us," "our," "our company," "the Company" or similar terminology refer to Renewal Fuels, Inc., including its consolidated subsidiaries.

**SUMMARY OF SIGNIFICANT RISKS**

An investment in our common stock involves substantial risks. The most significant risks include: our pre-revenue, development-stage status with no operating history in fusion energy; the unproven nature of the Texatron™ platform and risk that we may never achieve net-positive energy or commercial viability; substantial capital requirements and potential going concern issues; extensive regulatory hurdles (DOE, NRC, EPA); intense competition in the fusion sector; and risks related to our common stock (e.g., volatility, limited liquidity on OTC Markets). See "Item 1A. Risk Factors" for a more detailed discussion of these and other risks.

iii

**Item 1. Business**

**Overview**

Renewal Fuels, Inc. (the "Company," "we," "us," or "our") is an advanced energy company focused on developing and commercializing compact, aneutronic fusion power systems to provide clean, sustainable, and scalable baseload electricity. Our core technology platform, the Texatron™, is a patent pending pulsed toroidal fusion reactor designed to enable distributed power generation for industrial, data center, defense, and grid-constrained applications. We are pursuing a Power-as-a-Service business model, where we intend to own and operate Texatron™ units and sell electricity on a per-kilowatt-hour basis, rather than selling the reactors themselves.

Originally incorporated in New Jersey in 1947 as Tech Laboratories, Inc., the Company has undergone several transformations, including a name change to Renewal Fuels, Inc. in 2007 and a shift toward renewable energy initiatives. On December 16, 2025, the Company entered into a Master Sales Agreement and Share Exchange Agreement in connection with a business combination with Kepler Fusion Technologies Inc. ("Kepler Fusion"). Although the transaction did not close as of December 31, 2025 because required closing mechanics had not yet been satisfied, the transaction subsequently closed on February 27, 2026, at which time Kepler Fusion became a wholly owned subsidiary of the Company.

In connection with this strategic transition, the Company has changed its legal name at the state level to American Fusion, Inc. and has redomesticated from Delaware to Texas. On February 27, 2026, the Special 2020 Series A Preferred Share of the Company, which carries super-voting rights sufficient to control stockholder matters, was transferred to Earth Sciences Fund I LLC and Brent Nelson. As a result of this transfer, Earth Sciences Fund I LLC became the holder of the Special 2020 Series A Preferred Share and holds the voting power associated with that class of stock. The Company's common stock continues to trade on the OTC Markets under the symbol "RNWF." A voluntary corporate name and symbol change with FINRA has been submitted but has not yet become effective as of the date of this registration statement.

As of the date of this registration statement, we are a development-stage company with no revenue from operations. Our activities are primarily focused on research and development ("R&D"), prototype testing, intellectual property ("IP") expansion, and preparation for commercial deployment. We are pre-commercial and have not yet achieved net-positive energy fusion or generated power for sale. Our success depends on overcoming significant technological, regulatory, and financial challenges inherent in the fusion energy sector. We refer you to Item 1A. Risk Factors for a discussion of these and other risks.

**Our Technology Platform**

Our proprietary Texatron™ fusion energy platform is based on a pulsed magneto-inertial fusion architecture that combines toroidal plasma confinement with helical magnetic field topologies for enhanced stability. Unlike traditional fusion approaches that rely on large, steady-state reactors (e.g., tokamaks or stellarators), the Texatron™ operates in a cyclic manner, with each pulse consisting of plasma formation, rapid compression and heating, temporary confinement during which fusion reactions may occur, and controlled dissipation before resetting for the next cycle.

Key technical features include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Toroidal Geometry and Magnetic Confinement**: Plasma is formed and confined within a closed toroidal chamber, where twisted magnetic field lines
promote magnetohydrodynamic (MHD) stability. This design draws on established plasma physics principles, such as those related to Grad-Shafranov
equilibria, while reducing system complexity and electromagnetic stress compared to conventional systems.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Pulsed Operation**: Plasma heating is achieved through fast-rising pulses via resistive heating and converging shock waves, enabling fusion-relevant
temperatures and densities transiently. This approach minimizes material exposure to extreme conditions and supports modular scaling.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Aneutronic Fusion Fuel Cycles**: The Texatron™ is optimized for deuterium-helium-3 (D-He³) reactions, which release energy primarily
as energetic charged particles rather than neutrons. This enables potential direct electrical energy conversion by exerting pressure
on the magnetic field, eliminating the need for steam turbines or thermal cycles. Benefits include reduced neutron flux and material
damage, minimal induced radioactivity and long-lived waste, and compatibility with high-efficiency power generation. Our technology is
protected by a substantial and growing IP portfolio, including several pending patent applications covering reactor architecture, plasma
confinement, energy conversion, controls, manufacturing methods, and deployment systems. We have filed 20 patents to date and plan to
file at least 240 additional patent applications by the end of 2026, in addition to maintaining trade secrets for critical know-how.

The Texatron™ platform is being developed as a family of modular systems with planned configurations ranging from approximately 1 megawatt (MW) to 500 MW, allowing deployment across diverse applications. Proof-of-principle experiments, including Version 9 prototype testing in Midland, Texas, have demonstrated stable toroidal plasma formation at sub-fusion temperatures, validating key confinement concepts. We anticipate demonstrating a 100 MW Texatron™ system before the end of 2026, subject to successful R&D and financing.

Our technology is protected by a substantial IP portfolio, including several pending patent applications covering reactor architecture, plasma confinement, energy conversion, controls, manufacturing methods, and deployment systems. In addition to several pending patent applications, we protect critical know-how through trade secret programs and confidentiality agreements. We plan to file at least 250 additional patent applications by the end of 2026, in addition to maintaining trade secrets for critical know-how.

**Market Opportunity and Commercial Strategy**

The global demand for clean, reliable baseload power is accelerating, driven by the energy transition, AI data center growth, industrial electrification, and geopolitical energy security needs. Fusion energy represents a transformative solution, offering unlimited fuel supply, zero carbon emissions, and high energy density. According to industry estimates, the fusion market could exceed $1 trillion by 2040, with applications in grid power, remote operations, and high-demand sectors.

Unlike centralized utility-scale fusion programs with decade-long timelines, we are targeting distributed deployment models. Our Power-as-a-Service approach involves owning and operating Texatron™ units at customer sites, selling electricity under long-term contracts. Initial target markets include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **AI and Hyperscale Data Centers**: Providing 24/7 `baseload power to address surging energy demands (e.g., projected 160% growth in U.S.
data center electricity use by 2030).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Industrial and Advanced Manufacturing**: Supporting emission-free operations for sectors like steel, chemicals, and mining.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Defense and Critical Infrastructure**: Delivering secure, resilient power for military bases and remote facilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Commercial and Residential Providers**: Integrating with grids in energy-constrained regions.

Indicative pricing targets are competitive with existing baseload generation (e.g., $0.05–$0.10 per kWh), while offering advantages in siting flexibility, minimal environmental footprint, and rapid deployment. We intend to deploy thousands of units globally over time, creating a fleet-based energy infrastructure platform. Our commercialization strategy emphasizes modular deployment, ownership and operation of fusion assets, and long-term infrastructure-style revenue models. We intend to pursue partnerships and LOIs for pilot deployments, such as with data center providers or defense installations.

**Competition**

The fusion energy sector is highly competitive and includes both public and private entities pursuing various approaches, such as magnetic confinement (e.g., tokamaks by ITER or Commonwealth Fusion Systems), inertial confinement (e.g., laser-based by National Ignition Facility and Pacific Fusion), and alternative concepts (e.g., field-reversed configuration by TAE Technologies). Recent high-profile transactions, such as the merger between TMTG and TAE Technologies in December 2025, have increased sector visibility and investment. We differentiate through our pulsed, aneutronic design, modular scalability, and focus on near-term commercial viability. We also face indirect competition from other renewable energy sources, such as solar, wind, and advanced fission technologies.

**Suppliers and Customers**

We rely on third-party suppliers for components such as magnets, vacuum systems, and diagnostic equipment. Key suppliers are selected based on quality, cost, and alignment with our IP protections. As a development-stage company, we have no material customer contracts yet, but we are in discussions with potential partners in data centers and industry for pilot deployments. We depend on a limited number of suppliers for specialized components and may face supply chain risks, including shortages of rare materials like helium-3.

**Intellectual Property**

Our IP strategy is central to our competitive advantage. We hold several pending patents applications on the Texatron™ architecture and related innovations, with hundreds of additional patent filings planned. We also protect trade secrets through confidentiality agreements and internal controls.

**Government Regulation**

Fusion development is subject to regulations from the U.S. Department of Energy (DOE), Nuclear Regulatory Commission (NRC), and Environmental Protection Agency (EPA), including export controls on sensitive technologies under the Atomic Energy Act and Energy Reorganization Act. We intend to comply with all applicable laws, including environmental impact assessments and IAEA standards for international expansion. Our operations may also be affected by federal incentives, such as those under the Inflation Reduction Act, and changes in energy policy.

**Employees**

As of March 16, 2026, our core team totals 16 full-time employees and consultants, and the Company intends to hire 20 engineers with specific expertise for our new facility in North Fort Worth, Texas, primarily in R&D, engineering, and management. Our team includes experts in plasma physics, materials science, and energy systems. We have no collective bargaining agreements.

**Properties**

Our principal executive offices are located at 8 The Green, Suite #12401, Dover, DE 19901. We are currently searching for a new leased facility in North Fort Worth, Texas, near the Alliance Airport, for R&D, testing, and manufacturing for prototype and commercial reactor development. This type of property is adequate for our current needs.

**Legal Proceedings**

The Company is currently pursuing legal proceedings in the Superior Court of the State of Washington, King County, relating to the cancellation of shares issued in connection with transactions that were not consummated as intended. These proceedings seek judicial authorization to cancel improperly issued shares and correct the Company's shareholder ledger. Additional information regarding this matter is described under Item 3, Legal Proceedings.

**Corporate History**

Renewal Fuels, Inc. (the "Company") was originally incorporated in New Jersey in 1947 as Tech Laboratories, Inc. The Company became a public reporting issuer through a registration statement on Form SB-2 filed with the Securities and Exchange Commission ("SEC") in 1999 and was publicly traded on the OTC market.

In 2007, the Company redomiciled to Delaware and changed its name to Renewal Fuels, Inc. pursuant to a Certificate of Merger and Certificate of Ownership filed on July 9, 2007. During this period, the Company disclosed changes in management and business direction through SEC filings.

The Company filed a Form 15-12G on March 31, 2009, to terminate its registration under the Securities Exchange Act of 1934 and suspend its duty to file periodic reports, having been current in its filings through the quarter ended September 30, 2008.

From 2009 through 2019, the Company maintained limited public disclosure. In 2020, the Company underwent a change in control through a series of private transactions involving the transfer of its Special 2020 Series A Preferred Share, which carried majority voting control:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On March 16, 2020,
Synergy Management Group LLC transferred the Special 2020 Series A Preferred Share to Krisa Management, LLC, resulting in Krisa Management
and Carey Cooley acquiring majority voting control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On July 29, 2020,
Krisa Management, LLC transferred the Special 2020 Series A Preferred Share to Manufacturing 360, LLC, resulting in Manufacturing 360,
LLC and Richard Hawkins acquiring majority voting control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On August 6, 2020,
Carey Cooley resigned as the Company's sole director, president, secretary, and treasurer, and appointed Richard Hawkins to those
positions. Mr. Hawkins has served continuously as Chief Executive Officer and sole director since that date.

Following the 2020 control transition, the Company resumed public disclosure through OTC Markets and has continued to provide annual, quarterly, and current information. The Company has not issued toxic or highly dilutive convertible instruments and has maintained governance and disclosure practices consistent with its current strategy.

In December 2025, the Company entered into a definitive business combination agreement with Kepler Fusion Technologies Inc., pursuant to which Kepler Fusion became our wholly owned subsidiary on February 27, 2026. This transaction integrated Kepler Fusion's assets, technology, and operations into the Company. This transaction represents the Company's pivot to advanced fusion energy development. The Company intends to change its corporate name to American Fusion, Inc. in the near future

On February 27, 2026, the Special 2020 Series A Preferred Share of the Company, which carries super-voting rights sufficient to control stockholder matters, was transferred to Earth Sciences Fund I LLC and Brent Nelson. As a result of this transfer, Earth Sciences Fund I LLC became the holder of the Special 2020 Series A Preferred Share and holds the voting power associated with that class of stock.

The Company is currently a development-stage entity with no revenue from operations and has included audited financial statements prepared by a PCAOB-registered independent public accounting firm in this registration statement on Form 10, as required by applicable SEC rules. The audit of these financial statements has been completed prior to the filing of the Form 10.

**Available Information**

Our website is www.keplerfusion.com, which will be transitioning to www.americanfusionenergy.com in the near future. Access to our information that may be material or of interest to our investors is available via our website. The contents of our website are not incorporated by reference into this Report or in any other report or document we file with the SEC, and any references to our website are intended to be inactive textual references only. All information that we have filed with the SEC can also be accessed through the SEC's website at www.sec.gov.

**Forward-Looking Statements**

This section contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results could differ materially due to risks described in Item 1A. These statements are based on our current expectations and are subject to risks and uncertainties, including those discussed in Item 1A. Risk Factors.

**Item 1A. Risk Factors**

*An investment in our common stock involves a high degree of risk. You should carefully consider the following risk factors, together with all of the other information included in this registration statement, including our financial statements and the related notes and Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations, before making an investment decision. If any of the following risks actually occurs, our business, financial condition, results of operations, or cash flows could be materially and adversely affected, and the value of an investment in our common stock may decline, and you could lose all or part of your investment. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties of which we are unaware, or that we currently believe are not material, may also become important factors that adversely affect our business. You should carefully consider the following factors in addition to the other information contained in this registration statement. See "Forward-Looking Statements" in Item 1.*

**Risks Related to Our Business and Technology**

***We are a development-stage company with a history of losses and no revenue, and we may never achieve profitability.***

We are a pre-revenue, development-stage company focused on fusion energy technology. Since our inception in 1947, we have undergone multiple business transformations, including periods of limited operations and reporting suspensions. The Company reported net losses of $255,333 and $773,994 for the years ended December 31, 2025 and 2024, respectively. As of December 31, 2025 and 2024, the Company had accumulated deficits of $20,356,048 and $20,100,715, respectively. Our operations have been funded primarily through equity issuances and related-party loans, and we have no history of generating revenue from our Texatron™ platform or any other product. We expect to continue incurring significant losses as we advance R&D, prototype testing, and commercialization efforts. If we fail to achieve technological milestones, such as demonstrating a 100 MW Texatron™ system by the end of 2026, or secure additional financing (including our planned $50 million raise in 2026), we may be unable to continue as a going concern. Our independent auditors may issue a qualified opinion on our financial statements if substantial doubt exists about our ability to continue operations.

***Our fusion technology is unproven and may never achieve commercial viability.***

The Texatron™ platform relies on pulsed magneto-inertial fusion using aneutronic fuels like deuterium-helium-3 (D–He³), which requires higher plasma temperatures than traditional deuterium-tritium systems. We have not yet achieved net-positive energy fusion, sustained reactions, or grid-scale power generation. Proof-of-principle experiments, such as our Version 9 prototype in Midland, Texas, have demonstrated stable plasma formation at sub-fusion temperatures, but scaling to fusion-relevant conditions involves significant uncertainties, including plasma instability, MHD disruptions, material degradation from charged particles, and efficient direct energy conversion. If we cannot overcome these technical challenges, our technology may fail, rendering our IP and investments worthless.

***We depend on successful R&D and prototype testing, which are inherently uncertain and costly.***

Our success hinges on advancing the Texatron™ through milestones like third-party IP valuation, audited financials, and a 100 MW demonstration by end-2026. R&D expenses are expected to increase substantially, and unforeseen issues (e.g., component failures, data anomalies, or safety incidents) could delay progress. We have limited resources and may not attract or retain specialized talent in plasma physics, materials science, or engineering. Past experiments validate core concepts, but full-scale testing may reveal flaws, leading to redesigns, cost overruns, or abandonment.

***Our aneutronic fusion approach involves unique risks, including fuel supply challenges.***

While D–He³ fusion offers benefits like reduced neutron damage and minimal waste, it requires rare helium-3, which is scarce on Earth and primarily sourced from lunar regolith or tritium decay. Supply disruptions, geopolitical issues, or price volatility could hinder development. Alternative fuels may not perform as expected, and our direct energy conversion methods remain experimental, potentially resulting in lower efficiency or system failures.

***Our pulsed operation model may introduce additional engineering complexities and failure modes.***

The Texatron™'s cyclic pulsed design, involving rapid compression and dissipation, could lead to fatigue in magnetic coils, vacuum systems, or structural components over repeated cycles. Unanticipated wear or synchronization errors in pulse timing may cause system failures, increasing maintenance costs and delaying commercialization.

***We may not achieve the projected efficiencies or cost reductions from our modular design.***

Our Texatron™ is designed for modular scaling (1 MW to 500 MW), but manufacturing complexities, integration issues, or unforeseen economies of scale limitations could result in higher-than-expected costs per unit. If modular deployment does not yield the anticipated reductions in construction time or expenses, our Power-as-a-Service model may not be competitive.

***Our IP development timeline may not be achieved, exposing us to competitive risks.***

We plan to file at least 250 additional patent applications by the end of 2026, but delays in drafting, prosecution, or approvals could leave our technology unprotected. If competitors file similar patents first or challenge ours, we may lose market advantage or face infringement claims.

***We depend on third-party validations and partnerships for key milestones.***

Our development timeline includes third-party valuation of our intellectual property and potential collaborations (e.g., for data center pilots or university research). If these validations are unfavorable or partnerships fail to materialize, it could delay financing, erode investor confidence, or require us to seek alternatives at higher cost.

***Our reliance on aneutronic fusion may limit our ability to achieve net-positive energy in the near term.***

Aneutronic D–He³ fusion requires significantly higher plasma temperatures and densities than deuterium-tritium systems, which have themselves not yet achieved sustained net-positive energy at scale. If we cannot reach these conditions efficiently within our pulsed architecture, our timeline for commercialization could be substantially delayed or our technology may prove commercially unviable.

***We may experience material delays or failures in prototype scaling and testing.***

Our current Version 9 prototype testing in Midland, Texas, is at sub-fusion temperatures. Scaling to higher power outputs (e.g., 100 MW demonstration by end-2026) involves increased magnetic field strengths, energy inputs, and material stresses that could reveal unforeseen instabilities, component failures, or safety issues, requiring iterative redesigns and additional capital.

***Our direct energy conversion technology is experimental and may not achieve expected efficiencies.***

While charged particle output from aneutronic reactions theoretically enables direct electrical generation without thermal cycles, practical implementation (e.g., magnetic field pressure capture) remains unproven at scale. Lower-than-expected conversion efficiency could make our systems uneconomic compared to conventional generation.

***We face risks associated with fuel sourcing and availability.***

Helium-3 is extremely rare on Earth and expensive to produce or extract. Any disruption in supply (e.g., from tritium decay sources or future lunar mining concepts) or significant price increases could impair our ability to conduct experiments or deploy systems, forcing reliance on alternative fuels with inferior characteristics.

***Safety incidents involving our prototypes could result in significant liability or reputational harm.***

High-energy plasma, strong magnetic fields, and pulsed power systems pose risks of electrical hazards, implosions, or radiation exposure (even if minimal in aneutronic systems). Any incident could lead to injuries, regulatory shutdowns, litigation, or negative publicity, delaying development and harming investor confidence.

***We may not achieve the anticipated benefits of direct energy conversion.***

Our reliance on charged particle output for direct electrical generation is experimental and may yield lower efficiencies than projected due to magnetic field losses or particle scattering. If thermal cycles become necessary as a fallback, this could increase system complexity, costs, and environmental footprint, undermining our competitive advantage.

**Regulatory and Environmental Risks**

***We are subject to extensive government regulations, and failure to obtain approvals could prevent commercialization.***

Fusion development requires approvals from the U.S. Department of Energy (DOE), Nuclear Regulatory Commission (NRC), and Environmental Protection Agency (EPA), including export controls under the Atomic Energy Act. Our Texatron™ may need NRC licensing for demonstration plants, environmental impact assessments, and compliance with IAEA standards for international expansion. Regulatory processes are lengthy (potentially years), uncertain, and evolving—changes in fusion guidelines or policy (e.g., under the ADVANCE Act) could delay us. Non-compliance risks fines, shutdowns, or bans.

***Environmental, health, and safety risks could impact operations and public perception.***

Although aneutronic fusion produces minimal radiation, our prototypes involve high-energy plasma and magnetic fields, posing risks of electromagnetic interference, material failures, or accidents. Public opposition to nuclear technologies (including fusion) could lead to protests, litigation, or permitting denials. Climate-related regulations (e.g., IRA incentives) may benefit us but could change unfavorably.

***Fusion-specific regulatory frameworks are evolving and uncertain.***

The NRC and DOE have limited precedent for regulating commercial fusion (as opposed to fission). Emerging guidelines (e.g., under the ADVANCE Act or DOE fusion programs) could impose unexpected requirements, timelines, or costs. Changes in federal fusion policy or funding priorities could adversely affect us.

***We may be subject to export control and national security restrictions.***

Our technology involves sensitive plasma physics and magnetic confinement know-how that may be classified as dual-use or subject to ITAR/EAR export controls. Restrictions on international collaboration, sales, or technology transfer could limit our global deployment strategy.

***Environmental permitting and public opposition could delay or prevent deployments.***

Even with low radiation output, siting Texatron™ units near customers (e.g., data centers) may require environmental impact statements under NEPA. Public or community opposition to fusion (due to nuclear associations) could result in local zoning denials or delays.

***Changes in energy and climate policies could adversely affect our business.***

We depend on favorable policies like the Inflation Reduction Act (IRA) incentives for clean energy and fusion funding. Repeals, modifications, or delays in these programs (e.g., 45Q carbon credits or DOE grants) could reduce our access to subsidies, increase costs, or diminish market demand for fusion technologies.

***We face risks related to environmental, social, and governance (ESG) expectations.***

Investors and regulators increasingly focus on ESG factors. Our fusion technology aims for low emissions, but perceived environmental impacts (e.g., water use in cooling or rare material mining for helium-3) could lead to negative ratings, boycotts, or additional reporting burdens under SEC climate disclosure rules.

***Compliance with evolving data privacy and security regulations could increase costs.***

As we target data centers and AI applications, we may process sensitive operational data subject to laws like GDPR, CCPA, or emerging AI regulations. Breaches or non-compliance could lead to fines, reputational damage, or restrictions on our technology.

**Market and Competition Risks**

***The fusion energy market is nascent and highly competitive, and we may not achieve market acceptance.***

Fusion remains experimental, with no commercial plants operational. Competitors like TAE Technologies (recently merged with TMTG), Commonwealth Fusion Systems, and international programs (e.g., ITER) have more funding and advanced prototypes. We also face indirect competition from renewables (solar, wind), advanced fission (e.g., microreactors by NNE or Oklo), and fossil fuels. If alternatives advance faster or prove cheaper, demand for our Texatron™ may not materialize. High-profile sector events (e.g., TMTG/TAE merger) increase visibility but intensify competition for talent, funding, and partners.

***Our Power-as-a-Service model is untested and depends on customer adoption.***

We plan to deploy modular Texatron™ units (1–500 MW) for data centers, industry, and defense, but we have no contracts yet. Customers may prefer established energy sources due to fusion's perceived risks or high upfront costs. Energy price volatility, policy changes (e.g., subsidies expiration), or economic downturns could reduce demand.

***We face intense competition from both fusion and non-fusion energy sources.***

In addition to fusion competitors (e.g., TAE Technologies, Commonwealth Fusion Systems, Helion Energy), we compete with established renewables (solar, wind, battery storage), advanced fission (small modular reactors), and traditional baseload sources (natural gas, nuclear fission). Rapid advancements in any of these could reduce demand for fusion-based solutions.

***The AI and data center market may not adopt fusion power as quickly as anticipated.***

While we target hyperscale data centers for their massive baseload needs, customers may prioritize proven technologies or delay adoption until fusion proves reliable at scale. Shifts in AI energy demand or alternative solutions (e.g., onsite fission) could reduce our addressable market.

***Demand for baseload power may be affected by advancements in alternative technologies.***

Rapid progress in energy storage (e.g., advanced batteries), renewables integration, or AI efficiency could reduce the need for fusion-based baseload solutions. If data centers or industries shift to decentralized solar-plus-storage, our targeted markets may shrink.

***Energy policy and incentives are subject to change.***

Our business model relies on favorable energy transition policies (e.g., Inflation Reduction Act credits, carbon pricing, or DOE fusion funding). Repeal or modification of these incentives could reduce customer interest or our economic viability.

***Geopolitical events could disrupt our fuel supply and international expansion.***

Helium-3 sourcing may be impacted by international trade tensions or conflicts affecting tritium production or rare isotope markets. Restrictions on technology exports (e.g., to China or Russia) could limit our global deployment plans, increasing costs or excluding key markets.

**Financial and Operational Risks**

***We require substantial additional capital, and we may not be able to obtain it on favorable terms.***

We expect to need at least $50 million in 2026 for R&D, testing, and operations, with ongoing requirements thereafter. Our history includes periods of limited liquidity and reporting suspensions. If we cannot raise funds through equity, debt, or grants, we may curtail activities or cease operations. Dilutive financings could harm shareholders, and debt could impose restrictions.

***We rely on key suppliers and may face supply chain disruptions.***

We depend on third-party suppliers for magnets, vacuum systems, and helium-3. Shortages, geopolitical tensions (e.g., rare isotopes), or quality issues could delay development. We have no long-term supply agreements yet.

***Our intellectual property may not adequately protect our technology, or we may infringe others' rights.***

We hold patents on Texatron™ innovations and plan 250+ filings by 2026, but IP protection is uncertain in emerging fusion. Competitors may challenge our patents or develop workarounds. Infringement claims could result in costly litigation or redesigns.

***We depend on key personnel and may not attract or retain talent.***

Our small team of 10 key personal (and 20 planned future engineering staff) includes experts like Dr. John E. Brandenburg (CTO). Loss of key personnel could disrupt R&D. The fusion sector's talent competition may hinder recruitment.

***Our planned $50 million financing may not close on acceptable terms or at all.***

We are planning a $50 million raise in 2026 to fund development. Failure to complete this (or future) financing on favorable terms could force us to scale back R&D, delay milestones, or seek dilutive alternatives.

***We may face challenges in manufacturing and scaling production.***

We currently have no dedicated manufacturing facilities and rely on third-party suppliers. Scaling to produce modular Texatron™ units globally could encounter quality control issues, cost overruns, or delays, particularly given the specialized nature of fusion components.

***We may not be able to obtain insurance adequate to cover our risks.***

The novel nature of fusion technology may make insurance coverage limited, expensive, or unavailable for certain risks (e.g., prototype accidents, IP disputes). Any uninsured losses could be material.

***Inflation and interest rate fluctuations could increase our costs.***

Rising costs for materials, labor, or energy (e.g., due to inflation or high interest rates) could strain our limited resources, particularly for R&D and prototype construction. Our planned financings may become more expensive or unavailable in a high-rate environment.

***Currency exchange rate fluctuations could affect our international operations.***

Our plans for global expansion (e.g., to Africa, India, Middle East) expose us to foreign currency risks. Fluctuations in exchange rates could increase costs for imported components (e.g., helium-3) or reduce the competitiveness of our pricing in foreign markets.

***We may encounter difficulties in managing growth if we scale successfully.***

If we achieve technological breakthroughs, rapid expansion could strain our management, operations, financial controls, and supply chains. Inadequate infrastructure, hiring delays, or integration of new personnel may lead to inefficiencies, quality issues, regulatory non-compliance, or increased vulnerability to operational disruptions.

**Risks Related to Our Corporate Structure and History**

***Our history as a public company and past reporting lapses may attract scrutiny.***

From 2009–2019, we had limited operations and suspended SEC reporting via Form 15 in 2009. The 2020 custodianship and control changes (via preferred share transfers) revived us, but regulators or investors may view us as a former shell, increasing scrutiny. Our OTC status and planned future uplist (NASDAQ/TXSE) depend on meeting requirements.

***The Kepler Fusion merger may present integration risks.***

The December 2025 merger with Kepler Fusion is complete, but integrating operations, IP, and teams could divert resources or cause disruptions. Unforeseen liabilities from Kepler could arise.

***Recent changes in control through preferred stock transfers could lead to governance instability.***

Our history includes multiple transfers of the Special 2020 Series A Preferred Share, which carries majority voting control. The most recent transfer on February 27, 2026, to Earth Sciences Fund I LLC and Brent Nelson further concentrates control. This could result in decisions that do not align with minority shareholder interests, attract regulatory scrutiny, or create uncertainty in our governance structure.

**General Economic and Market Risks**

***Economic conditions could adversely affect us.***

Inflation, interest rate hikes, or recessions may increase costs or reduce financing availability. Geopolitical events (e.g., energy crises) could impact supply chains or demand.

***Cybersecurity threats could harm our operations.***

Our R&D involves sensitive data; breaches could expose IP or cause delays.

**Legal, Governance, and Public Company Risks**

***Our history of control changes and past reporting suspensions may lead to increased scrutiny.***

The 2020 custodianship and preferred share transfers that resulted in current control could attract regulatory or investor attention. Our prior Form 15 termination and limited disclosure period may raise concerns about governance continuity.

***We may be unable to maintain effective internal controls as a public company.***

Upon effectiveness of this Form 10, we will become subject to SOX Section 404 requirements. Our small size and limited resources may result in material weaknesses in internal controls over financial reporting, leading to restatements, penalties, or loss of investor confidence.

***Our common stock may be thinly traded, leading to price volatility.***

Our stock currently trades on OTC Markets with low volume. An uplist to NASDAQ or TXSE is planned but not guaranteed. Thin trading could result in extreme price swings unrelated to fundamentals.

***We may face shareholder litigation or activist pressure.***

As a public company with a development-stage profile and recent merger, we may be subject to securities class actions, derivative suits, or activist campaigns, diverting management attention and incurring costs.

***Our dependence on government grants and partnerships exposes us to additional risks.***

We may seek DOE or other grants for fusion development, but these could include strings (e.g., reporting requirements, IP sharing). Loss of partnerships (e.g., with universities or Trinity Group for data centers) could slow progress.

***We may be subject to anti-corruption and trade compliance laws.***

Our international expansion plans (e.g., to Africa, India, Middle East) expose us to laws like the Foreign Corrupt Practices Act (FCPA) and U.S. trade sanctions. Violations could result in severe penalties, investigations, or business restrictions.

***Insider transactions and related-party dealings could create conflicts.***

Our history includes related-party loans and control changes. Future transactions with affiliates (e.g., CEO Hawkins) may raise conflict concerns, requiring disclosure and potentially leading to shareholder challenges or regulatory scrutiny.

**Risks Related to Our Common Stock and Being a Public Company**

***Our common stock is thinly traded and subject to price volatility.***

Our common stock currently trades on the OTC Markets with limited volume and liquidity. As a result, relatively small sales or purchases can disproportionately affect the price, leading to extreme volatility. Factors unrelated to our performance (e.g., market sentiment toward fusion energy, macroeconomic conditions, or news about competitors like TAE Technologies) could cause significant price swings. There is no assurance that an active trading market will develop or be sustained, particularly prior to any uplist to NASDAQ or the Texas Stock Exchange (TXSE).

***Future sales of our common stock or securities convertible into common stock could cause the market price to decline.***

We may issue additional shares of common stock or securities convertible into or exercisable for common stock (e.g., in connection with financings, debt settlements, employee compensation, or acquisitions) to raise capital or incentivize personnel. Such issuances, including from existing warrants, options, or convertible instruments, could dilute existing shareholders and depress the market price of our common stock.

***We may not be able to maintain the listing of our common stock on a national securities exchange if we uplist.***

We intend to apply for listing on NASDAQ or the Texas Stock Exchange (TXSE) following the effectiveness of this registration statement. However, we may not meet initial listing standards (e.g., minimum bid price, shareholders' equity, or public float requirements) or maintain compliance thereafter. Failure to uplist or a subsequent delisting could reduce liquidity, impair investor confidence, and limit our access to capital markets.

***We have a relatively small public float and may be subject to "penny stock" rules if we fail to uplist.***

If we remain quoted on the OTC Markets, our common stock could be considered a "penny stock" under SEC rules if the price falls below $5.00 per share (or if we otherwise meet the definition). Penny stock rules impose additional disclosure requirements and restrictions on broker-dealers, which could reduce liquidity and make it more difficult for investors to buy or sell our shares.

***There may be limited analyst coverage and institutional interest in our common stock.***

As a small, development-stage company in an emerging sector, we may receive limited coverage from securities analysts. Lack of analyst reports or institutional ownership could reduce visibility, trading volume, and demand for our stock, contributing to price volatility.

***We will incur increased costs and demands on management as a result of becoming a public company.***

Upon the effectiveness of this Form 10, we will become subject to the full reporting requirements of the Exchange Act, including annual and quarterly reports, proxy statements, and compliance with Sarbanes-Oxley Act (SOX) Section 404 internal controls. These obligations will increase legal, accounting, insurance, and administrative expenses and divert management attention from business operations. Our limited resources and small team may make compliance challenging.

***We may fail to maintain effective internal controls over financial reporting.***

As a public company, we will be required to evaluate and maintain effective internal controls under SOX Section 404. Our small size and limited accounting resources may result in material weaknesses or significant deficiencies. Any failure to remediate could lead to restatements, regulatory sanctions, loss of investor confidence, or difficulty accessing capital.

***Provisions in our certificate of incorporation and bylaws may discourage takeovers.***

Our governing documents may include provisions (e.g., staggered board, supermajority voting for certain actions) that could delay or prevent a change in control, even if beneficial to shareholders. These anti-takeover measures could depress our stock price or deter acquisition offers.

***We do not intend to pay dividends in the foreseeable future.***

We have never paid cash dividends and do not anticipate paying any in the near term, as we intend to retain earnings (if any) for R&D and growth. Investors seeking dividends may find our stock less attractive.

***Our executive officers and directors have significant control over the Company.***

Our executive officers and directors beneficially own a substantial portion of our voting stock (including through prior control changes). This concentration could influence corporate actions (e.g., mergers, executive compensation) in ways that are not aligned with minority shareholders' interests.

***Our common stock is currently limited to unsolicited quotations on OTC Markets, and we must complete a broker-dealer review under SEC Rule 15c2-11 to restore full quotation eligibility, which could adversely affect trading liquidity.***

<br> Our common stock is currently quoted on OTC Markets; however, it is designated as eligible for unsolicited quotations only. This means no broker-dealer has completed the initial information review required under Rule 15c2-11 of the Securities Exchange Act of 1934 to publish proprietary quotations or provide continuous market making in our shares. As a result, all existing quotations reflect unsolicited customer orders only, which typically results in wider bid-ask spreads, increased price volatility, and limited trading liquidity. A sponsoring broker-dealer must file a Form 211 with FINRA and complete the requisite review of our issuer information under Rule 15c2-11 before competing quotations can be published and continuous market making can commence. If we are unable to secure a sponsoring broker-dealer, or if the Form 211 review process is delayed or denied due to incomplete disclosures, regulatory review, or other factors, our common stock will remain in unsolicited-only status, and investors may continue to face significant difficulty buying or selling shares at favorable prices. This limited trading environment could harm our ability to attract capital, maintain market visibility, and could result in price declines that do not reflect the underlying value of our business.

**Forward-Looking Statements**

The risks described above are not exhaustive. New risks may emerge, and our business, financial condition, results of operations, and prospects could be materially and adversely affected by any of these or other risks. We may identify additional risks in future filings. See also "Forward-Looking Statements" in Item 1.

**ITEM 1B. Unresolved Staff Comments**

Not Applicable

**ITEM 1C. Cybersecurity**

We recognize the critical importance of safeguarding our systems and data, particularly given our focus on proprietary fusion energy technology and intellectual property. Cybersecurity risks could include unauthorized access, data breaches, ransomware, or other disruptions that could compromise our R&D efforts, prototype testing data, trade secrets, or operational systems.

**Risk Management and Strategy**

Our cybersecurity risk management processes are managed by our executive management team (currently our Chief Executive Officer, with support from consultants and third-party IT providers). These processes include:

* Regular
monitoring of network activity and system logs.

* Use
of firewalls, antivirus software, and access controls.

* Employee
training on phishing and data security best practices.

* Backup
and recovery procedures for critical data.

We have not yet established a formal cybersecurity committee of the Board (due to our small size and single-director structure), but cybersecurity is reviewed as part of overall risk oversight by our Board of Directors (currently consisting solely of our Chief Executive Officer).

**Governance**

Our Chief Executive Officer is responsible for overseeing cybersecurity risks and receives periodic updates on threats, incidents, and mitigation efforts. Significant cybersecurity matters are escalated to the full Board as needed.

**Cybersecurity Incidents<br>** 

<br> To date, we have not experienced any material cybersecurity incidents that have had, or are reasonably likely to have, a material adverse effect on our business, financial condition, or results of operations.

We continue to evaluate and enhance our cybersecurity measures as our operations expand and technology risks evolve.

**Item 1D. [Reserved]** 

**ITEM 2. Properties**

We do not own any real property. Our principal executive offices are located at 8 The Green, Suite #12401, Dover, DE 19901, which we lease on a month-to-month basis. This space is used primarily for administrative purposes.

We also lease R&D and prototype testing facilities in Midland, Texas, which we use for development and testing of our Texatron™ fusion energy platform, including the Version 9 prototype. The Texas facility was leased under a short-term agreement and provides sufficient space for our current experimental and engineering activities as we look for a new facility in North Fort Worth, Texas.

We believe that our current facilities are adequate for our present needs and that additional space can be obtained on commercially reasonable terms as needed to accommodate future growth and expansion of our operations.

These leased properties are subject to standard commercial lease terms, including rent escalations and maintenance obligations. We do not anticipate any material difficulties in renewing or replacing these leases when they expire.

**ITEM 3. Legal Proceedings**

The Company is currently pursuing legal proceedings in the Superior Court of the State of Washington, King County, relating to the cancellation of shares issued in connection with transactions that were never consummated.

In 2021, the Company entered into asset purchase agreements with certain third parties who represented that they owned operating businesses and intellectual property assets. In reliance on those representations and in anticipation of closing, the Company issued shares of its common stock at the direction of those counterparties to individuals designated by them.

The required closing deliverables, including the transfer of intellectual property, regulatory rights, operational documentation, and other assets contemplated by the agreements, were never delivered. As a result, the transactions did not close and the Company received no consideration for the shares that had been issued in anticipation of those transactions.

Because the shares were issued prior to completion of the contemplated closings, those shares remain reflected on the Company's shareholder ledger despite the failure of the underlying transactions. The Company's transfer agent has advised that cancellation of the affected shares requires a court order authorizing removal of the shares from the Company's shareholder records.

Accordingly, the Company initiated legal proceedings seeking judicial cancellation of the shares issued in connection with those failed transactions and confirmation that no party associated with those transactions has any legal or equitable interest in the Company's stock.

The shares issued in connection with the failed transactions consisted solely of common stock and did not involve the Company's Series A Preferred Stock or any securities currently used in the Company's governance structure.

Justin Costello, an individual identified as a shareholder in historical disclosures, was initially named in the action because he was associated with shares issued at the direction of one of the counterparties to the failed transactions. Mr. Costello is not an officer, director, or control person of the Company and has no involvement in the Company's management or operations. The Company filed a motion to dismiss Mr. Costello from the action on January 7, 2026, and the Court subsequently entered an order on February 26, 2026 dismissing all claims against Mr. Costello without prejudice.

The Company notes that Mr. Costello has been named as a defendant in an unrelated enforcement action brought by the Securities and Exchange Commission. The Company is not a party to that matter, and the events described in that enforcement action do not involve the Company's current management, operations, governance, or capitalization.

The Company continues to pursue relief against the remaining parties associated with the failed transactions in order to obtain a judicial order authorizing cancellation of the improperly issued shares and permitting the Company's transfer agent to correct the Company's shareholder ledger.

The shares associated with the failed transactions are currently subject to administrative restrictions with the Company's transfer agent and are not transferable.

**ITEM 4. Mine and Safety Disclosure**

Not applicable.

**PART II**

**ITEM 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities**

**Market Information**

Our common stock is currently quoted on the OTC Markets Group under the symbol "RNWF." There is no established public trading market for our common stock on a national securities exchange. Trading on the OTC Markets is limited and subject to the risks associated with over-the-counter securities, including low liquidity and potential volatility. The OTC quotation is limited and sporadic, and there can be no assurance that a more active trading market will develop or be sustained in the future.

The following table sets forth the high and low bid prices for our common stock for the periods indicated, as reported by the OTC Markets Group. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission, and may not necessarily represent actual transactions.

**Fiscal Year Ended December 31, 2025** 

* First
Quarter: High $0.00, Low $0.00

* Second
Quarter: High $0.0001, Low $0.0001

* Third
Quarter: High $0.0003, Low $0.0003

* Fourth
Quarter: High $0.041, Low $0.028

**Fiscal Year Ended December 31, 2024** 

* First
Quarter: High $0.00, Low $0.00

* Second
Quarter: High $0.00, Low $0.00

* Third
Quarter: High $0.00, Low $0.00

* Fourth
Quarter: High $0.00, Low $0.00

**Holders of Record**

As of March 16, 2026, there were approximately 145 holders of record of our common stock. The number of beneficial owners is likely significantly greater due to shares held in street name by brokers and other nominees.

**Dividend Policy**

We have never declared or paid any cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future. We currently intend to retain any future earnings to fund the development and growth of our business, including research and development of the Texatron™ platform. Any future determination to declare cash dividends will be made at the discretion of our Board of Directors and will depend on our financial condition, results of operations, capital requirements, general business conditions, and other factors that our Board of Directors may deem relevant.

**Recent Sales of Unregistered Securities**

During the period from January 1, 2024 through the date of this registration statement, the Company issued an aggregate of 329,739,715 shares of its common stock to consultants and professional service providers as compensation for services rendered to the Company, including strategic advisory, corporate development, legal services, and other operational support.

These issuances were made in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, as transactions not involving a public offering. The recipients represented that they were acquiring the securities for investment purposes and not with a view toward distribution.

The shares were issued with appropriate restrictive legends in accordance with the Securities Act. No underwriters, placement agents, or finders were used in connection with these issuances, and no underwriting discounts or commissions were paid.

 **Equity Compensation Plans**

We do not currently have any equity compensation plans under which equity securities are authorized for issuance. Any future equity incentive plans will be disclosed in subsequent filings.

**Issuer Purchases of Equity Securities**

We did not repurchase any shares of our common stock during the periods covered by this registration statement.

**ITEM 6. [Reserved]**

In accordance with the rules and regulations of the Securities and Exchange Commission, Item 6 has been reserved and is not applicable to this registration statement.

**ITEM 7. Management's Discussion and Analysis of Financial Condition and Results of Operations**

 

*The following discussion should be read in conjunction with our consolidated financial statements and the related notes contained elsewhere in this Report and in our other Securities and Exchange Commission filings. The following discussion may contain predictions, estimates, and other forward-looking statements that involve a number of risks and uncertainties, including those discussed under "Risk Factors" and elsewhere in this Report. These risks could cause our actual results to differ materially from any future performance suggested below.*

**Overview**

Renewal Fuels, Inc. is a public company that historically maintained limited operations while pursuing strategic transactions intended to establish an operating business. During the periods presented, the Company's activities consisted primarily of maintaining its corporate structure, addressing legacy liabilities, and pursuing strategic initiatives intended to transition the Company into an operating technology business.

On December 16, 2025, the Company entered into a Master Sales Agreement and Share Exchange Agreement in connection with a planned reverse acquisition involving Kepler Fusion Technologies Inc. The agreements contemplated the acquisition of 100% of the issued and outstanding equity of Kepler in exchange for newly issued shares of the Company's common stock.

The transaction did not close prior to December 31, 2025, because certain closing mechanics had not yet been satisfied as of year end. The transaction subsequently closed on February 27, 2026, at which time Kepler became a wholly owned subsidiary of the Company on February 27, 2026.

For financial reporting purposes, the transaction will be accounted for as a reverse acquisition under ASC Topic 805. Although Renewal Fuels, Inc. is the legal acquirer, Kepler is considered the accounting acquirer because Kepler's shareholders obtained a controlling voting interest in the combined entity and Kepler's management will control the ongoing operations.

Because the transaction closed after December 31, 2025, the financial statements included in this report do not reflect Kepler's assets, liabilities, or operations. Future financial statements will reflect Kepler as the accounting predecessor entity.

Preliminary valuation analysis prepared by Rockport Valuation LLC indicates an estimated transaction value of approximately $50.3 million based on the public market value of the Company's shares and liabilities assumed as of the acquisition date. The purchase price allocation remains preliminary and is subject to further analysis and adjustment during the measurement period permitted under ASC Topic 805.

**Results of Operations**

The Company generated no operating revenue during the years ended December 31, 2025 and December 31, 2024. Activities during these periods were limited primarily to corporate administration, legal expenses, consulting costs, and costs associated with the negotiation and execution of the Kepler Fusion business combination.

Operating expenses consisted primarily of professional fees, consulting expenses, and general administrative costs necessary to maintain the Company's public reporting status and pursue strategic transactions.

The Company recorded recurring operating losses during the periods presented and had an accumulated deficit of approximately $20.3 million as of December 31, 2025.

**Liquidity and Capital Resources**

Historically, the Company has financed its operations through advances from related parties and the issuance of convertible promissory notes. As of December 31, 2025, the Company had notes payable to related parties totaling approximately $473,523.

The Company also had an accumulated deficit of approximately $20.3 million as of December 31, 2025 and has historically generated operating losses. As a result, the Company has relied on external financing to fund its operations.

Management believes the successful completion of the Kepler Fusion transaction on February 27, 2026 provides a pathway toward establishing operating activities. However, the Company will require additional capital to fund development of Kepler's technology platform and to support ongoing operations.

There can be no assurance that additional financing will be available on acceptable terms, or at all.

Based on preliminary valuation analysis, the business combination may result in the recognition of significant intangible assets and goodwill once the purchase price allocation process is completed.

**Critical Accounting Policies and Estimates**

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.

Significant accounting policies are described in the notes to the consolidated financial statements included elsewhere in this report. Management believes the following accounting policies involve the most significant judgments and estimates:

**Business Combination Accounting**

The consummated business combination with Kepler Fusion Technologies Inc. will be accounted for as a reverse acquisition under ASC Topic 805. Determining the accounting acquirer and the fair value of identifiable assets and liabilities acquired will require significant management judgment and valuation analysis.

**Going Concern**

The Company's financial statements have been prepared assuming it will continue as a going concern. As discussed in the notes to the financial statements, the Company has incurred recurring losses and has an accumulated deficit, which raises substantial doubt about its ability to continue as a going concern.

**Stock Based Compensation**

The Company periodically issues equity securities to consultants and service providers in consideration for services rendered. These issuances are measured based on the fair value of the equity instruments issued on the grant date.

**Forward-Looking Statements**

This section contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results could differ materially due to risks described in Item 1A. These statements are based on our current expectations and are subject to risks and uncertainties, including those discussed in Item 1A. Risk Factors.

**ITEM 7A. Quantitative and Qualitative Disclosure About Market Risk**

As a "smaller reporting company" we are not required to provide information required by this Item. We do not currently have any material exposure to market risk, including interest rate risk, foreign currency exchange rate risk, commodity price risk, or equity price risk. As we advance our research and development activities and begin to generate revenue or hold financial instruments in the future, we may become subject to such risks, which could materially affect our financial condition and results of operations.

**ITEM 8. Financial Statements and Supplementary Data**

The financial statements required by this Item are set forth at the end of this registration statement beginning on page F-1.

**ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure**

None.

On December 17, 2025, the Company engaged JVCPA, P.C., an independent registered public accounting firm, to audit the Company's consolidated financial statements for the fiscal years ended December 31, 2025 and 2024. The engagement includes the audit of the Company's consolidated balance sheets as of December 31, 2025 and 2024 and the related statements of operations, changes in stockholders' equity, and cash flows for the years then ended, together with the related notes to the consolidated financial statements.

Prior to the engagement of JVCPA, P.C., the Company did not have an independent registered public accounting firm engaged to audit its financial statements for those periods. The decision to engage JVCPA, P.C. was approved by management and the Company's board of directors.

During the Company's two most recent fiscal years and through the date of engagement, the Company has not had any disagreements with any accountant on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure.

**ITEM 9A. Controls and Procedures**

***Evaluation of Disclosure Controls and Procedures***

Our management, with the participation of our Chief Executive Officer (who serves as our principal executive officer and principal financial officer), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of December 31, 2025. Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Based on this evaluation, our principal executive and principal financial officer concluded that, as of March 16 our disclosure controls and procedures were effective at the reasonable assurance level.

***Management's Report on Internal Controls over Financial Reporting***

This registration statement does not include a report of management's assessment of the effectiveness of our internal control over financial reporting or an attestation report of our registered public accounting firm due to a transition period established by rules of the Securities and Exchange Commission for newly public companies. As a non-accelerated filer and smaller reporting company, we are exempt from the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act.

As a non-accelerated filer and smaller reporting company, we are not currently required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002. However, pursuant to Section 404(a), management is responsible for establishing and maintaining adequate internal control over financial reporting. Management will perform its first annual assessment of the effectiveness of internal control over financial reporting for the fiscal year ending December 31, 2026 (or the first full fiscal year after the effectiveness of this registration statement), and such assessment will be included in our Annual Report on Form 10-K for that year.

***Changes in Internal Control over Financial Reporting***

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

***Inherent Limitations on Internal Controls***

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness for future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. No evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.

**ITEM 9B. Other Information**

None.

We have no information to report under this Item 9B that has not otherwise been disclosed in this registration statement or in our other filings with the Securities and Exchange Commission.

**ITEM 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections**

Not Applicable.

**PART III**

**ITEM 10. Directors, Executive Officers and Corporate Governance**

The following table sets forth information regarding our current executive officers and directors as of the date of this registration statement:

---

| | | |
|:---|:---|:---|
| **Name** | **Age** | **Position** |
| Richard Hawkins | 62 | Chief Executive Officer, Chairman & Secretary |
| Michael G. Smith | 65 | Chief Legal Officer & Director |
| Dewight L. Cartwright | 73 | Chief Operating Officer |
| Sebastian E. Hoyos | 38 | Chief Revenue Officer |
| Brent Nelson | 64 | Director |
| Fabrice David | 46 | Independent Director |
| Andrew S. Mikulski | 34 | Independent Director |

---

**Biographies of Executive Officers and Directors**

***Richard Hawkins****<br>* 

<br> Mr. Hawkins has served as our Chief Executive Officer, President, Secretary, Treasurer, and sole director since August 6, 2020. He has been instrumental in the Company's transition from a dormant entity to its current focus on advanced fusion energy technology through the merger with Kepler Fusion Technologies Inc. in December 2025. Prior to assuming control in 2020, Mr. Hawkins was involved in various business ventures, including Prior to assuming control of the Company in 2020, Mr. Hawkins was active in infrastructure-focused entrepreneurship, public company restructurings, and advanced communications initiatives. He has served as a technical consultant to the WiMAX Forum, contributing to standards development efforts related to next-generation wireless and aviation communication systems, including AeroMACS surface communications architecture for airport environments. He has also been involved in energy-adjacent infrastructure strategy, including Smart Grid communications integration, distributed systems planning, and capital structuring for early-stage technology ventures. Mr. Hawkins has led multiple public company reorganizations, reverse mergers, and capital formation initiatives, with a focus on repositioning legacy issuers into emerging technology sectors. He holds responsibility for the overall strategic direction, operations, and corporate governance of the Company.

***Michael G. Smith***

Michael G. Smith serves as Chief Legal Officer of Kepler Fusion Technologies Inc. and brings more than two decades of experience in intellectual property law, advanced technology development, and complex federal litigation. Mr. Smith holds a J.D. from Capital University Law School and an M.B.A., and has drafted and prosecuted over 200 patent applications across a broad range of technologies, including aerospace systems, rocket propulsion, medical devices, software, and advanced energy systems. He has prior experience with leading technology-focused law firms and has represented clients in federal courts, including matters before the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit. Mr. Smith has also supervised global patent prosecution efforts and advised on intellectual property strategy, licensing, and corporate transactions. At Kepler, he oversees all legal affairs, intellectual property development, and regulatory strategy. Mr. Smith serves as Chief Legal Officer of the Company and as a member of the Board of Directors.

***Dewight Cartwright***

Dewight L. Cartwright serves as Chief Operating Officer of Kepler Fusion Technologies Inc. and brings more than four decades of experience in large-scale construction, infrastructure development, and government-contracted engineering projects. Mr. Cartwright has founded and led multiple construction and underground utility companies, overseeing complex civil, industrial, and federally contracted projects, including work performed for the U.S. Army Corps of Engineers and other government agencies. Since joining Kepler in 2018, he has been responsible for operational execution, facility development, fabrication, testing, and manufacturing oversight of the Company's advanced energy and aerospace technologies, including the Texatron™ fusion platform. His experience spans project management, safety compliance, contractor coordination, and deployment readiness, supporting the Company's transition from research and development to scalable commercial operations. Mr. Cartwright serves as an executive officer of the Company but is not a director.

***Brent Nelson***

Brent Nelson serves as Chief Executive Officer of Kepler Fusion Technologies Inc. and is responsible for the Company's strategic direction, corporate development, and commercialization of its advanced fusion energy technologies. Mr. Nelson has more than 30 years of experience in technology development, entrepreneurship, and capital markets, having founded and led multiple companies across energy, aerospace, and advanced technology sectors. Throughout his career, he has overseen intellectual property development, product commercialization, and strategic transactions involving emerging technologies. At Kepler, Mr. Nelson leads the advancement of the Texatron™ aneutronic compact fusion platform, corporate financing initiatives, intellectual property strategy, and public market positioning as the Company transitions toward infrastructure-scale energy deployment. Mr. Nelson serves as a member of the Board of Directors but is not an executive officer of the Company.

***Sebastian E. Hoyos***

Sebastian E. Hoyos serves as Chief Revenue Officer of the Company and is responsible for developing the Company's commercial strategy and revenue generation initiatives related to the deployment of its advanced energy technologies. Mr. Hoyos is a senior energy markets executive with more than 15 years of experience originating, structuring, negotiating, and executing complex energy transactions across regulated and deregulated markets in the United States and internationally. He has negotiated and originated more than 200 commercial and industrial solar and storage contracts, structured utility-scale solar and wind power purchase agreements, and held senior roles with Diverxia, ENGIE Impact, Walmart, Hospital Energy LLC, and Duke Energy where he worked on renewable procurement, energy market strategy, and long-term energy contract development. Mr. Hoyos holds an MBA with a concentration in Finance from East Carolina University and a Bachelor of Science in Electrical Engineering from the University of North Carolina at Charlotte. Mr. Hoyos serves as an executive officer of the Company but is not a director.

***Fabrice David***

Fabrice David serves as an Independent Director of the Company. Mr. David is an independent scientific researcher, inventor, and strategic advisor with more than 20 years of experience in fusion-related energy science, advanced nuclear phenomena, and experimental power technologies. He has authored or co-authored more than 130 scientific publications and holds numerous patents spanning advanced energy systems, applied nuclear science, and experimental physics. Mr. David previously served as a partner and board member of DEUO Dynamics in the United Kingdom where he participated in strategic oversight of fusion and advanced energy research initiatives and also founded and operated a photovoltaic solar distribution business focused on renewable energy commercialization. He holds Bachelor's and Master's degrees in Biochemistry from Paris-Sorbonne University. Mr. David serves as a director of the Company but is not an executive officer.

***Andrew S. Mikulski***

Andrew S. Mikulski serves as an Independent Director of the Company. Mr. Mikulski is an electrical engineer and advanced electronics industry professional with expertise in power electronics, magnetics, sensors, actuators, and high-reliability electrical systems used across aerospace, defense, industrial, and energy infrastructure applications. He currently serves as Product Manager for Magnetics, Sensors and Actuators at KEMET Electronics Corporation, a subsidiary of Yageo Corporation, where he provides technical and commercial leadership for electromagnetic component technologies used in power conversion systems, sensing platforms, and advanced electrical architectures. Earlier in his career he served as an electrical engineer at Textron Systems and also held engineering roles with Lumenpulse Lighting and Communication & Power Industries. Mr. Mikulski holds a Bachelor of Science in Electrical Engineering from Northeastern University with a minor in Business Administration. Mr. Mikulski serves as a director of the Company but is not an executive officer.

**Family Relationships**

There are no family relationships between or among any of the current directors, executive officers or persons nominated or charged to become directors or executive officers. We do not have any arrangements or understandings pursuant to which our directors were selected as directors.

**Involvement in Certain Legal Proceedings**

During the past ten years, none of our directors or executive officers has been involved in any of the following events that would require disclosure under Item 401(f) of Regulation S-K:

* A
petition under the federal bankruptcy laws or any state insolvency law was filed by or against, or a receiver, fiscal agent or similar
officer was appointed by a court for the business or property of such person, or any partnership in which he was a general partner at
or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at
or within two years before the time of such filing.

* Such
person was convicted in a criminal proceeding or is a subject of a pending criminal proceeding (excluding traffic violations and other
minor offenses).

* Such
person was the subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent
jurisdiction, permanently or temporarily enjoining him from, or otherwise limiting, the following activities: (i) acting as a futures
commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant,
any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment
adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank,
savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;
(ii) engaging in any type of business practice; or (iii) engaging in any activity in connection with the purchase or sale of any security
or commodity or in connection with any violation of federal or state securities laws or federal commodities laws.

* Such
person was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority
barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in (i) above,
or to be associated with persons engaged in any such activity.

* Such
person was found by a court of competent jurisdiction in a civil action or by the SEC to have violated a federal or state securities
law, and the judgment has not been reversed, suspended, or vacated.

* Such
person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated
any federal commodities law, and the judgment has not been subsequently reversed, suspended or vacated.

**Code of Ethics**

We have not yet adopted a formal code of ethics applicable to our principal executive officer, principal financial officer, principal accounting officer, or persons performing similar functions. Given our small size and current stage of development, we believe it is not yet practical to adopt such a code. We intend to adopt a code of ethics as our operations grow and become more complex.

**Director Terms**<br>

Directors are elected at the annual meeting of stockholders and hold office until their successors are elected and qualified, or until their earlier death, resignation, or removal. Our Board of Directors currently consists of one director, and we have no classified or staggered board structure.

**Section 16(a) Beneficial Ownership Reporting Compliance**

Section 16(a) of the Securities Exchange Act of 1934 requires our officers, directors, and persons who own more than ten percent of a registered class of our equity securities to file reports of ownership and changes in ownership with the Securities and Exchange Commission. To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations from certain reporting persons, no such reports were required to be filed during the fiscal year ended December 31, 2025, as we were not subject to the reporting requirements of Section 16(a) prior to the effectiveness of this registration statement.

**ITEM 11. Executive Compensation**

As a smaller reporting company, we have elected to comply with the scaled disclosure requirements of Regulation S-K Items 402(m)–(r).

The following table sets forth the compensation awarded to, earned by, or paid to our named executive officer(s) for the fiscal years ended December 31, 2025 and 2024 (or such shorter period as applicable):

**Summary Compensation Table**

The following table presents the compensation awarded to or earned by or paid to our named executive officers during the fiscal years ended December 31, 2025 and 2024.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and**<br> **Principal Position** | **Year** | **Salary<br> ($)** | **Bonus<br> ($)** | **Option<br> Awards<br> ($)** | **Non-Equity<br> Incentive Plan<br> Compensation<br> ($)** | **Nonqualified<br> Deferred<br> Compensation<br> Earnings<br> ($)** | **All Other<br> Compensation<br> ($)** | **Total<br> ($)** |
| ***Richard Hawkins*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;*Chief Executive Officer* | 2025 | $50000 |  | $— |  |  | $— | $50000 |
| ***Richard Hawkins*** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;*Chief Executive Officer* | 2024 | $45000 |  | $— |  |  | $— | $45000 |

---

**Narrative Disclosure**<br>

During the fiscal years presented, compensation for Richard Hawkins, the Company's Chief Executive Officer and sole director during the applicable periods, consisted of accrued cash compensation for services rendered. Such compensation has not been paid in cash and is recorded as a liability of the Company pursuant to promissory notes issued to an affiliated consulting entity controlled by Mr. Hawkins. The notes reflect principal amounts only and do not bear interest.

For the fiscal year ended December 31, 2025, the Company accrued $50,000 in compensation for Mr. Hawkins. For the fiscal year ended December 31, 2024, the Company accrued $45,000 in compensation for Mr. Hawkins. These amounts represent compensation earned for executive management, governance oversight, regulatory compliance, and public company reporting responsibilities. Because the promissory notes evidencing this accrued compensation are payable to an entity controlled by Mr. Hawkins, the arrangements constitute related party transactions

Except as described above, the Company has not granted any stock awards, option awards, or non-equity incentive compensation to any executive officer or director. No perquisites, benefits, or other compensation were provided during the periods presented.

**Outstanding Equity Awards at Fiscal Year-End**

No executive officer held any outstanding equity awards as of the end of the most recent fiscal year.

**Director Compensation**

The Company has not adopted a formal director compensation program. During the fiscal years presented, Mr. Hawkins did not receive any separate compensation for his service as a director.

The Company currently has independent directors; however, none of the directors have received compensation for their service as directors as of the date of this registration statement. Any future director compensation will be determined by the Board of Directors based on the Company's financial condition, market practices, and other relevant considerations.

**ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters**

The following table sets forth information regarding the beneficial ownership of our common stock as of March 611 2026, by:

* Each
person (or group of affiliated persons) known to us to beneficially own more than 5% of our outstanding common stock;

* Each
of our directors and named executive officers; and

* All
of our directors and executive officers as a group.

Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options or warrants currently exercisable or convertible, or exercisable or convertible within 60 days of March 6, 2026, are deemed outstanding for computing the percentage ownership of the person holding such securities but are not deemed outstanding for computing the percentage ownership of any other person.

**Security Ownership Table** 

---

| | | |
|:---|:---|:---|
| | **Shares of common stock<br> Beneficially Owned** | **Shares of common stock<br> Beneficially Owned** |
| <br>**Name and Address of Beneficial Owner <sup>(1)</sup>** | **Number** | **Percentage <sup>(2)</sup>** |
| **Executive Officers, Directors and Director Nominees** |  |  |
| Richard Hawkins <sub>(4)</sub> | 120000000 | 4.06% |
| Michael G. Smith |  | 0% |
| Dewight Cartwright |  | 0% |
| Sebastian E. Hoyos |  | 0% |
| Fabrice David |  | 0% |
| Andrew S. Mikulski |  | 0% |
| Brent Nelson <sup>(5)</sup> |  | 0% (but majority control via preferred |
| **All directors and executive officers as a group (7 persons)** | 120000000 \* | 4.06% |
| **5% or Greater Stockholders** |  |  |
| Justin Costello <sub>(3)</sub> | 1753000000 | 59.3% |
| Brent Nelson / Earth Sciences Fund I LLC — see table above and footnote (5) for details on preferred share voting control. |  |  |

---

\* Less than 1%.

(1) Except as otherwise indicated, the business address of our directors and executive officers is c/o Renewal Fuels, Inc. 401 North Carroll Avenue, Suite 192, Southlake, Texas 76092.

(2) Based on 2,954,801,029 shares of common stock outstanding as of March 16, 2026.

(3) Based on information available to the Company, Mr. Costello holds of record 1,753,000,000 shares of the Company's common stock. The address of Mr. Costello is Lompoc Federal Correctional Complex, Lompoc, California. These shares are currently subject to administrative hold and are the subject of legal proceedings described under "Legal Proceedings" in this registration statement.

(4) Mr. Hawkins previously held the Special 2020 Series A Preferred Share, which carries majority voting control of the Company, as described in Item 1. Business – Corporate History. This share was transferred on February 27, 2026, to Earth Sciences Fund I LLC, as described in footnote (5). The address for Richard Hawkins is c/o Renewal Fuels, Inc., 401 N Carroll Ave., Ste. 192, Southlake, TX 76092.

(5) Brent Nelson, through Earth Sciences Fund I LLC (an entity owned by him), holds the Special 2020 Series A Preferred Share, which carries super-voting rights sufficient to control stockholder matters, as transferred on February 27, 2026. This share does not represent common stock ownership but provides majority voting power. The address for Brent Nelson and Earth Sciences Fund I LLC is c/o Renewal Fuels, Inc., 401 N Carroll Ave., Ste. 192, Southlake, TX 76092.

**Note on Form of Securities**: Our common stock is issued in book-entry form through our transfer agent, Clear Trust, LLC, and is not represented by physical certificates. Beneficial owners hold shares through brokerage accounts or nominees, with transfers recorded electronically.

**Equity Compensation Plan Information<br>** 

<br> We do not have any equity compensation plans under which equity securities are authorized for issuance. Therefore, the table required by Item 201(d) of Regulation S-K is not applicable.

The information in this table is based on 2,954,801,029 shares of common stock outstanding as of February 12, 2026. Percentages are calculated assuming no exercise of options or warrants, as none are outstanding.

**Changes in Control**

We are not aware of any arrangements the operation of which may at a subsequent date result in a change in control of the Company, other than the preferred share transfers described in the footnotes above.

**ITEM 13. Certain Relationships and Related Transactions, and Director Independence**

**Related Party Transactions**

During the past two fiscal years and through the date of this registration statement, there have been no transactions, and there are no proposed transactions, in which we were or are to be a participant and the amount involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years, and in which any related person had or will have a direct or indirect material interest, except as follows:

&nbsp;&nbsp;&nbsp;&nbsp;• **Accrued Executive Compensation**: As disclosed in Item 11, compensation earned by our Chief Executive
 Officer has been accrued and recorded as a liability pursuant to promissory notes issued
 to an affiliated consulting entity controlled by Mr. Hawkins. These notes reflect principal
 amounts only and do not bear interest. Additional information regarding these arrangements
 is included in the notes to our financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;• **Merger with Kepler Fusion**: The December 2025 business combination with Kepler Fusion Technologies
 Inc. involved the issuance of 240,000,000 common shares to Kepler shareholders closed on
 February 27, 2026, involving the issuance of 240,000,000 common shares to Kepler shareholders.
 No related-party consideration was paid beyond the share issuance to Kepler equity holders.

&nbsp;&nbsp;&nbsp;&nbsp;• **Preferred Share Transfer**: On February 27, 2026, the Special 2020 Series A Preferred Share was transferred
 to Earth Sciences Fund I LLC, an entity owned by Brent Nelson. This transaction resulted
 in a change in voting control but involved no cash consideration or other material terms
 to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;• **Executive Compensation**: As disclosed in Item 11, compensation earned by our Chief Executive Officer
 has been accrued and recorded as a liability pursuant to promissory notes and has not been
 paid in cash.

All related-party transactions have been approved by our Board of Directors and are on terms believed to be no less favorable to us than could be obtained from unaffiliated third parties.

**Policies and Procedures for Related Party Transactions**

We do not currently have a formal written policy or procedure for the review, approval, or ratification of related-party transactions. All such transactions are reviewed and approved by our Board of Directors on a case-by-case basis, considering the nature of the transaction, the related person's interest, and whether the terms are fair and reasonable.

**Director Independence**

Our Board of Directors currently consists of Richard Hawkins, Fabrice David and Andrew S. Mikulski. Mr. Hawkins serves as Chief Executive Officer of the Company and therefore is not considered independent under the independence standards of NASDAQ or the NYSE. The Board has determined that Mr. David and Mr. Mikulski qualify as independent directors under those standards.

As a smaller reporting company, we are not required to maintain a majority of independent directors or to maintain separately designated audit, compensation, or nominating committees.

**ITEM 14. Principal Accounting Fees and Services**

**Principal Accounting Fees**

The following table sets forth the fees billed to us by our independent registered public accounting firm for professional services rendered for the fiscal years ended December 31, 2024 and 2025 (or such shorter period as applicable):

---

| | | |
|:---|:---|:---|
|  | **Year Ended December 31,** | **Year Ended December 31,** |
|  | **2025** | **2024** |
| Audit fees | $8000 | 8000 |
| Audit-related fees | $— | $— |
| Tax fees | $— | $— |
| All other fees | $— | $— |

---

**Pre-Approval Policies**

Our Board of Directors (acting as the audit committee) pre-approves all audit and non-audit services provided by our independent registered public accounting firm. All fees reported above were pre-approved.

JVCPA, Inc. (PCAOB ID 7333) has served as our independent registered public accounting firm since December 17, 2025.

**PART IV**

**ITEM 15. Exhibits and Financial Statements Schedules**

**(a)** **Exhibits** The
 following exhibits are filed as part of this registration statement or incorporated by reference herein:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**<u>Exhibit No.</u>** | &nbsp;&nbsp;**<u>Description</u>** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>Incorporated by Reference</u>** |
| &nbsp;&nbsp;3.1 | &nbsp;&nbsp;[Amended and Restated Certificate of Incorporation of Renewal Fuels, Inc. (as currently in effect)](ex3x1.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;3.2 | &nbsp;&nbsp;[Bylaws of Renewal Fuels, Inc. (as currently in effect)](ex3x2.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.1 | &nbsp;&nbsp;[Master Sales Agreement dated December 16, 2025](ex10x1.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.2 | &nbsp;&nbsp;[Share Exchange Agreement with Kepler Fusion Technologies, Inc. dated December 16, 2025](ex10x2.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.3 | &nbsp;&nbsp;[Stock Purchase Agreement dated December 16, 2025](ex10x3.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.4 | &nbsp;&nbsp;[Consulting Services Agreement between Renewal Fuels, Inc. and Richard Hawkins dated January 1, 2025](ex10x4.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.5 | &nbsp;&nbsp;[Consulting Services Agreement between American Fusion, Inc. and Michael G. Smith dated January 30, 2026](ex10x5.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.6 | &nbsp;&nbsp;[Consulting Services Agreement between American Fusion, Inc. and Dewight L Cartwright dated February 11, 2026](ex10x6.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.7 | &nbsp;&nbsp;[Independent Director Advisory Agreement between American Fusion, Inc. and Fabrice David dated February 23, 2026](ex10x7.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.8 | &nbsp;&nbsp;[Independent Director Advisory Agreement between American Fusion, Inc. and Andrew S. Mikulski dated March 6, 2026](ex10x8.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;10.9 | &nbsp;&nbsp;[Consulting Services Agreement between American Fusion, Inc. and ND Grid Energy Solutions LLC dated March 9, 2026](ex10x9.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;14.1 | &nbsp;&nbsp;Code of Ethics | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not Applicable |
| &nbsp;&nbsp;21.1 | &nbsp;&nbsp;[Subsidiaries of the Registrant: Kepler Fusion Technologies Inc.](ex21x1.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;23.1 | &nbsp;&nbsp;[Consent of JV CPA Inc. independent registered public accounting firm](ex23x1.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;31.1 | &nbsp;&nbsp;[Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31x1.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;31.2 | &nbsp;&nbsp;[Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31x2.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith |
| &nbsp;&nbsp;32.1 | &nbsp;&nbsp;[Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32x2.htm) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Furnished |

---

**(b) Financial Statement Schedules**

All financial statement schedules are omitted because they are not applicable, not required, or the required information is included in the financial statements or notes thereto.

**RENEWAL FUELS, INC.**

**INDEX TO CONSOLIDATED FINANCIAL STATEMENTS**

---

| | |
|:---|:---|
|  | **Page** |
| Reports of Independent Registered Public Accounting Firm (PCAOB ID 7333) | F-2 |
| Consolidated Balance Sheets as of December 31, 2025 and 202<u>4</u> | F-3 |
| Consolidated Statements of Operations for the Fiscal Years Ended December 31, 2025 and 202<u>4</u> | F-4 |
| Consolidated Statements of Stockholders' Equity for the Fiscal Years Ended December 31, 2025 and 202<u>4</u> | F-5 |
| Consolidated Statements of Cash Flows Equity for the Fiscal Years Ended December 31, 2025 and 202<u>4</u> | F-6 |
| Notes to Consolidated Financial Statements | F-7 |

---

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the Shareholders and the Board of Directors

Renewal Fuels, Inc.

**Opinion on the Financial Statements**

We have audited the accompanying consolidated balance sheets of Renewal Fuels Inc. and its subsidiaries (the Company) as of December 31, 2025 and 2024, the related consolidated statements of operations, changes in equity and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

**Substantial doubt about the Company's ability to continue as a going concern**

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1, Going Concern to the financial statements, the Company has a working capital deficit of $1,200,875 and an accumulated deficit of $20,356,048 as of December 31, 2025. Additionally, the Company had a working capital deficit of $1,008,342 and an accumulated deficit of $20,100,715 as of December 31, 2024, and has not established revenue sources to cover its operating costs. These factors raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**Basis for Opinion**

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

**Critical Audit Matters**

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. We determined that there are no critical audit matters.

---

| |
|:---|
| ![A close up of a letter AI-generated content may be incorrect.](image_001.jpg) |
| We have served as the Company's auditor since 2024. |
| Houston, Texas |
| **March 16, 2026**<br> **PCAOB ID: 7333** |

---

**RENEWAL FUELS, INC. AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **December 31,**<br>**2025** | **December 31,**<br>**2024** |
| **ASSETS** |  |  |
| **Current Assets:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $2525 | $2525 |
| **Total current assets** | $2525 | $2525 |
| **TOTAL ASSETS** | $**2525** | $**2525** |
| **LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)** |  |  |
| **Current Liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | $58500 | $8000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable | 473523 | 383873 |
| &nbsp;&nbsp;&nbsp;&nbsp;Litigation liability | 671377 | 618994 |
| **Total current liabilities** | $1203400 | $1010867 |
| **Total Liabilities** | $**1203400** | $**1010867** |
| **Stockholders' Equity (Deficit):** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred Stock, Series B, par $0.001; 20,000,000 authorized; 1 issued |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common Stock, par $0.001; 3B authorized;<br> 2,939,061,314 and 2,625,061,314 issued at 12/31/25 and 12/31/24 | $2939061 | $2625061 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 16216112 | 16467312 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (20356048) | (20100715) |
| **Total Stockholders' Equity (Deficit)** | $**(1200875)** | $**(1008342)** |
| **TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY** | $**2525** | $**2525** |

---

The accompanying notes are an integral part of these consolidated financial statements.

**RENEWAL FUELS, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

---

| | | |
|:---|:---|:---|
|  | **Year Ended<br> December 31,** | **Year Ended<br> December 31,** |
|  | **2025** | **2024** |
| **Operating Expenses:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Consulting Fees | $136000 | $75000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Officer compensation | $0 | $45000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | $52450 | $27000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Professional Fees | $8000 | $8000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Advertisement and marketing expenses | $6500 |  |
| **Total Operating Expenses** | $202950 | $155000 |
| **Operating Loss** | $(202950) | $(155000) |
| **Other Income (Expense):** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Litigation Expenses and Interest on Litigation Expenses | $(52383) | $(618994) |
| **Total Other Income (Expense)** | $(52383) | $(618994) |
| **NET LOSS** | $**(255333)** | $**(773994)** |
| Weighted average shares outstanding - basic and diluted | 2671264054 | 2625061314 |
| Basic and diluted loss per share | $(0.00010) | $(0.00029) |

---

The accompanying notes are an integral part of these consolidated financial statements.

**RENEWAL FUELS, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Common Stock**<br>**Issuable** | **Additional Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Total**<br>**Equity** |
| Balance, December 31, 2023 | 1 | $0 | 2625061314 | $2625061 | $0 | $16467312 | $(19326721) | $(234348) |
| Net loss - 2024 |  |  |  |  |  |  | $(773994) | $(773994) |
| **Balance, December 31, 2024** | **1** | $**0** | **2625061314** | $**2625061** | $**0** | $**16467312** | $**(20100715)** | $**(1008342)** |
| Shares issued - Note conversions |  |  | 314000000 | $314000 |  | $(251200) |  | $62800 |
| Net loss - 2025 |  |  |  |  |  |  | $(255333) | $(255333) |
| **Balance, December 31, 2025** | **1** | $**0** | **2939061314** | $**2939061** | $**0** | $**16216112** | $**(20356048)** | $**(1200875)** |

---

The accompanying notes are an integral part of these consolidated financial statements.

**RENEWAL FUELS, INC. AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

---

| | | |
|:---|:---|:---|
|  | **Year Ended<br> December 31,<br> 2025** | **Year Ended<br> December 31,<br> 2024** |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(255333) | $(773994) |
| **Adjustments to reconcile net loss to net cash:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Convertible notes issued for consulting services | $100000 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued interest on notes payable | $52450 | $27000 |
| **Accrued interest on litigation liability** | $52383 | $(618994) |
| Changes in operating assets and liabilities: |  |  |
| **Increase in accounts payable and accrued expenses** | $50500 | $8000 |
| **Accrued consulting and other operating expenses** |  | 120000 |
| **Net cash used in operating activities** |  |  |
| CASH FLOWS FROM INVESTING ACTIVITIES |  |  |
| **Net cash used in investing activities** | $— | $(0) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| Net cash provided by financing activities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net change in cash | $— |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash at beginning of period | $2525 | 2525 |
| &nbsp;&nbsp;&nbsp;&nbsp;CASH AT END OF PERIOD | $2525 | 2525 |
| &nbsp;&nbsp;&nbsp;&nbsp;Supplemental disclosure of non-cash activities: |  |  |
| Conversion of notes payable into common stock | 62800 |  |
| Convertible notes issued for services | 100000 |  |

---

The accompanying notes are an integral part of these consolidated financial statements.

**RENEWAL FUELS, INC.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

For the Years Ended December 31, 2025 and 2024

**NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION**

***Organization and Business***

Renewal Fuels, Inc. ("RNWF" or the "Company") is a Delaware corporation. As of December 31, 2025, the Company was a public company with minimal assets and limited business operations. On December 16, 2025, the Company entered into a Master Sales Agreement and Share Exchange Agreement with Kepler Fusion Technologies Inc. ("Kepler"); however, the transaction did not close as of December 31, 2025 because required closing contingencies, including delivery of the Special 2020 Series A Preferred Control Share, had not been satisfied prior to year-end. The transaction subsequently closed on February 27, 2026, as described in Note 10.

The Company's common stock is quoted on the OTC Markets under the symbol "RNWF."

*Microcap Advisors' LLC*

Microcap Advisors' LLC is a business advisory and corporate consulting firm that provides strategic advisory services to microcap and small-capitalization companies listed on the OTC Markets and other public markets. The firm specializes in advising early-stage public companies on capital markets strategy, corporate governance, investor relations, and compliance matters. Microcap Advisors' LLC has been engaged by the Company to provide general business advisory services in connection with the Company's OTC Markets listing and corporate development activities.

***Basis of Presentation***

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). All intercompany transactions and balances have been eliminated in consolidation.

***Principle of Consolidation***

 ****

The Company's subsidiaries were inactive during the period and had no assets, liabilities, revenues, expenses, or operations. Accordingly, consolidation of these entities would have no effect on the accompanying consolidated financial statements.

***Going Concern***

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As of December 31, 2025, the Company has an accumulated deficit of approximately $20.36 million and has incurred recurring losses from operations. These factors raise substantial doubt about the Company's ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

***Use of Estimates***

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Significant estimates include the assessment of contingent liabilities. Actual results could differ from those estimates.

 ****

**RENEWAL FUELS, INC.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

For the Years Ended December 31, 2025 and 2024

***Cash and Cash Equivalents***

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.

***Business Combinations***

The Company accounts for business combinations in accordance with ASC 805, Business Combinations. Under ASC 805, the acquirer recognizes and measures the identifiable assets acquired, liabilities assumed, and any noncontrolling interest in the acquiree at their fair values as of the acquisition date. The excess of the consideration transferred over the fair value of the net identifiable assets acquired is recorded as goodwill. No business combination has been recognized in these financial statements as the Kepler transaction did not close until February 27, 2026 (see Note 10).

For reverse acquisitions, the consideration transferred is determined from the perspective of the accounting acquirer and is measured as the fair value of the equity interests the accounting acquirer would have had to issue to give the owners of the legal acquirer the same percentage ownership interest in the combined entity.

***Goodwill***

Goodwill represents the excess of the consideration transferred over the fair value of the net identifiable assets acquired in a business combination. Goodwill is not amortized but is tested for impairment at least annually in accordance with ASC 350, Intangibles—Goodwill and Other. No goodwill has been recognized as of December 31, 2025.

***Fair Value Measurements***

The Company follows ASC 820, Fair Value Measurement, which establishes a framework for measuring fair value. The standard establishes a three-level hierarchy:

&nbsp;&nbsp;&nbsp;&nbsp;• Level 1: Quoted prices in active markets for identical assets or liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;• Level 2: Observable inputs other than Level 1 prices; and

&nbsp;&nbsp;&nbsp;&nbsp;• Level 3: Unobservable inputs that are significant to the fair value.

***Contingencies***

The Company follows ASC 450, Contingencies, to account for loss contingencies. Liabilities are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated.

***Earnings Per Share***

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share includes the dilutive effect of potential common shares. For periods with a net loss, diluted loss per share equals basic loss per share.

***Income Taxes***

The Company accounts for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts and their respective tax bases. A valuation allowance is established when it is more likely than not that deferred tax assets will not be realized. The Company experienced a change in control during the year; accordingly, the utilization of net operating loss carryforwards may be limited under IRC Section 382.

**RENEWAL FUELS, INC.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

For the Years Ended December 31, 2025 and 2024

**NOTE 3 – INCOME TAXES**

As of December 31, 2025 and 2024, the Company had net operating loss carryforwards of approximately $20.4 million and $20.1 million, respectively. Due to the uncertainty of realizing any tax benefits, the Company has recorded a full valuation allowance against its deferred tax assets.

---

| | | |
|:---|:---|:---|
| **Description** | **December 31, 2025** | **December 31, 2024** |
| &nbsp;&nbsp;Net operating loss carryforward | $20356372 | $20100715 |
| &nbsp;&nbsp;Valuation allowance | (20356372) | (20100715) |
| &nbsp;&nbsp;**Net deferred tax asset** | $**—** | $**—** |

---

**NOTE 4 – STOCKHOLDERS' EQUITY**

***Preferred Stock***

The Company has authorized 20,000,001 shares of preferred stock, par value $0.001 per share. As of December 31, 2025 and 2024, one (1) share of Series A Preferred Stock was issued and outstanding.

***Common Stock***

The Company has authorized 3,000,000,000 shares of common stock, par value $0.001 per share. As of December 31, 2025, and 2024, 2,939,061,314 and 2,625,061,314 shares of common stock were issued and outstanding, respectively.

As of December 31, 2024, the Company had 2,007,857,621 restricted common shares and 617,203,693 unrestricted common shares issued and outstanding.

During the year ended December 31, 2025, the Company issued 314,000,000 unrestricted common shares and removed the restriction on 100,000,000 restricted common shares previously issued in 2021. No restricted common shares were issued during the year.

As of December 31, 2025, the Company had 1,907,857,621 restricted common shares and 1,031,203,693 unrestricted common shares issued and outstanding.

***Common Stock Issuable***

As of December 31, 2025, the Company has not recorded any Common Stock Issuable because the business combination with Kepler Fusion Technologies Inc. had not closed as of year-end. Section 3.3 of the Master Sales Agreement dated December 16, 2025 contemplates the issuance of 240,000,000 shares of common stock in connection with the transaction. These shares will be recorded upon closing of the transaction, which occurred on February 27, 2026 (see Note 10).

No Common Stock Issuable has been recorded as of December 31, 2025 as the business combination had not closed as of year-end.

Upon closing of the transaction and issuance of the 240,000,000 shares, the Company will record the Common Stock Issuable and subsequently reclassify it to Common Stock.

**RENEWAL FUELS, INC.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

For the Years Ended December 31, 2025 and 2024

**NOTE 5 – LITIGATION PAYABLE**

On December 12, 2024, the Court of Alaska entered a judgment against the Company. The total judgment recognized in the consolidated statement of operations for the year ended December 31, 2024 is $618,994. The judgment accrues interest at an annual rate of 8.5% until paid.

During the year ended December 31, 2025, interest expense of $52,383 was recognized on the outstanding judgment balance, consistent with the amount recognized in the accompanying consolidated statement of operations for the year ended December 31, 2025. The total litigation payable balance as of December 31, 2025 is $671,377.

The Company is actively pursuing legal remedies to vacate the judgment on the grounds that the underlying asset purchase agreement was never consummated and no assets were delivered. The full amount of the judgment, together with accrued interest, has been recognized as a litigation payable in the accompanying consolidated balance sheets, as the obligation constitutes a determinable legal liability recorded in accordance with ASC 450 and ASC 855.

**NOTE 6 – NOTES PAYABLE – RELATED PARTIES**

As of December 31, 2025 and 2024, notes payable to related parties consisted of the following:

---

| | | |
|:---|:---|:---|
| **Description** | **December 31, 2025** | **December 31, 2024** |
| &nbsp;&nbsp;Pinnacle Consulting Services – May 2023 Note | $126073 | $167873 |
| &nbsp;&nbsp;Pinnacle Consulting Services – January 2024 Note | $92250 | $81000 |
| &nbsp;&nbsp;CMB Communications – June 2023 Note | $151200 | $135000 |
| &nbsp;&nbsp;Pinnacle Consulting Services – January 2025 Note | $54000 | $— |
| &nbsp;&nbsp;CMB Communications – January 2025 Note | $50000 | $— |
| &nbsp;&nbsp;**Total notes payable – related parties** | $**473523** | $**383873** |

---

The notes bear interest at rates ranging from 8% to 15% per annum. All notes were in default as of December 31, 2025. CMB Communications is controlled by Richard Hawkins, a related party.

**NOTE 7 – RELATED PARTY TRANSACTIONS**

During 2025, the Company issued convertible notes totaling $100,000 to Pinnacle Consulting Services Inc. and CMB Communications for consulting and advisory services rendered. See Note 6 for further details.

**NOTE 8 – COMMITMENTS AND CONTINGENCIES**

***Legal Matters***

In the normal course of business, the Company may be subject to various legal proceedings and claims. Other than the litigation payable described in Note 5, management is not aware of any pending or threatened litigation that would have a material adverse effect on the Company's financial position or results of operations.

***Risks and Uncertainties***

The Company's operations are subject to significant risks and uncertainties, including financial, operational, regulatory, and technological risks. The Company is in an early stage of development with limited operating history and may require substantial additional capital to fund its operations.

**RENEWAL FUELS, INC.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

For the Years Ended December 31, 2025 and 2024

**NOTE 9 – BUSINESS COMBINATION (SUBSEQUENT EVENTS)**

***Overview of Transaction***

On December 16, 2025, the Company entered into a Master Sales Agreement (the "MSA") among Manufacturing 360, LLC ("Seller"), Earth Sciences Fund I LLC ("ESF" or "Buyer"), RH2 Equity Partners, LP ("Consultant"), and the Company, and a Share Exchange Agreement (the "SEA") between the Company and Brent Nelson, the sole shareholder of Kepler Fusion Technologies Inc. ("Kepler"). The agreements contemplate a reverse-merger share exchange transaction under which RNWF would acquire 100% of the issued and outstanding equity interests of Kepler in exchange for newly issued shares of RNWF common stock.

***Transaction Not Closed as of December 31, 2025***

Although the definitive agreements were executed on December 16, 2025, the transaction was not completed as of December 31, 2025, because the required closing mechanics had not been satisfied prior to year-end. Specifically, delivery of the Special 2020 Series A Preferred Control Share to ESF had not occurred by December 31, 2025. The Costello share litigation is not a condition precedent to closing per Section 5.11 of the MSA.

As a result, the December 31, 2025 financial statements reflect no business combination recognized, no goodwill or identifiable intangible assets recorded, no Kepler assets or liabilities consolidated, and a zero operating asset position at year-end.

***Subsequent Closing – February 27, 2026***

The transfer of the Special 2020 Series A Preferred Control Share occurred on February 27, 2026, at which point all closing conditions under the MSA and SEA were satisfied. Accordingly, the acquisition date under ASC 805 is February 27, 2026, and purchase accounting will be applied prospectively from that date.

***Anticipated Accounting Treatment***

The transaction will be accounted for as a reverse acquisition in accordance with ASC 805-40. Although RNWF is the legal acquirer, Kepler is expected to be the accounting acquirer for financial reporting purposes. The following factors support this determination: (1) Kepler's former shareholders will hold approximately 89.7% of the voting rights in the combined entity; (2) Kepler's designees will control the board of directors; (3) Kepler's management will comprise the senior management team; and (4) RNWF was a non-operating public shell with minimal assets.

Upon completion of the purchase price allocation, the Company anticipates recognizing identifiable intangible assets and any resulting goodwill (or bargain purchase gain). The closing stock price on OTC Markets on February 27, 2026 was $0.0356. Rockport Investment Partners is performing the valuation analysis and purchase price allocation work. The Company anticipates engaging JV CPA Inc. for a sub-period audit covering the post-closing period, including full ASC 805 purchase accounting.

***Key Terms of the Transaction***

The MSA provides for: (a) the sale of one share of RNWF Special 2020 Series A Preferred Stock (the "Control Share") from Manufacturing 360, LLC to ESF for $1,000, which carries 60% voting power; (b) the simultaneous share exchange with Kepler; and (c) a consulting engagement with RH2 Equity Partners, LP. The Share Exchange Agreement contemplates the issuance of 240,000,000 shares of RNWF common stock to Kepler's shareholders. RH2 Equity Partners will receive 1,000,000 shares of post-reverse-split common stock vesting quarterly over 36 months for extended advisory services.

The Company has evaluated subsequent events through the date these consolidated financial statements were issued.

**RENEWAL FUELS, INC.**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

For the Years Ended December 31, 2025 and 2024

**10. SUBSEQUENT EVENTS**

***Closing of Kepler Business Combination***

On February 27, 2026, the Company completed the business combination with Kepler Fusion Technologies Inc. as described in Note 10. On that date, the Special 2020 Series A Preferred Control Share was transferred to Earth Sciences Fund I LLC, satisfying all remaining closing conditions under the Master Sales Agreement and Share Exchange Agreement. As a result, Kepler became a wholly owned subsidiary of the Company, and Kepler's former shareholders obtained approximately 89.7% ownership of the combined entity. The closing stock price of RNWF common stock on OTC Markets on February 27, 2026 was $0.0356.

The acquisition date for purposes of ASC 805 is February 27, 2026. Purchase price allocation will be performed prospectively from that date and will include the recognition of identifiable intangible assets and any resulting goodwill or bargain purchase gain. The purchase price allocation is expected to be completed during the measurement period permitted under ASC 805-10-25-13 through 25-19. The Company anticipates a stub-period audit or review covering the post-closing period for SEC reporting purposes in connection with its pending Form 10 filing.

No other events have occurred subsequent to December 31, 2025 that would require recognition or disclosure in the accompanying financial statements, other than as disclosed herein.

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| March 16, 2026 | **RENEWAL FUELS, INC.** | **RENEWAL FUELS, INC.** |
|  | By: | */s/ Richard Hawkins* |
|  |  | Richard Hawkins |
|  |  | Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Richard Hawkins, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

IN WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney as of the date indicated.

Date: March 16, 2026<br> By: /s/ Richard Hawkins<br> Richard Hawkins<br> Chief Executive Officer and Sole Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/ Richard Hawkins* | Chief Executive Officer, President, Secretary, Treasurer, and sole Director | March 16, 2026 |
| Richard Hawkins |  |  |

---

## Exhibit 3.1

Exhibit 3.1

![](image_002.jpg)

![](image_003.jpg)

![](image_004.jpg)

![](image_005.jpg)

![](image_006.jpg)

![](image_007.jpg)

![](image_008.jpg)

![](image_009.jpg)

![](image_010.jpg)

![](image_011.jpg)

![](image_012.jpg)

## Exhibit 3.2

Exhibit 3.2

![](image_013.jpg)

![](image_014.jpg)

![](image_015.jpg)

![](image_016.jpg)

![](image_017.jpg)

![](image_018.jpg)

![](image_019.jpg)

![](image_020.jpg)

![](image_021.jpg)

![](image_022.jpg)

![](image_023.jpg)

![](image_024.jpg)

![](image_025.jpg)

![](image_026.jpg)

![](image_027.jpg)

![](image_028.jpg)

![](image_029.jpg)

![](image_030.jpg)

![](image_031.jpg)

![](image_032.jpg)

![](image_033.jpg)

![](image_034.jpg)

![](image_035.jpg)

![](image_036.jpg)

## Exhibit 10.1

Exhibit 10.1

**MASTER SALES AGREEMENT**

This Master Sales Agreement (this **"Agreement"**) is entered into as of December 16, 2025 (the **"Effective Date"**), by and among:

&nbsp;&nbsp;&nbsp;&nbsp;a) **Manufacturing 360, LLC,** a Washington limited liability company ("Seller"), in its capacity
 as the sole record and beneficial owner of one (1) share of the Special 2020 Series A Preferred
 Stock of Renewal Fuels, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;b) **Earth Sciences Fund I LLC,** a Texas limited liability company ("Buyer" or "ESF");
 and

&nbsp;&nbsp;&nbsp;&nbsp;c) **RH2 Equity Partners, LP**, a Delaware limited partnership (the **"** Consultant"
 or "RH2", and, together with Seller and Buyer, each a "Party" and
 collectively the "Parties").

This Agreement sets forth the terms and conditions governing the transfer of control of Renewal Fuels, Inc. through the sale of the Special 2020 Series A Preferred Share, the simultaneous share exchange transaction involving Kepler Fusion Technologies Inc., and the engagement of RH2 to provide transitional and compliance-related services in connection with the Transaction and post-closing integration.

**RECITALS**

**WHEREAS, Seller is the sole record and beneficial owner of one (1) share of the Special 2020 Series A Preferred Stock of Renewal Fuels, Inc., a Delaware corporation traded on OTC Markets under symbol RNWF ("RNWF"), which one (1) share (the "Control Share") carries voting rights equal to sixty percent (60%) of the total voting power of all outstanding voting securities of RNWF, voting together with the common stock as a single class on all matters submitted to shareholders;**

**WHEREAS, Buyer desires to acquire from Seller, and Seller desires to transfer to Buyer, all of Seller's right, title, and interest in and to the Control Share, free and clear of all liens, claims, pledges, encumbrances, and restrictions other than those arising under applicable securities laws, pursuant to the terms of this Agreement and the related Stock Transfer Agreement;**

**WHEREAS, immediately upon the transfer of the Control Share to Buyer, RNWF, as the surviving public corporation under Buyer's voting control, shall enter into a Share Exchange Agreement with Kepler Fusion Technologies Inc. ("Kepler"), pursuant to which RNWF shall acquire all of the issued and outstanding shares or other equity interests of Kepler in a reverse-merger share exchange transaction (the "Share Exchange");**

**WHEREAS, the Parties acknowledge and agree that the transfer of the Control Share to Buyer and the consummation of the Share Exchange with Kepler are interdependent, shall occur simultaneously, and neither transaction shall close unless both transactions close at the same time;**

**WHEREAS, Consultant shall provide transitional administrative, compliance, disclosure, and capital-markets support to RNWF in connection with the Transaction and post-closing integration pursuant to a separate Consulting Agreement to be executed concurrently herewith;**

**WHEREAS, the Parties desire to set forth in this Agreement the terms, conditions, covenants, obligations, and closing deliverables pertaining to the transfer of control of RNWF, the simultaneous Share Exchange with Kepler, and the execution and delivery of all related definitive agreements and supporting instruments; and**

**WHEREAS, the Parties enter into this Agreement in reliance upon the representations, warranties, disclosures, and covenants contained herein and intend for this Agreement to govern the overall structure, coordination, and closing mechanics of the Transaction.**

**1.** DEFINITIONS

As used in this Agreement, the following terms shall have the meanings set forth below. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Transaction Agreements, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;1.1. "Acquired
 Business" means the equity interests, operations,
 contracts, assets, intellectual property, rights, and business activities of Kepler Fusion
 Technologies Inc. to be acquired by RNWF pursuant to the Share Exchange Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;1.2. "Agreement" means this Master Sales Agreement, together with all exhibits,
 schedules, and any other documents incorporated by reference herein.

&nbsp;&nbsp;&nbsp;&nbsp;1.3. "Buyer" or "ESF" means
 Earth Sciences Fund I LLC, a Texas limited liability company, and its permitted successors
 and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;1.4. "Closing" means the consummation of the Transaction, including (a)
 the transfer of the Control Share to Buyer, (b) the execution and delivery of the Share Exchange
 Agreement, and (c) the simultaneous acquisition by RNWF of all issued and outstanding shares
 or equity interests of Kepler, subject to the satisfaction or waiver of all conditions precedent
 set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;1.5. "Closing
 Date" means the date on which the Closing occurs.

&nbsp;&nbsp;&nbsp;&nbsp;1.6. "Consultant" or "RH2" means
 RH2 Equity Partners, LP, a Delaware limited partnership, together with its authorized officers,
 agents, and affiliates.

&nbsp;&nbsp;&nbsp;&nbsp;1.7. "Consulting
 Agreement" means the agreement between Consultant
 and RNWF executed concurrently with this Agreement, pursuant to which Consultant shall provide
 transitional, administrative, compliance, and disclosure services.

&nbsp;&nbsp;&nbsp;&nbsp;1.8. "Control
 Share" means the one (1) share of Special 2020 Series
 A Preferred Stock of RNWF held by Seller, which carries voting rights equal to sixty percent
 (60%) of the total voting power of all outstanding voting securities of RNWF, voting together
 with the common stock as a single class on all matters.

&nbsp;&nbsp;&nbsp;&nbsp;1.9. "Definitive
 Agreements" means collectively this Agreement, the
 Stock Transfer Agreement, the Share Exchange Agreement, the Consulting Agreement, and all
 other agreements, instruments, exhibits, schedules, certificates, and closing deliverables
 executed in connection with the Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;1.10. "Disclosure
 Schedules" means the schedules delivered by a Party
 to the other Parties in connection with this Agreement, setting forth exceptions to that
 Party's representations, warranties, or other matters required to be disclosed hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;1.11. "Kepler" means Kepler Fusion Technologies Inc. (or any designated
 successor entity), the private company to be acquired by RNWF pursuant to the Share Exchange
 Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;1.12. "Person" means any individual, corporation, partnership, limited
 liability company, joint venture, association, trust, unincorporated organization, governmental
 authority, or other legal entity.

&nbsp;&nbsp;&nbsp;&nbsp;1.13. "Purchase
 Price" means one thousand dollars ($1,000), payable
 by Earth Sciences Fund I LLC to Manufacturing 360, LLC as consideration for the Control Share,
 as required by the Letter of Intent dated November 27, 2025 and memorialized in the Stock
 Transfer Agreement."

&nbsp;&nbsp;&nbsp;&nbsp;1.14. "RNWF" means Renewal Fuels, Inc., a Delaware corporation traded
 on OTC Markets under the symbol RNWF.

&nbsp;&nbsp;&nbsp;&nbsp;1.15. "Seller" means Manufacturing 360, LLC, a Washington limited liability
 company, in its capacity as the record and beneficial owner of the Control Share.

&nbsp;&nbsp;&nbsp;&nbsp;1.16. "Share
 Exchange" means the reverse-merger share exchange
 transaction pursuant to which RNWF shall acquire all of the issued and outstanding shares
 or equity interests of Kepler, as provided in the Share Exchange Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;1.17. "Share
 Exchange Agreement" or "SEA" means
 the definitive agreement between RNWF and Kepler pursuant to which RNWF shall acquire one
 hundred percent (100%) of the issued and outstanding equity of Kepler.

&nbsp;&nbsp;&nbsp;&nbsp;1.18. "Stock
 Transfer Agreement" or "STA" means
 the agreement between Seller and Buyer relating to the transfer of the Control Share, executed
 concurrently with this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;1.19. "Transaction" means the collective transactions contemplated by the Definitive
 Agreements, including (a) the transfer of the Control Share to Buyer, (b) the Share Exchange
 between RNWF and Kepler, and (c) the execution of the Consulting Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;1.20. "Transaction
 Agreements" means this Agreement, the STA, the SEA,
 the Consulting Agreement, and any additional documents or instruments executed in connection
 with the Transaction.

**2.** PURCHASE
 AND SALE OF CONTROL SHARE

&nbsp;&nbsp;&nbsp;&nbsp;2.1. Transfer
 of Control Share. Subject to the terms and conditions of this Agreement and the Stock Transfer
 Agreement, Seller shall sell, assign, transfer, and deliver to Buyer, and Buyer shall purchase
 from Seller, all of Seller's right, title, and interest in and to the Control Share,
 free and clear of all liens, pledges, encumbrances, security interests, claims, options,
 or restrictions of any kind other than restrictions imposed by applicable securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;2.2. Voting
 Rights. The Parties acknowledge and agree that the Control Share constitutes one share of
 the Special 2020 Series A Preferred Stock of RNWF, which carries voting rights equal to sixty
 percent of the total voting power of all outstanding voting securities of RNWF, voting together
 with the common stock as a single class on all matters. Upon consummation of the transfer
 of the Control Share, Buyer shall possess and exercise full voting control of RNWF in accordance
 with such rights.

&nbsp;&nbsp;&nbsp;&nbsp;2.3. Form
 of Transfer. The transfer of the Control Share shall be effected at Closing by the delivery
 to Buyer or Buyer's designee of a duly executed and medallion guaranteed stock power
 endorsed by Seller, any other transfer instruments reasonably required by RNWF or its transfer
 agent to record Buyer as the sole record and beneficial owner of the Control Share, and evidence
 reasonably satisfactory to Buyer confirming that all corporate records, books, and ledgers
 of RNWF reflect Buyer as the holder of the Control Share as of the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;2.4. No
 Assumed Liabilities. Buyer is purchasing only the Control Share. Buyer is not assuming any
 liabilities, debts, obligations, agreements, contracts, or responsibilities of Seller of
 any kind, whether fixed, contingent, known, unknown, asserted, or unasserted, except as expressly
 set forth in this Agreement or any other Definitive Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;2.5. As
 Is Transaction. Buyer acknowledges that the Control Share is being transferred on an as is,
 where is basis, without any express or implied representation or warranty of any kind by
 Seller, except for the representations expressly set forth in this Agreement and the Stock
 Transfer Agreement. Buyer acknowledges that it has conducted its own investigation into RNWF
 and has not relied on any representation or warranty of Seller or any other Person except
 as expressly provided herein.

&nbsp;&nbsp;&nbsp;&nbsp;2.6. Simultaneous
 Closing Condition. The Parties acknowledge and agree that the transfer of the Control Share
 shall not occur unless the Share Exchange between RNWF and Kepler closes simultaneously,
 and the Share Exchange shall not occur unless the transfer of the Control Share closes simultaneously.
 Neither Party shall be obligated to close unless both components of the Transaction close
 at the same time.

**3.** REVERSE
 MERGER AND TRANSACTION CONDITIONS

&nbsp;&nbsp;&nbsp;&nbsp;3.1. Reverse
 Merger Commitment. The Parties acknowledge and agree that the Transaction requires RNWF to
 acquire all of the issued and outstanding equity interests of Kepler pursuant to the Share
 Exchange Agreement. RNWF shall acquire the Acquired Business in exchange for newly issued
 shares of RNWF common stock or such other securities as may be negotiated between RNWF and
 Kepler and memorialized in the Share Exchange Agreement. The Acquired Business shall include
 all contracts, operations, assets, intellectual property, rights, and interests of Kepler,
 except as expressly excluded by the Share Exchange Agreement. RNWF acknowledges that the
 Purchase Price for the Control Share is one thousand dollars ($1,000), consistent with the
 Stock Transfer Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;3.2. Simultaneous
 Closing Condition. The transfer of the Control Share to Buyer and the acquisition of Kepler
 by RNWF shall close simultaneously. Neither component of the Transaction shall close unless
 both components close at the same time. The obligations of all Parties to complete the Transaction
 are expressly conditioned upon the simultaneous consummation of the Share Exchange and the
 transfer of the Control Share.

&nbsp;&nbsp;&nbsp;&nbsp;3.3. Share
 Exchange Terms. The Parties currently contemplate that the Share Exchange shall involve the
 issuance by RNWF of two hundred forty million shares of RNWF common stock in exchange for
 all issued and outstanding shares of Kepler. The final structure, including whether any preferred
 stock such as Series B Preferred Stock shall be used in lieu of or in addition to common
 stock, shall be determined by RNWF and Kepler and reflected in the Share Exchange Agreement.
 The Share Exchange Agreement shall identify the Kepler equity interests being exchanged and
 shall include the following elements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) identification
 and transfer of all Kepler equity interests to RNWF

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) issuance
 or delivery of the agreed consideration by RNWF

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) a
 schedule of any excluded assets or retained liabilities

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) closing
 deliverables required from Kepler

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) any
 post-closing covenants or obligations

&nbsp;&nbsp;&nbsp;&nbsp;3.4. Kepler
 Equity Transfer. At Closing, Kepler shall deliver to RNWF all equity interests representing
 one hundred percent of the issued and outstanding shares of Kepler, free and clear of all
 liens, claims, and encumbrances, together with all necessary transfer documents required
 to vest full ownership of the Acquired Business in RNWF. Kepler shall also deliver all corporate
 records, organizational documents, intellectual property assignments, contract assignments,
 and any other instruments reasonably required to complete the Share Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;3.5. No
 Issuance of RNWF Common Stock at Initial Closing. The Parties acknowledge that no RNWF common
 stock shall be issued at the initial closing of the Transaction except as expressly provided
 in the Share Exchange Agreement. Any equity consideration payable to Kepler shall be issued
 only in accordance with the definitive terms negotiated between RNWF and Kepler and memorialized
 in the Share Exchange Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;3.6. Capital
 Structure and Post Closing Alignment. RNWF shall take all actions reasonably required to
 align its capital structure with the Transaction, including implementing any reverse stock
 split, preferred share designation, or other corporate action contemplated by the Share Exchange
 Agreement. RNWF and Kepler shall cooperate in good faith to ensure that the capital structure
 of the combined company reflects the ownership and control percentages agreed in the Share
 Exchange Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;3.7. Conditions
 Precedent. The obligations of the Parties to consummate the Transaction shall be subject
 to the satisfaction or waiver of the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) execution
 of the Stock Transfer Agreement, Share Exchange Agreement, and Consulting Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) confirmation
 that RNWF has authority to issue the consideration required under the Share Exchange Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) delivery
 of all required corporate approvals and consents from RNWF, Seller, Buyer, and Kepler

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) delivery
 of all required third party consents for the assignment or transfer of any contract, permit,
 or license included in the Acquired Business if such consent is required

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) no
 material adverse change in the business or condition of RNWF or Kepler between the Effective
 Date and the Closing Date

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f) confirmation
 of OTC IQ access or reasonable assurance of imminent access

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g) execution
 and delivery of all closing deliverables required by the Transaction Agreements

&nbsp;&nbsp;&nbsp;&nbsp;3.8. Failure
 to Complete Reverse Merger. If the Share Exchange has not been fully completed within sixty
 (60) days following the Closing Date, for any reason other than a breach of this Agreement
 by Seller or RH2, neither Seller nor RH2 shall be obligated to transfer or maintain the Control
 Share with Buyer, and Seller and RH2 may terminate this Agreement upon written notice to
 Buyer. Upon such termination, the Transaction shall be unwound in accordance with Section
 3.8, and each Party shall bear its own costs, with no further obligations except those expressly
 stated to survive termination.

&nbsp;&nbsp;&nbsp;&nbsp;3.9. PCAOB
 Auditor Engagement and Payment Requirement. Within sixty (60) days following the Closing
 Date, Buyer and Kepler shall cause RNWF to (a) formally engage a PCAOB-qualified auditor,
 and (b) fully pay all outstanding and required auditor fees, including any fees owed to Rockport
 or any successor valuation or audit provider. Buyer shall be solely responsible for all such
 auditor-related costs. Failure to satisfy this obligation within the 60-day period shall
 constitute a condition subsequent permitting Seller and RH2 to unwind the Transaction and
 reclaim the Control Share, in addition to any other remedies available under this Agreement.

**4.** CONSULTING
 AGREEMENT AND TRANSITIONAL SERVICES

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1. Engagement
 of Consultant. At Closing, RNWF shall enter into a Consulting Agreement with RH2 pursuant
 to which RH2 shall provide transitional administrative, compliance, disclosure, and capital
 markets support to RNWF. The Consulting Agreement shall be effective immediately upon execution
 and shall be structured to support the Transaction, the post-closing integration of the Acquired
 Business, and the ongoing reporting and regulatory obligations of RNWF as a public company.

&nbsp;&nbsp;&nbsp;&nbsp;4.2. Initial
 Compliance and Corporate Services. RH2 shall provide initial transitional services in support
 of RNWF's immediate regulatory, administrative, and disclosure needs, including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) preparation
 and coordination of corporate documentation and supporting materials required for the Transaction

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) support
 with OTC Markets profile updates, disclosure filings, and compliance obligations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) assistance
 with change of control reporting, corporate governance alignment, and capital structure reconciliation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) support
 for preparation and filing of documents related to the rescission and cancellation of the
 Costello Shares

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) coordination
 with RNWF management, Kepler personnel, and Buyer to implement Transaction related deliverables

&nbsp;&nbsp;&nbsp;&nbsp;4.3. Cash
 Fee. Upon execution of the Consulting Agreement, RNWF shall pay RH2 Equity Partners a one-time
 cash fee of twenty thousand dollars ($20,000), as set forth in Section 5.1 of the Letter
 of Intent.

&nbsp;&nbsp;&nbsp;&nbsp;4.4. Retained
 Notes. RH2 Equity Partners shall retain the outstanding Pinnacle Notes and CMB Notes totaling five hundred thousand five hundred ninety-two
 dollars ($500,592) . Such notes shall convert in accordance with
 the Consulting Agreement and the Debt Settlement and Assignment Agreements to be executed
 at Closing.

&nbsp;&nbsp;&nbsp;&nbsp;4.5. Quarterly
 Value Floor and True-Up. Each quarterly vested tranche shall have a minimum notional value
 of thirty thousand dollars ($30,000). If the market value of any tranche is less than such
 amount, RNWF shall issue additional common shares as a true-up to ensure compliance with
 this requirement , or
 RNWF shall have the option, at its sole discretion, to pay thirty thousand dollars ($30,000)
 in lieu of that quarterly's vesting by Consultant.

&nbsp;&nbsp;&nbsp;&nbsp;4.6. Registration
 Rights. RNWF shall include all securities issued to RH2 under this Agreement and the Consulting
 Agreement in the next registration statement filed with the Securities and Exchange Commission.

&nbsp;&nbsp;&nbsp;&nbsp;4.7. Independent
 Advisor Status. RH2 shall provide services strictly as an independent contractor and shall
 have no authority to bind RNWF or act as its officer, agent, or fiduciary.

&nbsp;&nbsp;&nbsp;&nbsp;4.8. Extended
 Services Period. Following completion of the Transaction, RH2 shall provide extended advisory
 and oversight services to RNWF for a period of three years unless otherwise agreed by the
 Parties. Such services may include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) financial
 reporting oversight and accounting management support

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) preparation
 and coordination of OTC Markets and SEC disclosure filings

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) support
 for post-closing corporate actions and regulatory matters

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) strategic
 advisory services related to investor relations, internal governance, and operational execution

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) project
 management and coordination related to the integration of the Acquired Business

&nbsp;&nbsp;&nbsp;&nbsp;4.9. Extended Services Compensation. As
 consideration for the extended advisory and oversight services described in Section 4.8,
 RNWF shall issue to RH2 one million (1,000,000) shares of RNWF common stock, issued post–reverse
 split, vesting quarterly over thirty-six (36) months, with a minimum quarterly notional value
 of thirty thousand dollars ($30,000), and subject to true-up share issuances **,** or RNWF
 shall have the option, at its sole discretion, to pay thirty thousand dollars ($30,000) in
 lieu of that quarterly's vesting by Consultant, as described in Section 4.5. All such
 securities shall include registration rights consistent with Section 4.6 and shall be issued
 in accordance with the Consulting Agreement and the Letter of Intent.

&nbsp;&nbsp;&nbsp;&nbsp;4.10. Documentation
 and Reporting. RH2 shall maintain records of services performed and shall provide periodic
 updates to RNWF and Buyer regarding the status of compliance, disclosure, litigation support,
 and other transitional or extended activities. RNWF shall cooperate in good faith by providing
 timely access to corporate records, personnel, and information necessary for RH2 to perform
 its obligations.

&nbsp;&nbsp;&nbsp;&nbsp;4.11. Survival
 of Certain Obligations. The obligations of RNWF relating to compensation payable to RH2 under
 the Consulting Agreement, including any deferred compensation, equity-based awards, registration
 rights, or true up share issuances, shall survive the Closing and shall remain binding on
 RNWF and its successors and assigns in accordance with their terms.

**5.** CONDITIONS
 TO CLOSING

The obligations of the Parties to consummate the Transaction shall be subject to the satisfaction, at or prior to the Closing (as defined below), of each of the following conditions, any of which may be waived in whole or in part by mutual written agreement of the Parties:

&nbsp;&nbsp;&nbsp;&nbsp;5.1. Execution
 of Definitive Agreements. The Parties shall have executed the Stock Transfer Agreement, the
 Share Exchange Agreement, and the Consulting Agreement, together with all exhibits, schedules,
 and supporting documents required by each such agreement, including the Seller's Debt
 Assignment and Settlement Agreements described in Section 5.4 of the Letter of Intent and
 the Consulting Agreement required by Section 5.1 of the Letter of Intent providing for the
 $20,000 one-time cash fee and the advisory compensation structure referenced therein..

&nbsp;&nbsp;&nbsp;&nbsp;5.2. Delivery
 of Control Share. Seller shall have delivered to Buyer or Buyer's designee all instruments
 necessary to transfer the Control Share, including a duly executed and medallion guaranteed
 stock power and any other transfer documents reasonably required by RNWF or its transfer
 agent.

&nbsp;&nbsp;&nbsp;&nbsp;5.3. Delivery
 of Kepler Equity. Kepler shall have delivered to RNWF all equity interests representing one
 hundred percent of the issued and outstanding shares of Kepler, together with all transfer
 documents required to vest full ownership of the Acquired Business in RNWF.

&nbsp;&nbsp;&nbsp;&nbsp;5.4. Delivery
 of Consideration. Buyer and RNWF shall have delivered the consideration required under the
 Stock Transfer Agreement and the Share Exchange Agreement, as applicable.

&nbsp;&nbsp;&nbsp;&nbsp;5.5. Corporate
 Approvals. RNWF shall have delivered all required board and controlling shareholder consents
 authorizing the Transaction, the Share Exchange, the entry into the Consulting Agreement,
 and all related corporate actions.

&nbsp;&nbsp;&nbsp;&nbsp;5.6. Third
 Party Consents. All third party consents necessary for the assignment or transfer of any
 contract, permit, or license included in the Acquired Business shall have been obtained to
 the extent such consents are required for Closing.

&nbsp;&nbsp;&nbsp;&nbsp;5.7. Absence
 of Material Adverse Change. There shall have been no material adverse change in the business,
 operations, assets, or financial condition of RNWF or Kepler between the Effective Date and
 the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;5.8. Confirmation
 of OTC IQ Access. RNWF shall have confirmed that it has active OTC IQ access or has received
 reasonable assurance of imminent reinstatement sufficient to enable required post closing
 disclosures.

&nbsp;&nbsp;&nbsp;&nbsp;5.9. Delivery
 of Valuation Report. Kepler shall have delivered to RNWF, ESF, and Consultant a current independent
 valuation report for Kepler prepared by Rockport (or another valuation firm reasonably acceptable
 to RNWF and ESF). The valuation shall be paid for by Kepler, and delivery of such valuation
 shall be a condition precedent to Closing. Closing Deliverables. Each Party shall have delivered
 all closing deliverables required under this Agreement and the other Transaction Agreements.

&nbsp;&nbsp;&nbsp;&nbsp;5.10. Payment
 of One-Time Cash Fee. RNWF shall have paid to RH2 the twenty thousand dollar ($20,000) one-time
 cash fee or shall have entered into a mutually agreed alternative payment arrangement.

&nbsp;&nbsp;&nbsp;&nbsp;5.11. Costello
 Share Litigation Not a Condition. The Parties acknowledge and agree that the pending litigation
 relating to the rescission and cancellation of the Costello Shares shall not be a condition
 precedent to Closing, and the Transaction shall proceed regardless of the timing or outcome
 of such litigation.

**6.** CLOSING
 DELIVERABLES

At the closing of the Transaction (the "Closing"), the following documents and instruments shall be executed, delivered, and exchanged by the respective Parties, unless waived by mutual written agreement:

&nbsp;&nbsp;&nbsp;&nbsp;6.1. <u>By Seller (Manufacturing 360, LLC):</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) a
 duly executed and medallion guaranteed stock power transferring the Control Share to Buyer
 or Buyer's designee

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any
 transfer documents reasonably required by RNWF or its transfer agent to record Buyer as the
 sole record and beneficial owner of the Control Share

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) all
 written consents, resolutions, and authorizations of Seller necessary to approve and consummate
 the transfer of the Control Share

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) any
 other documents reasonably requested by Buyer that are necessary or appropriate to complete
 the transfer of the Control Share

&nbsp;&nbsp;&nbsp;&nbsp;6.2. <u>By Buyer (Earth Sciences Fund I LLC):</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) the
 purchase price for the Control Share as set forth in the Stock Transfer Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) executed
 counterparts of all Transaction Agreements to which Buyer is a party

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) all
 written consents, resolutions, or authorizations required of Buyer to approve and consummate
 the Transaction

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) any
 other supporting documents reasonably requested by Seller or RNWF to effect the Transaction

&nbsp;&nbsp;&nbsp;&nbsp;6.3. <u>By RNWF (Renewal Fuels, Inc.):</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) executed
 counterparts of the Share Exchange Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) all
 board and controlling shareholder resolutions authorizing the Transaction, the Share Exchange,
 and the Consulting Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) evidence
 of OTC IQ access or reasonable assurance of imminent reinstatement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) a
 certified copy of the current RNWF capitalization table

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) any
 required officer resignations or appointments to effectuate the Transaction if applicable

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f) corporate
 records, minute books, stock ledgers, and organizational documents reasonably requested for
 post-closing governance

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g) any
 other documents required under the Transaction Agreements

&nbsp;&nbsp;&nbsp;&nbsp;6.4. <u>By Consultant (RH2 Equity Partners, LP):</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) the
 executed Consulting Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) written
 acknowledgments regarding the retention of the Pinnacle Notes and CMB Notes as compensation,
 consistent with this Agreement and the three (3) related Settlement and Exchange Agreements
 that are to be executed contemporaneously with this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) any
 independent contractor or non-affiliation acknowledgments required under the Consulting Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) any
 other documents required of Consultant under the Transaction Agreements

&nbsp;&nbsp;&nbsp;&nbsp;6.5. <u>By Kepler (Kepler Fusion Technologies Inc.):</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) all
 equity interests representing one hundred percent of the issued and outstanding shares of
 Kepler

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) all
 instruments of transfer necessary to vest full ownership of the Acquired Business in RNWF

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) copies
 of contracts, intellectual property assignments, licenses, financial statements, and organizational
 documents

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) all
 written consents and approvals required for the assignment of any contract, lease, permit,
 or license included in the Acquired Business if such consent is required for Closing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) any
 other documents required under the Share Exchange Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;6.6. <u>General Deliverables By All Parties:</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) executed
 counterparts of all Transaction Agreements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) all
 certificates, schedules, exhibits, and ancillary documents required by the Transaction Agreements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) closing
 certificates or confirmations required under any Transaction Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) any
 other documents mutually required to effect the Closing

**7.** REPRESENTATIONS
 AND WARRANTIES

Each Party represents and warrants to the other Parties as of the Effective Date and as of the Closing Date as follows, and acknowledges that the other Parties are relying on such representations and warranties in entering into this Agreement and the Transaction Agreements:

&nbsp;&nbsp;&nbsp;&nbsp;7.1. <u>Representations and Warranties of Seller</u>. Seller represents and warrants to Buyer and RNWF that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Seller
 is the sole record and beneficial owner of the Control Share and has full authority to transfer
 the Control Share

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) the
 Control Share is free and clear of all liens, claims, encumbrances, pledges, restrictions,
 or adverse interests other than restrictions imposed by applicable securities laws

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Seller
 has full power and authority to execute, deliver, and perform this Agreement and the other
 Transaction Agreements to which Seller is a party

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) the
 execution and delivery of this Agreement do not violate any agreement, contract, order, or
 law applicable to Seller

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) no
 consent or approval of any third party is required for Seller to consummate the transfer
 of the Control Share except as expressly stated in this Agreement

&nbsp;&nbsp;&nbsp;&nbsp;7.2. <u>Representations and Warranties of Buyer</u>. Buyer hereby represents and warrants to Seller and RNWF that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Buyer
 is duly organized, validly existing, and in good standing under the laws of its jurisdiction
 of formation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Buyer
 has full power and authority to execute, deliver, and perform this Agreement and each Transaction
 Agreement to which Buyer is a party

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) the
 execution and delivery of this Agreement do not violate any agreement, contract, order, or
 law applicable to Buyer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Buyer
 has the financial capacity to deliver the purchase price for the Control Share as set forth
 in the Stock Transfer Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) no
 consent or approval of any third party is required for Buyer to consummate the Transaction
 except as expressly stated in this Agreement

&nbsp;&nbsp;&nbsp;&nbsp;7.3. <u>Representations and Warranties of RNWF</u>. RNWF represents and warrants to Seller and Buyer that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) RNWF is duly organized, validly existing, and in good standing under the laws of the State of Delaware

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) RNWF has full power and authority to execute, deliver, and perform this Agreement and each Transaction Agreement to which it is a party including the Share Exchange Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) the execution and delivery of this Agreement do not violate any agreement, contract, order, or law applicable to RNWF

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) RNWF's authorized and outstanding capital stock is accurately reflected in the capitalization table delivered at Closing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) no consent or approval of any third party is required for RNWF to consummate the Transaction except as expressly stated in this Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f) RNWF has obtained all corporate approvals required to consummate the Transaction including board and controlling shareholder approvals

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g) RNWF has disclosed to Buyer the status of the Costello Share litigation as of the Effective Date

&nbsp;&nbsp;&nbsp;&nbsp;7.4. <u>Representations and Warranties of Consultant.</u> Consultant represents and warrants to the other Parties
 that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Consultant has full authority to execute, deliver, and perform this Agreement and the Consulting Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) the execution and delivery of this Agreement do not violate any agreement, contract, order, or law applicable to Consultant

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Consultant acknowledges that it is acting solely as an independent contractor and shall not be deemed an officer, director, employee, or control person of RNWF unless separately agreed in writing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Consultant
 is not relying on any representation or warranty of any other Party except those expressly
 set forth in the Transaction Agreements

&nbsp;&nbsp;&nbsp;&nbsp;7.5. <u>Representations and Warranties of Kepler.</u> Kepler represents and warrants to RNWF and Buyer that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) Kepler is duly organized, validly existing, and in good standing under the laws of its jurisdiction of formation

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Kepler has full authority to execute, deliver, and perform the Share Exchange Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Kepler owns all equity interests to be transferred free and clear of all liens, claims, or encumbrances except as disclosed in the Share Exchange Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Kepler has delivered its organizational documents, contracts, and intellectual property materials required under the Transaction

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) the execution and delivery of the Share Exchange Agreement do not violate any agreement, contract, order, or law applicable to Kepler

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f) no
 consent or approval of any third party is required for Kepler to consummate the Share Exchange
 except as expressly stated in the Share Exchange Agreement

**8.** COVENANTS

&nbsp;&nbsp;&nbsp;&nbsp;8.1. <u>Further Assurances</u>. Each Party shall execute and deliver such additional documents and shall
 take such further actions as may be reasonably necessary or appropriate to carry out the
 provisions of this Agreement and the other Transaction Agreements and to consummate the Transaction.
 Each Party shall cooperate in good faith with the other Parties to complete all filings,
 notices, and approvals required for the Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;8.2. <u>Conduct of Business Prior to Closing</u>. Between the Effective Date and the Closing Date, each Party
 shall use commercially reasonable efforts to preserve its business, assets, and goodwill
 and shall not take any action that would reasonably be expected to materially impair or delay
 its ability to consummate the Transaction or perform its obligations under this Agreement.
 RNWF and Kepler shall not enter into any material transaction outside the ordinary course
 of business without the prior written consent of Buyer except as required to complete the
 Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;8.3. <u>Confidentiality</u>.
 Each Party shall maintain in strict confidence all confidential or non public information
 received from the other Parties in connection with the negotiation and performance of this
 Agreement. No Party shall disclose such information except to its legal, financial, or accounting
 advisors or as required by applicable law or stock market rules. Each Party shall ensure
 that any such advisors comply with this confidentiality covenant.

&nbsp;&nbsp;&nbsp;&nbsp;8.4. <u>Required Filings and Regulatory Matters</u>. RNWF shall make all filings and submissions required
 by applicable law or stock market rules to effect the Change of Control and the Share Exchange
 including any updates to its OTC Markets profile and any required state or federal corporate
 filings. Buyer shall reasonably cooperate with RNWF in preparing and providing any information
 required for such filings or submissions.

&nbsp;&nbsp;&nbsp;&nbsp;8.5. <u>Public Announcements</u>. No Party shall issue any press release or public announcement regarding
 this Agreement or the Transaction without the prior written consent of the other Parties
 except where required by applicable law. If disclosure is required by law, the disclosing
 Party shall provide the other Parties with a reasonable opportunity to review and comment
 on the proposed disclosure before it is made.

&nbsp;&nbsp;&nbsp;&nbsp;8.6. <u>Access to Books and Records</u>. Prior to the Closing, RNWF and Kepler shall provide Buyer with
 reasonable access during normal business hours to their books, records, contracts, and financial
 information for the purpose of completing Buyer's confirmatory review and preparing
 for the Share Exchange. Buyer shall maintain the confidentiality of all such information
 in accordance with Section 8.3.

&nbsp;&nbsp;&nbsp;&nbsp;8.7. <u>Restriction on Transfer of Control Share</u>. Seller shall not transfer, pledge, encumber, or otherwise
 dispose of the Control Share between the Effective Date and the Closing Date except to Buyer
 pursuant to this Agreement. Seller shall immediately notify Buyer of any attempted or threatened
 adverse claim affecting the Control Share.

&nbsp;&nbsp;&nbsp;&nbsp;8.8. <u>Litigation Cooperation</u>. RNWF shall continue to pursue the litigation relating to the Costello Shares
 and shall cooperate in good faith with Buyer in providing updates on the status of such litigation.
 Buyer acknowledges that the successful cancellation of the Costello Shares is not a condition
 to Closing and agrees that the Transaction shall proceed regardless of the timing or outcome
 of the litigation.

&nbsp;&nbsp;&nbsp;&nbsp;8.9. <u>Operation of RNWF Post Closing</u>. Following the Closing, RNWF shall take such corporate actions as
 may be reasonably necessary to give effect to the Transaction including implementing the
 Share Exchange, updating corporate governance, and integrating the Acquired Business. RNWF
 shall cooperate with Consultant in carrying out the transitional and extended services described
 in the Consulting Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;8.10. <u>No Solicitation of Competing Transactions</u>. From the Effective Date until the earlier of
 Closing or termination of this Agreement, neither RNWF nor Seller shall solicit, negotiate,
 or enter into any agreement relating to any competing sale of control, equity sale, merger,
 or similar transaction with any other party. RNWF shall promptly notify Buyer of any unsolicited
 inquiry or proposal received.

**9.** INDEMNIFICATION

Each Party acknowledges and agrees that, as an essential component of the transactions contemplated by this Agreement, the allocation of risk set forth in this Section is fundamental to the Parties' decision to enter into and consummate the Transaction. Accordingly, the indemnification obligations described in this Section shall apply following the Closing and, where expressly stated, prior to the Closing, and shall govern the rights and responsibilities of the Parties with respect to any losses, liabilities, claims, damages, costs, or expenses arising out of or relating to the matters specified herein. The indemnification obligations in this Section shall operate in addition to, and not in limitation of, any rights or remedies available at law, in equity, or under any other Transaction Agreement, except to the extent expressly limited herein.

&nbsp;&nbsp;&nbsp;&nbsp;9.1. <u>Indemnification by Seller</u>. Seller
 shall indemnify and hold harmless Buyer and RNWF and their respective officers, directors,
 managers, members, partners, agents, and representatives from and against any and all losses,
 liabilities, claims, damages, costs, and expenses including reasonable attorneys fees arising
 out of or relating to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) any breach by Seller of any representation, warranty, covenant, or obligation under this Agreement or any other Transaction Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any claim or liability relating to Seller's ownership or transfer of the Control Share prior to the Closing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) any claim asserted by a third party alleging an adverse interest, lien, pledge, or encumbrance on the Control Share arising prior to the Closing

&nbsp;&nbsp;&nbsp;&nbsp;9.2. <u>Indemnification by Buyer</u>. Buyer shall indemnify and hold harmless Seller and RNWF and their respective
 officers, directors, managers, members, partners, agents, and representatives from and against
 any and all losses, liabilities, claims, damages, costs, and expenses including reasonable
 attorneys fees arising out of or relating to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) any breach by Buyer of any representation, warranty, covenant, or obligation under this Agreement or any other Transaction Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Buyer's failure to deliver the purchase price for the Control Share in accordance with the Stock Transfer Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) any claim asserted by a third-party alleging Buyer lacks authority to enter into or consummate the Transaction

&nbsp;&nbsp;&nbsp;&nbsp;9.3. <u>Indemnification by RNWF</u>. RNWF shall indemnify and hold harmless Seller and Buyer and their respective
 officers, directors, managers, members, partners, agents, and representatives from and against
 any and all losses, liabilities, claims, damages, costs, and expenses including reasonable
 attorneys fees arising out of or relating to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) any breach by RNWF of any representation, warranty, covenant, or obligation under this Agreement or any other Transaction Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any liability of RNWF arising from events occurring prior to the Closing other than liabilities expressly disclosed or assumed in the Transaction Agreements

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) any claim that RNWF failed to obtain the corporate approvals required to consummate the Transaction

&nbsp;&nbsp;&nbsp;&nbsp;9.4. <u>I ndemnification by Consultant</u>. Consultant shall indemnify and hold
 harmless Seller, Buyer, and RNWF and their respective officers, directors, managers, members,
 partners, agents, and representatives from and against any and all losses, liabilities, claims,
 damages, costs, and expenses including reasonable attorney's fees arising out of or
 relating to

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) any breach by Consultant of any representation, warranty, covenant, or obligation under this Agreement or the Consulting Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Consultant's acts or omissions in performing transitional or extended services except to the extent such losses result from the instructions or actions of RNWF

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) any claim asserted by a third-party alleging Consultant's violation of a confidentiality or non-disclosure obligation

&nbsp;&nbsp;&nbsp;&nbsp;9.5. <u>Indemnification by Kepler</u>. Kepler shall indemnify and hold harmless RNWF and Buyer and their respective
 officers, directors, managers, members, partners, agents, and representatives from and against
 any and all losses, liabilities, claims, damages, costs, and expenses including reasonable
 attorneys fees arising out of or relating to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) any breach by Kepler of any representation, warranty, covenant, or obligation under the Share Exchange Agreement or any other Transaction Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any liability of Kepler arising from events occurring prior to the Closing other than liabilities disclosed in the Share Exchange Agreement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) any claim that Kepler lacks proper title to the equity interests to be exchanged or that such equity interests are subject to an undisclosed lien, claim, or encumbrance

&nbsp;&nbsp;&nbsp;&nbsp;9.6. <u>Claims Procedure</u>. A Party seeking indemnification under this Section shall provide the indemnifying
 Party with prompt written notice of any claim for which indemnification is sought. Failure
 to provide such notice shall not relieve the indemnifying Party of its obligations except
 to the extent that the failure materially prejudices the indemnifying Party's ability
 to defend the claim. The indemnifying Party shall have the right to assume the defense of
 any claim with counsel reasonably acceptable to the indemnified Party, provided that the
 indemnified Party may participate in such defense at its own expense. No settlement of any
 claim shall be made without the prior written consent of the indemnified Party if such settlement
 imposes any obligation or admission of liability on the indemnified Party.

&nbsp;&nbsp;&nbsp;&nbsp;9.7. <u>Limitations</u>.
 No Party shall be liable under this Section for any consequential, special, incidental, exemplary,
 or punitive damages except to the extent such damages are awarded to a third party in a claim
 covered by this Section. The indemnification obligations under this Section shall survive
 the Closing for the period set forth in the applicable Transaction Agreements or, if no period
 is specified, for a period of two years following the Closing Date.

**10.** MISCELLANEOUS

&nbsp;&nbsp;&nbsp;&nbsp;10.1. <u>Entire Agreement</u>. This Agreement together with the other Transaction Agreements constitutes
 the entire agreement among the Parties with respect to the subject matter hereof and supersedes
 all prior negotiations, understandings, or agreements whether written or oral relating to
 such subject matter. No Party has relied upon any statement, representation, warranty, or
 agreement of any other Party except as expressly set forth in this Agreement or in the other
 Transaction Agreements.

&nbsp;&nbsp;&nbsp;&nbsp;10.2. <u>Amendments and Waivers</u>. No amendment or modification of this Agreement shall be valid unless in
 writing and executed by all Parties. No waiver of any provision of this Agreement shall be
 effective unless in writing and executed by the Party granting such waiver. No failure or
 delay by any Party in exercising any right, remedy, power, or privilege under this Agreement
 shall operate as a waiver thereof.

&nbsp;&nbsp;&nbsp;&nbsp;10.3. <u>Notices</u>.
 All notices, requests, demands, and other communications required or permitted under this
 Agreement shall be in writing and shall be deemed given:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) when delivered personally

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) on the date sent if sent by electronic mail with confirmation of transmission

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) one business day after being deposited for overnight delivery with a nationally recognized courier service

Notices shall be sent to the addresses set forth in the signature pages or to such other address as a Party may designate by written notice to the other Parties.

&nbsp;&nbsp;&nbsp;&nbsp;10.4. <u>Governing Law</u>. This Agreement and all disputes arising under or relating to this Agreement shall
 be governed by and construed in accordance with the laws of the State of Delaware without
 regard to its conflict of laws principles.

&nbsp;&nbsp;&nbsp;&nbsp;10.5. <u>Assignment</u>.
 No Party may assign or transfer this Agreement or any of its rights or obligations hereunder
 without the prior written consent of the other Parties except that Buyer may assign its rights
 under this Agreement to an affiliated entity designated to hold the Control Share. Any assignment
 in violation of this Section shall be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;10.6. <u>Binding Effect</u>. This Agreement shall be binding upon and shall inure to the benefit of the Parties
 and their respective successors and permitted assigns.

&nbsp;&nbsp;&nbsp;&nbsp;10.7. <u>Severability</u>.
 If any provision of this Agreement is determined to be invalid, illegal, or unenforceable
 in any respect, the validity, legality, and enforceability of the remaining provisions shall
 not be affected. The Parties shall negotiate in good faith to replace any invalid or unenforceable
 provision with a valid provision that most closely reflects the original intent of the Parties.

&nbsp;&nbsp;&nbsp;&nbsp;10.8. <u>Counterparts</u>.
 This Agreement may be executed in multiple counterparts each of which shall be deemed an
 original but all of which together shall constitute one and the same agreement. Signatures
 transmitted by electronic means shall be deemed original signatures for all purposes.

&nbsp;&nbsp;&nbsp;&nbsp;10.9. <u>Transaction Agreements</u>. Each Transaction Agreement shall be interpreted together with this Agreement
 to the extent reasonably possible. In the event of a conflict between this Agreement and
 any other Transaction Agreement, the provisions of the other Transaction Agreement shall
 control solely with respect to the subject matter of that agreement.

&nbsp;&nbsp;&nbsp;&nbsp;10.10. <u>Fees and Expenses</u>. Except as otherwise expressly provided in this Agreement, each Party shall
 bear its own costs and expenses incurred in connection with the negotiation, execution, and
 performance of this Agreement and the other Transaction Agreements. RNWF shall be responsible
 for all issuer level fees associated with the Change of Control, the Share Exchange, and
 required corporate filings.

&nbsp;&nbsp;&nbsp;&nbsp;10.11. <u>Third Party Beneficiaries</u>. This Agreement is for the sole benefit of the Parties and their
 permitted successors and assigns and shall not confer upon any third party any legal or equitable
 right, benefit, or remedy of any kind except as expressly provided in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;10.12. <u>Further Actions</u>. Each Party shall take such further actions and execute such additional documents
 as may be reasonably necessary or appropriate to carry out the intent of this Agreement and
 the other Transaction Agreements.

&nbsp;&nbsp;&nbsp;&nbsp;10.13. <u>Survival</u>.
 All covenants and obligations of the Parties that by their terms contemplate performance
 after the Closing shall survive the Closing. All representations, warranties, and indemnification
 obligations shall survive the Closing for the periods set forth in Section 9.

&nbsp;&nbsp;&nbsp;&nbsp;10.14. <u>Headings</u>.
 The headings contained in this Agreement are for convenience only and shall not affect the
 interpretation of this Agreement.

*{Signature Page Follows}*

 

 

 

 

 

IN WITNESS WHEREOF, the Parties have executed this Master Sales Agreement as of the Effective Date first written above.

**SELLER**

Manufacturing 360, LLC

By: <u>/s/ Richard Hawkins</u> 

Richard Hawkins, Sole Member

**BUYER**

Earth Sciences Fund I LLC

By: <u>/s/ Brent Nelson</u> 

Brent Nelson, CEO

**RNWF**

Renewal Fuels, Inc.

By: <u>/s/ Richard Hawkins</u> 

Richard Hawkins, CEO & Chairman

**CONSULTANT**

RH2 Equity Partners, LP

By: <u>/s/ Richard Hawkins</u> 

Richard Hawkins, Managing Partner

 

 

 

 

The following exhibits and schedules are attached to this Agreement and incorporated herein:<br>

**Exhibit A – Stock Transfer Agreement**

Agreement between Seller and Buyer relating to the transfer of the Control Share.

**Exhibit B – Share Exchange Agreement**

Agreement between RNWF and Kepler relating to the exchange of all issued and outstanding equity of Kepler.

**Exhibit C – Consulting and Advisory Services Agreement**

Agreement between RNWF and Consultant relating to transitional and extended advisory services.

**Exhibit D – Pinnacle Note Settlement, Exchange and Assignment Agreement**

Agreement governing the settlement, exchange, and assignment of the Pinnacle Notes held by Consultant, including issuance of shares and assignment of remaining value to Buyer's designated assignees.

**Exhibit E – CMB Note Settlement, Exchange and Assignment Agreement**

Agreement governing the settlement, exchange, and assignment of the CMB Notes held by Consultant, including issuance of shares and assignment of remaining value to Buyer's designated assignees.<br>**Exhibit F – Settlement and Exchange Designated Agreement**

Agreement governing the settlement, exchange, and assignment of the Pinnacle and CMB Notes held by Consultants, including issuance of shares and assignment of remaining value to Buyer's designated assignees.<br>

**Schedule 2 – RNWF Capitalization Table**

Delivered by RNWF at Closing and updated as of the Closing Date.

**Schedule 3 – Kepler Organizational Documents**

Including formation documents, good standing, contracts, IP lists, and corporate records.

**Schedule 4 – Seller Transfer Documents**

Including the endorsed stock power and any instruments required for transfer of the Control Share.

**Schedule 5 – Buyer Corporate Approvals**

Buyer's resolutions and consents authorizing entry into the Transaction.

## Exhibit 10.2

Exhibit 10.2

**Share Exchange Agreement**

This Share Exchange Agreement (this "Agreement") is entered into as of December 16, 2025 (the "Effective Date"), by and between Renewal Fuels, Inc., a Delaware corporation ("RNWF" or the "Company"), and Brent Nelson, an individual and the sole controler of Kepler Fusion Technologies Inc., a Texas corporation ("KEPLER" or the "Target") (the "Seller"). RNWF and Seller may be referred to herein individually as a "Party" and collectively as the "Parties."

WHEREAS, pursuant to that certain Stock Purchase Agreement dated as of December 16, 2025 (the "Stock Purchase Agreement"), by and between Manufacturing 360, LLC, as seller, and Earth Sciences Fund I LLC, as buyer, ESF acquired control of RNWF by purchasing one (1) share of RNWF's 2020 Series A Special Preferred Stock (the "Control Share"), which carries two times the total voting power of all other outstanding securities of RNWF and therefore confers full shareholder-level voting control;

WHEREAS, following the consummation of the Stock Purchase Agreement pursuant to which Earth Sciences Fund I LLC ("ESF") acquired the Control Share of RNWF, the Parties intend to effect a business combination through a share exchange under which RNWF will acquire one hundred percent (100%) of the issued and outstanding equity interests of KEPLER;

WHEREAS, Seller owns or controls all of the issued and outstanding equity interests of KEPLER, which he desires to exchange with RNWF for newly issued shares of RNWF capital stock (the "Exchange Shares"), subject to the terms and conditions set forth herein;

WHEREAS, concurrently with the exchange, KEPLER shall become a wholly owned subsidiary of RNWF, and RNWF shall be the surviving publicly traded parent company of the combined enterprise (the "Reverse Merger"); and

WHEREAS, the Parties desire to enter into this Agreement to effect the exchange of equity interests and to set forth certain representations, warranties, covenants, and agreements with respect thereto.

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

**1.** DEFINITIONS AND INTERPRETATION

&nbsp;&nbsp;&nbsp;&nbsp;1.1. <u>Definitions</u>. For purposes of this Agreement, the following terms shall have the meanings set
forth below:

**"Affiliate"** means, with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by, or is under common control with, such Person.

**"Agreement"** has the meaning set forth in the Preamble.

**"Business Day"** means any day except Saturday, Sunday or any other day on which commercial banks located in New York, New York are authorized or required by Law to be closed for business.

**"Closing"** has the meaning set forth in Section 4.1.

**"Closing Date"** has the meaning set forth in Section 4.1.

**"RNWF"** means Renewal Fuels, Inc., a Delaware corporation.

**"Exchange Shares"** means the shares of RNWF capital stock issued to Seller in exchange for all of Seller's equity interests in KEPLER pursuant to this Agreement.

**"Governmental Authority"** means any federal, state, local or foreign government or political subdivision thereof, or any agency or instrumentality of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental authority (to the extent that the rules, regulations or orders of such organization or authority have the force of Law), or any arbitrator, court or tribunal of competent jurisdiction.

**"Law"** means any federal, state, local or foreign law, statute, ordinance, rule, regulation, code, order, constitution, treaty, common law, judgment, decree or other requirement or rule of law of any Governmental Authority.

**"Order"** means any order, injunction, judgment, decree, ruling, writ, assessment or arbitration award of a Governmental Authority.

**"Parties"** Parties means RNWF and Seller, and **"Party"** means either of them individually.

**"Person"** means an individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization, trust, association or other entity.

**"Reverse Merger"** has the meaning set forth in the recitals to this Agreement.

**"Seller"** means Brent Nelson, the sole controller of all outstanding equity interests of KEPLER.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2. <u>Interpretation</u>. Unless the context of this Agreement otherwise requires: (a) words of any gender
include each other gender; (b) words using the singular or plural number also include the plural or singular number, respectively; (c)
the terms "hereof," "herein," "hereby" and derivative or similar words refer to this entire Agreement; (d)
the terms "Article" or "Section" refer to the specified Article or Section of this Agreement; (e) references to "including"
shall mean "including, without limitation;" and (f) references to agreements and other documents shall be deemed to include
all subsequent amendments and other modifications thereto.

**2.** SHARE EXCHANGE

&nbsp;&nbsp;&nbsp;&nbsp;2.1. <u>Exchange of Kepler Equity Interests</u>. Seller hereby transfers, assigns, and
delivers to RNWF all of Seller's right, title, and interest in and to one hundred percent (100%) of the issued and outstanding equity
interests of KEPLER, free and clear of all Liens, and RNWF hereby accepts such equity interests in exchange for the issuance of the Exchange
Shares as set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;2.2. <u>Form of Transfer</u>. The transfer of the KEPLER equity interests shall be effected
at Closing through the delivery of all certificates, stock certificates, equity ledgers, assignments, or other instruments necessary to
transfer record and beneficial ownership of KEPLER to RNWF, and shall be reflected in the books and records of KEPLER immediately upon
Closing.

&nbsp;&nbsp;&nbsp;&nbsp;2.3. <u>No Assumed Liabilities</u>. RNWF is acquiring the Kepler Equity Interests only
and is not assuming any liabilities or obligations of Seller of any kind, whether known or unknown, fixed or contingent, unless expressly
set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;2.4. <u>As-Is Transaction</u>. RNWF acknowledges and agrees that the Kepler Equity Interests
are being transferred on an "as-is, where-is" basis, with all faults and without any representation or warranty of any kind,
express or implied, by Seller, except as expressly set forth in this Agreement. Buyer further acknowledges that it has conducted its own
independent investigation of KEPLER and RNWF and has not relied on any representations or warranties by Seller or any other Person, except
those expressly set forth in this Agreement.

**3.** EXCHANGE CONSIDERATION

As consideration for the transfer and assignment of all issued and outstanding equity interests of Kepler Fusion Technologies Inc. ("KEPLER") to Renewal Fuels, Inc. ("RNWF"), and in accordance with the overall transaction structure contemplated by the Master Sales Agreement dated December 16, 2025 (the "MSA"), the Parties acknowledge and agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;3.1. Effective as of the Closing, RNWF shall acquire all right, title, and interest
in and to one hundred percent (100%) of the issued and outstanding equity interests of KEPLER, free and clear of all liens, claims, and
encumbrances (except as set forth in this Agreement or the Disclosure Schedules), thereby making KEPLER a wholly owned subsidiary of RNWF.

&nbsp;&nbsp;&nbsp;&nbsp;3.2. <u>Acknowledgment of Prior Change of Control</u>. The Parties acknowledge that
voting and governance control of RNWF was previously transferred pursuant to the Stock Purchase Agreement dated December 16, 2025, between
Manufacturing 360, LLC, as seller, and Earth Sciences Fund I LLC, as buyer, under which Earth Sciences Fund I LLC acquired one (1) share
of RNWF's 2020 Series A Special Preferred Stock (the "Control Share"), which carries voting rights equal to two times
the aggregate voting power of all other outstanding classes and series of RNWF and therefore confers full shareholder-level voting control.
As a result of such transaction, Earth Sciences Fund I LLC, and its designated affiliates hold majority voting control of RNWF. This Agreement
does not transfer or modify the Control Shares or the voting rights associated therewith but instead effectuates the exchange of Seller's
equity interests in KEPLER for newly issued shares of RNWF in accordance with the terms set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;3.3. <u>Exchange Shares</u>. The Parties acknowledge and agree that the Exchange Shares
to be issued to Seller, whether at Closing or pursuant to post-Closing capitalization actions authorized by RNWF, shall constitute the
consideration for the acquisition of KEPLER pursuant to this Agreement.

**4.** CLOSING

&nbsp;&nbsp;&nbsp;&nbsp;4.1. <u>Closing</u>. The closing of the transactions contemplated by this Agreement
(the "Closing") shall take place remotely via electronic exchange of documents and signatures on or before December 16, 2025,
or at such other time as the Parties may mutually agree in writing (the "Closing Date").

&nbsp;&nbsp;&nbsp;&nbsp;4.2. <u>Deliveries by Seller</u>. At the Closing, Seller shall deliver, or cause to
be delivered, to RNWF the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) an executed assignment of all of Seller's equity interests in KEPLER, sufficient
to transfer to RNWF one hundred percent (100%) of the issued and outstanding equity interests of KEPLER, free and clear of all Liens;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) the organizational documents, corporate records, minute books, and capitalization
records of KEPLER, to the extent in Seller's possession or control;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) any additional transfer instruments reasonably required to effectuate the transfer
of KEPLER to RNWF as contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;4.3. <u>Deliveries by RNWF</u>. At the Closing, RNWF shall deliver to Seller:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) evidence of RNWF's obligation to issue the Exchange Shares to Seller, which
shall be duly authorized and issued either at Closing or pursuant to post-Closing capitalization actions in accordance with this Agreement
and the Master Sales Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any executed agreements or deliverables required under this Agreement or reasonably
requested by Seller to effectuate the exchange.

&nbsp;&nbsp;&nbsp;&nbsp;4.4. <u>Effect of Closing</u>. Upon consummation of the Closing:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) RNWF shall acquire all right, title, and interest in and to KEPLER, and Seller
shall become a wholly owned subsidiary of RNWF;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Seller shall be entitled to receive the Exchange Shares in accordance with this
Agreement and the Master Sales Agreement, and upon issuance Seller shall hold such Exchange Shares with all rights appurtenant thereto.

&nbsp;&nbsp;&nbsp;&nbsp;4.5. <u>Further Assurances</u>. Each Party agrees to execute and deliver such further
documents and take such additional actions after the Closing as may be reasonably necessary to carry out the intent and purpose of this
Agreement.

**5.** REPRESENTATIONS AND WARRANTIES OF SELLER

Seller hereby represents and warrants to RNWF as of the date hereof and as of the Closing Date as follows:

&nbsp;&nbsp;&nbsp;&nbsp;5.1. <u>Authority</u>. Seller has full legal capacity, power, and authority to enter
into this Agreement and to perform all obligations hereunder. This Agreement constitutes the valid and binding obligation of Seller, enforceable
against Seller in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;5.2. <u>Ownership of Kepler Equity</u>. Seller is the controller of one hundred percent
(100%) of the issued and outstanding equity interests of KEPLER, free and clear of all Liens (other than restrictions imposed by applicable
securities laws). Seller has not pledged, assigned, granted any option to purchase, or otherwise encumbered or disposed of any of such
equity interests, and no person has any right or interest therein.

&nbsp;&nbsp;&nbsp;&nbsp;5.3. <u>No Conflicts</u>. The execution, delivery, and performance of this Agreement
by Seller, and the consummation of the transactions contemplated hereby, do not and will not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) violate any Law applicable to Seller;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) require any consent, waiver, approval, or authorization of any Governmental Authority
or other third party; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) result in a breach or violation of, or constitute a default under, any agreement
or instrument to which Seller is a party or by which Seller or the equity interests of KEPLER are bound.

&nbsp;&nbsp;&nbsp;&nbsp;5.4. <u>No Proceedings</u>. There is no action, suit, proceeding, claim, arbitration,
or investigation pending or, to Seller's knowledge, threatened against Seller that challenges or could reasonably be expected to
prevent, delay, or make illegal the consummation of the transactions contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;5.5. <u>No Broker</u>. Seller has not engaged or used the services of any broker, finder,
or investment banker in connection with the transactions contemplated by this Agreement, and no person is entitled to any brokerage, finder's,
or similar fee or commission in connection therewith from Seller.

**6.** REPRESENTATIONS AND WARRANTIES OF RNWF

RNWF hereby represents and warrants to Seller as of the Effective Date and as of the Closing Date, as follows:

&nbsp;&nbsp;&nbsp;&nbsp;6.1. <u>Organization and Authority</u>. RNWF is a corporation duly organized, validly
existing, and in good standing under the laws of the State of Delaware. RNWF has full corporate power and authority to execute, deliver,
and perform this Agreement and to consummate the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;6.2. <u>Authorization and Enforceability</u>. The execution, delivery, and performance
of this Agreement by RNWF have been duly authorized by all necessary corporate action on the part of RNWF. This Agreement has been duly
executed and delivered by RNWF and constitutes a legal, valid, and binding obligation of RNWF, enforceable against RNWF in accordance
with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;6.3. <u>No Conflicts</u>. The execution, delivery, and performance of this Agreement
by RNWF and the consummation of the transactions contemplated hereby do not and will not (a) conflict with or violate the articles of
incorporation, bylaws, or other organizational documents of RNWF, (b) violate any law, regulation, judgment, order, or decree applicable
to RNWF, or (c) result in a breach of, constitute a default under, or require any consent under any agreement or instrument to which RNWF
is a party or by which it is bound.

&nbsp;&nbsp;&nbsp;&nbsp;6.4. <u>No Consents</u>. No consent, approval, or authorization of, or filing with,
any Governmental Authority or third party is required to be obtained or made by RNWF in connection with the execution and delivery of
this Agreement or the consummation of the transactions contemplated hereby, except such as have been duly obtained or made.

&nbsp;&nbsp;&nbsp;&nbsp;6.5. <u>Investment Intent</u>. RNWF is acquiring the equity interests of KEPLER pursuant
to this Agreement for its own account and not with a view to any distribution thereof in violation of the Securities Act of 1933, as amended,
or applicable state securities laws. RNWF understands that the KEPLER equity interests have not been registered under the Securities Act
or state securities laws and may not be resold except in compliance with applicable securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;6.6. <u>No Brokers</u>. RNWF has not employed or engaged any broker, finder, or financial
advisor in connection with the transactions contemplated by this Agreement, and no broker's or finder's fees or commissions
are or will be payable by RNWF to any third party in connection herewith.

**7.** MISCELLANEOUS

&nbsp;&nbsp;&nbsp;&nbsp;7.1. <u>Entire Agreement</u>. This Agreement constitutes the entire agreement between
the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous understandings, agreements, representations,
and warranties, both written and oral, with respect to such subject matter.

&nbsp;&nbsp;&nbsp;&nbsp;7.2. <u>Amendment and Waiver</u>. No amendment to or waiver of any provision of this
Agreement shall be effective unless in writing and signed by all Parties. No waiver of any breach of any provision shall be deemed a waiver
of any subsequent breach.

&nbsp;&nbsp;&nbsp;&nbsp;7.3. <u>Successors and Assigns</u>. This Agreement shall be binding upon and inure to
the benefit of the Parties and their respective successors and permitted assigns. No Party may assign this Agreement or any rights or
obligations hereunder without the prior written consent of the other Party.

&nbsp;&nbsp;&nbsp;&nbsp;7.4. <u>No Third-Party Beneficiaries</u>. Nothing in this Agreement, express or implied,
shall confer upon any person or entity other than the Parties and their respective successors and permitted assigns any legal or equitable
right, benefit, or remedy.

&nbsp;&nbsp;&nbsp;&nbsp;7.5. <u>Governing Law</u>. This Agreement shall be governed by and construed in accordance
with the laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision.

&nbsp;&nbsp;&nbsp;&nbsp;7.6. <u>Dispute Resolution</u>. Any dispute arising out of or relating to this Agreement
shall be resolved by binding arbitration administered by the American Arbitration Association in accordance with its Commercial Arbitration
Rules. The arbitration shall take place in Los Angeles County, California before a single arbitrator. Judgment on the award rendered by
the arbitrator may be entered in any court having jurisdiction thereof. The prevailing Party in any dispute or proceeding shall be entitled
to recover its reasonable attorneys' fees and costs.

&nbsp;&nbsp;&nbsp;&nbsp;7.7. <u>Counterparts</u>; Electronic Signatures. This Agreement may be executed in counterparts,
each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Signatures delivered
electronically (including by email or DocuSign) shall be deemed valid and binding for all purposes.

&nbsp;&nbsp;&nbsp;&nbsp;7.8. <u>Further Assurances</u>. Each Party shall execute and deliver such additional
documents and take such further actions as may be reasonably required to carry out the provisions and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;7.9. <u>Severability</u>. If any provision of this Agreement is held to be invalid,
illegal, or unenforceable in any respect, the validity, legality, or enforceability of the remaining provisions shall not in any way be
affected or impaired thereby.

{Signature Page Follows}

IN WITNESS WHEREOF, the Parties have executed this Share Exchange Agreement as of the Effective Date.

**RNWF:**

**Renewal Fuels, Inc.**

By: <u>/s/ Richard Hawkins</u>

Name: Richard Hawkins

Title: Chief Executive Officer

**SELLER:**

**Brent Nelson**

By: <u>/s/ Brent Nelson</u> 

Name: Brent Nelson

Title: CEO of Kepler Fusion Technologies Inc.

## Exhibit 10.3

Exhibit 10.3

**STOCK PURCHASE AGREEMENT**

This Stock Purchase Agreement (this "Agreement") is entered into as of December 16, 2025, by and between Manufacturing 360, LLC ("Seller"), and Earth Sciences Fund I LLC, a limited liability company ("Buyer"). Seller and Buyer may be referred to herein individually as a "Party" and collectively as the "Parties".

**Recitals**

WHEREAS, Seller is the record and beneficial owner of one (1) share of 2020 Series A Special Preferred Stock of RNWF (the "Control Share"), which carries voting rights equal to two times the aggregate number of all other issued and outstanding voting securities of RNWF combined, thereby granting the Control Share effective majority voting control over all matters requiring stockholder approval;

WHEREAS, based on the current outstanding capital stock of RNWF, which includes 2,814,061,314 shares of common stock issued and outstanding as of the Effective Date, the Control Share carries voting power equal to two times the aggregate number of all other issued and outstanding voting securities of RNWF combined, and therefore represents effective majority voting control over all matters requiring stockholder approval under Delaware law or applicable securities regulations;

WHEREAS, Buyer desires to acquire from Seller, and Seller desires to sell to Buyer, all right, title, and interest in and to the Control Share, free and clear of any liens, claims, or encumbrances, on the terms and subject to the conditions set forth in this Agreement. The Parties have agreed that the Purchase Price for the Control Share shall be as set forth in the Master Sales Agreement entered into between Seller and Buyer on the Effective Date;

WHEREAS, the acquisition of the Control Share by Buyer is a condition precedent to the execution and consummation of the coordinated transactions contemplated by the Master Sales Agreement, including the Share Exchange Agreement between RNWF and Kepler Fusion Technologies Inc. ("Kepler");

WHEREAS, the Parties intend that this Agreement shall be executed simultaneously with, and form an integral part of, a coordinated set of agreements and transactions, including (a) the Master Sales Agreement entered into among the Parties, (b) the Share Exchange Agreement between RNWF and Kepler (collectively, the "Transaction Documents");

NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, and intending to be legally bound, the Parties hereby agree as follows:

**1.** Definitions

**"Affiliate"** means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with such Person.

**"Agreement"** means this Stock Purchase Agreement, together with all schedules, exhibits, and other documents referenced herein or executed in connection herewith.

**"Ancillary Agreements"** means, collectively, the Master Sales Agreement, Share Exchange Agreement, including the Consulting Agreement between RNWF and RH2 Equity Partners, entered into concurrently with this Agreement, and any other agreements, instruments, or documents entered into by the Parties in connection with the Transaction.

**"Applicable Law"** means any federal, state, local, or foreign law, statute, ordinance, rule, regulation, order, judgment, decree, or other legal requirement applicable to the Parties or the transactions contemplated by this Agreement.

**"Business Day"** means any day other than a Saturday, Sunday, or other day on which banks are authorized or required by law to be closed in New York, New York.

**"Buyer"** means Earth Sciences Fund I, LLC, a limited liability company, and its successors and assigns.

**"Closing"** means the consummation of the transactions contemplated by this Agreement, including the transfer of the Control Share from Seller to Buyer.

**"Closing Date"** means the date on which the Closing occurs, as mutually agreed by the Parties.

**"Common Stock"** means the shares of common stock, par value $0.001 per share, of RNWF.

**"Company"** means Renewal Fuels, Inc., a Delaware corporation, publicly traded under the ticker symbol "RNWF."

**"Control Share"** means one (1) share of the Company's 2020 Series A Special Preferred Stock, par value $0.0001 per share, held by Seller, which carries voting rights equal to two times the aggregate number of all other issued and outstanding voting securities of RNWF combined.

**"Disclosure Schedules"** means the schedules delivered by each Party to the other in connection with this Agreement, setting forth exceptions to the representations and warranties and other matters.

**"Effective Date"** means the date first written above on which this Agreement is executed and deemed effective by the Parties.

**"RNWF"** means Renewal Fuels, Inc., a Delaware corporation and the subject of the change-of-control transaction described herein.

**"Exchange Act"** means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

**"Fundamental Representations"** means the representations and warranties of Seller set forth in Section 7.1(a) (Authority) and Section 7.1(b) (Ownership of Shares).

**"Governmental Authority"** means any U.S. federal, state, or local or non-U.S. government, governmental authority, regulatory or administrative agency, court, tribunal, or other body with jurisdiction over the Parties or the Transaction.

**"Indebtedness"** means, with respect to any Person, all obligations (a) for borrowed money, (b) evidenced by bonds, notes, or similar instruments, (c) for the deferred purchase price of goods or services outside the ordinary course of business, or (d) under capital leases.

**"Lien"** means any charge, claim, lien, pledge, security interest, encumbrance, mortgage, option, right of first refusal, or restriction of any kind.

**"Material Adverse Effect"** means any event, change, or effect that is materially adverse to the business, assets, financial condition, or operations of the applicable Party, or that would prevent or materially delay the consummation of the Transaction.

**"Master Sales Agreement"** means that certain Master Sales Agreement entered into as of December 16, 2025, by and among Seller and Buyer.

**"OTC Markets"** means the OTC Markets Group Inc. and the quotation system operated thereby, including OTC Pink and OTCQB.

**"Party"** means Seller or Buyer individually, and "Parties" means all of them collectively.

**"Person"** means an individual, corporation, limited liability company, partnership, joint venture, trust, governmental body, or other legal entity.

**"Preferred Stock"** means the 2020 Series A Special Preferred Stock of RNWF, par value $0.0001 per share, including the Control Share.

**"Purchase Price"** means one thousand dollars ($1,000) payable by Buyer to Seller for the Control Share, as required under the Letter of Intent dated November 27, 2025.

**"Reverse Merger"** means the transaction contemplated under the Share Exchange Agreement whereby Buyer shall become a wholly owned subsidiary of RNWF and RNWF shall become the publicly traded parent company of the combined enterprise.

**"SEC"** means the United States Securities and Exchange Commission.

**"Securities Act"** means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

**"Seller"** means Manufacturing 360, LLC, a limited liability company, and the record and beneficial owner of the Control Share.

**"Share Exchange Agreement" or "SEA"** means that certain Share Exchange Agreement to be entered into by and between RNWF and Kepler.

**"Stock Purchase Agreement" or "SPA"** means this Agreement.

**"Transaction"** means the collective transactions contemplated by this Agreement, including the sale of the Control Share, the Reverse Merger, and the execution of the Ancillary Agreements.

**"Transaction Agreements"** means this Agreement, the Master Sales Agreement, the Share Exchange Agreement, and all other documents executed in connection with the Transaction.

**2.** Purchase
 and Sale of the Control Share

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1. <u>Purchase and Sale</u>. Subject
 to the terms and conditions of this Agreement, Seller hereby agrees to sell, assign, transfer,
 and convey to Buyer, and Buyer agrees to purchase and accept from Seller, all right, title,
 and interest in and to the Control Share, free and clear of any liens, encumbrances, pledges,
 restrictions, charges, or claims of any kind, other than those arising under applicable federal
 and state securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2. <u>Purchase Price</u>. In consideration
 for the sale and transfer of the Control Share, Buyer shall pay to Seller the $1,000 Purchase
 Price (as defined in Section 1), in immediately available lawful funds of the United States,
 via wire transfer to an account designated in writing by Seller prior to Closing. The Purchase
 Price shall not be subject to adjustment except as otherwise provided in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3. <u>Payment Timing</u>. Payment of
 the Purchase Price shall be made simultaneously with the delivery of the Control Share and
 all related transfer instruments at the Closing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4. <u>Delivery of Share</u>. At Closing,
 Seller shall deliver to Buyer (or Buyer's designee) one or more medallion-guaranteed
 stock powers, along with the original share certificates representing the Control Share (if
 certificated), duly endorsed for transfer, or such other evidence of transfer acceptable
 to the transfer agent of RNWF.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5. <u>No Assumption of Liabilities</u>.
 Buyer shall not assume, and shall not be deemed to have assumed, any liabilities or obligations
 of Seller, whether known or unknown, fixed or contingent, other than those expressly provided
 in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.6. <u>Effect of Transfer</u>. Upon the
 consummation of the transactions contemplated by this Agreement, Buyer shall own the Control
 Share and shall have all of the rights of a holder thereof, including the full voting rights
 associated with the Control Share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.7. <u>Acknowledgment of Control</u>.
 Buyer acknowledges that, upon acquisition of the Control Share, Buyer will hold a majority
 of the total voting power of RNWF and shall have effective control over all shareholder-level
 decisions requiring approval under Delaware corporate law or applicable securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.8. <u>No Further Rights</u>. Except
 for the rights expressly granted in this Agreement, Buyer shall not have any right, title,
 or interest in or to any other assets of Seller or of RNWF. Buyer acknowledges that Seller
 makes no representations or warranties regarding RNWF or its business, operations, assets,
 liabilities, or prospects except as specifically stated in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.9. <u>As-Is; No Reliance</u>. Buyer
 acknowledges and agrees that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) the
 Control Share is being sold on an "as-is, where-is" basis, with all faults and
 without any representation or warranty, express or implied, by Seller, except as expressly
 set forth herein;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Buyer
 has conducted its own independent investigation, review, and analysis of RNWF and the Control
 Share and is not relying on any representation or warranty, oral or written, express or implied,
 of Seller or any of Seller's representatives except as expressly set forth in this
 Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Seller
 expressly disclaims any and all implied warranties, including any warranty of merchantability,
 fitness for a particular purpose, or non-infringement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.10. <u>Taxes</u>. Any transfer taxes,
 stamp duties, or similar governmental charges arising in connection with the sale of the
 Control Share shall be borne by Buyer. Each Party shall be responsible for its own income
 tax obligations related to this Agreement <u>.</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.11. <u>Further Assurances</u>. Each
 Party agrees to execute and deliver such further documents and instruments and to take such
 further actions as may be reasonably necessary to effectuate the purposes of this Section
 2 and to complete the sale and purchase of the Control Share as contemplated herein.

**3.** Representations
 and Warranties

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1. <u>Representations and Warranties of Seller</u>. Seller hereby represents and warrants to Buyer as of the Effective Date and
 as of the Closing Date as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.1. Authority. Seller has full legal
 right, power, and authority to execute and deliver this Agreement and each of the Transaction
 Documents to which Seller is a party and to consummate the transactions contemplated hereby
 and thereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.2. Title to Share. Seller is the sole
 legal and beneficial owner of the Control Share, free and clear of all liens, encumbrances,
 pledges, restrictions, charges, or claims of any kind, other than restrictions under applicable
 securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.3. Enforceability. This Agreement and
 each of the Transaction Documents have been duly authorized, executed, and delivered by Seller
 and constitute the legal, valid, and binding obligations of Seller, enforceable in accordance
 with their terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.4. No Conflicts. The execution, delivery,
 and performance of this Agreement by Seller, and the consummation of the transactions contemplated
 herein, do not and will not (a) violate any provision of applicable law or regulation; (b)
 conflict with any judgment, order, or decree applicable to Seller; or (c) require any consent
 or approval that has not been obtained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.5. No Legal Proceedings. There is no
 action, suit, investigation, claim, arbitration, or legal proceeding pending or, to Seller's
 knowledge, threatened against Seller that questions the validity of this Agreement or any
 of the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.6. No Brokers. No broker, finder, investment
 banker, or other intermediary is entitled to any brokerage, finder's, or similar fee
 or commission in connection with the transactions contemplated by this Agreement based on
 arrangements made by or on behalf of Seller.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.7. Accredited Investor. Seller is an
 entity that qualifies as an 'accredited investor' under Rule 501(a) of Regulation
 under the Securities Act and is acquiring the consideration for its own account and not with
 a view to any resale or distribution thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.8. Independent Legal Advice. Seller
 has had the opportunity to consult with legal and tax advisors of its choosing regarding
 this Agreement and the transactions contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.9. Sophistication. Seller is sufficiently
 experienced in financial and business matters to evaluate the merits and risks of the transactions
 contemplated herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.10. Valid Issuance. The Control Share
 were validly issued in accordance with the Company's Certificate of Designation for
 the 2020 Series A Special Preferred Stock and applicable law and are duly authorized, fully
 paid, and non-assessable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.11. No Governmental Approvals. No consent,
 approval, license, permit, order, or authorization of, or registration, declaration, or filing
 with, any governmental authority is required to be obtained or made by Seller in connection
 with the execution, delivery, or performance of this Agreement or the consummation of the
 transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.12. No Other Representations. Except
 as expressly set forth in this Agreement, Seller makes no representations or warranties,
 express or implied, at law or in equity, in respect of RNWF or the Control Share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1.13. Survival. The representations and
 warranties of Seller shall survive the Closing for a period of twelve (12) months.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2. <u>Representations and Warranties of Buyer</u>. Buyer represents and warrants to Seller as of the Effective Date and as of
 the Closing Date as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2.1. Organization and Authority. Buyer
 is a limited liability company duly organized, validly existing, and in good standing under
 the laws of the State of Delaware, with full power and authority to execute and deliver this
 Agreement and each of the Transaction Documents to which it is a party and to perform its
 obligations hereunder and thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2.2. Authorization; Enforceability. The
 execution, delivery, and performance by Buyer of this Agreement and the consummation of the
 transactions contemplated herein have been duly authorized by all necessary corporate action.
 This Agreement and each of the Transaction Documents constitute legal, valid, and binding
 obligations of Buyer, enforceable against Buyer in accordance with their terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2.3. No Conflicts. The execution, delivery,
 and performance of this Agreement and the consummation of the transactions contemplated herein
 do not and will not (a) violate any provision of applicable law or regulation; (b) conflict
 with or result in a breach of Buyer's articles of incorporation, bylaws, or other governing
 documents; or (c) require any consent or approval that has not been obtained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2.4. Investment Intent. Buyer is acquiring
 the Control Share for its own account for investment purposes only and not with a view to
 or for sale in connection with any distribution thereof in violation of the Securities Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2.5. Sophistication and Due Diligence.
 Buyer has conducted its own independent investigation and due diligence regarding RNWF and
 the Control Share and is capable of evaluating the risks and merits of acquiring the Control
 Share. Buyer acknowledges that except as expressly stated in this Agreement, neither Seller
 nor RNWF makes any representations or warranties regarding RNWF's condition or prospects.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2.6. No Brokers. No broker, finder, investment
 banker, or other intermediary is entitled to any brokerage, finder's, or similar fee
 or commission in connection with the transactions contemplated by this Agreement based on
 arrangements made by or on behalf of Buyer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2.7. No Legal Proceedings. There is no
 action, suit, investigation, claim, arbitration, or legal proceeding pending or, to Buyer's
 knowledge, threatened against Buyer that would affect Buyer's ability to perform its
 obligations hereunder or consummate the transactions contemplated by this Agreement.

**4.** Conditions
 to Closing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1. <u>Mutual Conditions</u>. The obligations
 of the Parties to consummate the transactions contemplated by this Agreement are subject
 to the satisfaction (or written waiver by both Parties) of the following conditions on or
 prior to the Closing Date:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) No
 Governmental Authority shall have enacted, issued, promulgated, enforced, or entered any
 Law or Order that is in effect and restrains, enjoins, or otherwise prohibits the consummation
 of the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) There
 shall be no pending or threatened litigation, arbitration or proceeding that seeks to restrain,
 enjoins, delay, or otherwise challenge the transactions contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2. <u>Conditions to Buyer's Obligations</u>.
 The obligation of Buyer to consummate the transactions contemplated hereby is subject to
 the satisfaction (or waiver by Buyer) of the following additional conditions on or prior
 to the Closing Date:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) The
 representations and warranties of Seller contained in this Agreement shall be true and correct
 in all material respects as of the date hereof and as of the Closing Date (except to the
 extent that any such representation or warranty is expressly made as of a specific date,
 in which case it shall be true and correct as of such specific date).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Seller
 shall have performed and complied in all material respects with all covenants, obligations,
 and agreements required to be performed by Seller under this Agreement on or prior to the
 Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Seller
 shall have delivered to Buyer all items required under Section 2.4, including stock powers,
 share certificates (if certificated), and any other documents reasonably requested by Buyer
 to effectuate the transfer of the Control Share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) All
 required third-party consents and approvals, if any, shall have been obtained to the extent
 necessary to consummate the transactions contemplated hereby. The Control Share shall be
 delivered free and clear of all liens, pledges, restrictions, and other encumbrances, other
 than restrictions arising under applicable securities laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3. <u>Conditions to Seller's Obligations</u>.
 The obligation of Seller to consummate the transactions contemplated hereby is subject to
 the satisfaction (or waiver by Seller) of the following additional conditions on or prior
 to the Closing Date:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) The
 representations and warranties of Buyer contained in this Agreement shall be true and correct
 in all material respects as of the date hereof and as of the Closing Date (except to the
 extent that any such representation or warranty is expressly made as of a specific date,
 in which case it shall be true and correct as of such specific date).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Buyer
 shall have performed and complied in all material respects with all covenants, obligations,
 and agreements required to be performed by Buyer under this Agreement on or prior to the
 Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Buyer
 shall have delivered the Purchase Price to Seller in accordance with Section 2.2, and shall
 have delivered any other documents or instruments reasonably requested by Seller in connection
 with the Closing.

**5.** Closing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1. <u>Closing Date</u>. The closing
 of the transactions contemplated by this Agreement (the "Closing") shall take
 place remotely via electronic exchange of documents and signatures on December 16, 2025,
 or at such other time and place as the Parties may mutually agree in writing (the "Closing
 Date").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2. <u>Conditions to Buyer's Obligations</u>.
 The obligations of Buyer to consummate the Closing are subject to the satisfaction or written
 waiver, on or before the Closing Date, of the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) The
 representations and warranties of Seller contained in this Agreement shall be true and correct
 in all material respects (and true and correct in all respects with respect to the Fundamental
 Representations set forth in Sections 3.1.1 through 3.1.4) as of the Closing Date (except
 for representations and warranties that speak as of a specific date, which shall be true
 and correct as of such date);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Seller
 shall have performed in all material respects all covenants and agreements required to be
 performed by it on or prior to the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) Seller
 shall have delivered the deliverables set forth in Section 2.4;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) Buyer
 shall have received evidence, in form and substance satisfactory to Buyer, that any known
 or material liabilities have been disclosed, resolved, or waived to Buyer's satisfaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) No
 Order shall have been issued by any Governmental Authority preventing the Closing or rendering
 the transactions contemplated hereby illegal or unenforceable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3. <u>Conditions to Seller's Obligations</u>.
 The obligations of Seller to consummate the Closing are subject to the satisfaction or written
 waiver, on or before the Closing Date, of the following conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) The
 representations and warranties of Buyer shall be true and correct in all material respects
 as of the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) Buyer
 shall have performed in all material respects all covenants and agreements required to be
 performed by it on or prior to the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4. Buyer shall have
 delivered the Purchase Price to Seller in accordance with Section 2.2.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5. <u>Waiver of Conditions</u>. Any
 condition set forth in this Section 5 may be waived in writing at or prior to the Closing
 by the Party entitled to the benefit thereof.

**6.** Covenants
 Prior to Closing

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1. <u>Conduct of Business</u>. From
 the date of this Agreement until the Closing, RNWF shall operate in the ordinary course of
 business consistent with past practice and shall not take any action outside the ordinary
 course without the prior written consent of Buyer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2. <u>No Transfer of Interests</u>.
 Seller shall not sell, assign, transfer, pledge, or otherwise dispose of any of the Control
 Share, or agree to do so, except as expressly contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3. <u>Exclusivity</u>. Seller shall
 not, solicit, encourage, or engage in any negotiations with any third party relating to the
 sale or transfer of the Control Share or any change of control of RNWF, equity, or business,
 other than to Buyer, until the earlier of (a) the Closing or (b) the termination of this
 Agreement. Seller shall immediately terminate any prior discussions with third parties upon
 execution hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4. <u>Notice of Material Events</u>.
 Seller shall promptly notify Buyer of (a) any material breach of this Agreement, (b) any
 fact or circumstance that would cause any representation or warranty of Seller to be inaccurate,
 or (c) any event or change that would materially affect RNWF.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5. <u>Access and Cooperation</u>. Seller
 shall provide Buyer and its representatives with reasonable access during normal business
 hours to RNWF's books, records, personnel, properties, and other relevant information,
 and shall cooperate with Buyer in completing its confirmatory due diligence.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6. <u>Efforts</u>. Each Party shall
 use commercially reasonable efforts to take all actions and to do all things necessary, proper,
 or advisable to consummate the transactions contemplated by this Agreement, including securing
 any required consents or approvals and satisfying the conditions to Closing.

<u>6</u>.7 <u>Public Announcements</u>. No Party shall make any public disclosure regarding this Agreement or the transactions contemplated hereby without the other Party's prior written consent, except as required by applicable Law or securities exchange rules (in which case, the disclosing Party shall provide the other Party with a reasonable opportunity to review and comment on such disclosure prior to its release) including compliance with Section 6 of the Letter of Intent.

**7.** Indemnification

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1. <u>Survival</u>. The representations,
 warranties, covenants, and agreements of the Parties contained in this Agreement shall survive
 the Closing for a period of eighteen (18) months, except (i) the Fundamental Representations
 (as defined in Section 1) shall survive until sixty (60) days after the expiration of the
 applicable statute of limitations, and (ii) claims arising from fraud or intentional misrepresentation
 shall survive indefinitely. All other representations and warranties shall survive for twelve
 (12) months following the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2. <u>Indemnification by Seller</u>.
 From and after the Closing, Seller shall indemnify, defend, and hold harmless Buyer, its
 affiliates, and their respective officers, directors, managers, employees, equity holders,
 successors, and assigns (collectively, the "Buyer Indemnified Parties") from
 and against any and all losses, liabilities, damages, claims, costs, interest, awards, judgments,
 and expenses (including reasonable attorneys' fees and costs of investigation and enforcement)
 ("Losses") arising out of or resulting from:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) any
 breach of any representation or warranty made by Seller in this Agreement or in any certificate
 or document delivered pursuant hereto;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any
 breach or non-fulfillment of any covenant or agreement of Seller in this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) any
 liabilities or obligations associated with the Control Share arising prior to the Closing
 that are not expressly assumed by Buyer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) any
 third-party claim relating to the ownership of the Control Share prior to the Closing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e) any
 taxes imposed on Seller with respect to the sale or transfer of the Control Share prior to
 the Closing Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f) any
 debt, liability, or obligation of Seller or any of its affiliates or principals, whether
 known or unknown, fixed or contingent, secured or unsecured, including without limitation
 any obligations arising from or related to any Small Business Administration or other government-backed
 financing, credit facility, loan, guaranty, or personal guaranty. Seller acknowledges and
 agrees that all such indebtedness remains the sole responsibility and liability of the original
 obligor(s) and guarantor(s). Seller shall indemnify, defend, and hold harmless Buyer and
 its affiliates from and against any and all Losses asserted by any lender, governmental agency,
 or third party in connection with any such indebtedness.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3. <u>Indemnification by Buyer</u>.
 From and after the Closing, Buyer shall indemnify, defend, and hold harmless Seller and its
 affiliates, and its and their respective officers, managers, employees, equity holders, successors,
 and assigns (collectively, the "Seller Indemnified Parties") from and against
 any and all Losses arising out of or resulting from:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) any
 breach of any representation or warranty made by Buyer in this Agreement or in any document
 delivered pursuant hereto;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any
 breach or non-fulfillment of any covenant, agreement, or obligation of Buyer in this Agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) the
 operation of RNWF or its subsidiaries after the Closing Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4. <u>Limitations</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) No
 Party shall be liable for indemnification under Sections 7.2 or 7.3 unless the aggregate
 amount of Losses exceeds $50,000 (the "Basket"), in which case the indemnified
 Party shall be entitled to recover all Losses from the first dollar; provided, the Basket
 shall not apply to breaches of Fundamental Representations. The maximum liability of either
 Party under this Article shall not exceed ten percent (10%) of the aggregate fair market
 value of the Purchase Price (the "Cap"), except for breaches of Fundamental Representations
 or fraud/intentional misconduct (which shall have no Cap).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) No
 claim for indemnification shall be brought after expiration of the applicable survival period
 set forth in Section 7.1, except for claims properly noticed before such expiration.

&nbsp;&nbsp;&nbsp;&nbsp;7.5. <u>Procedures</u>. The Party seeking
 indemnification shall promptly notify the indemnifying Party of any claim, demand, action,
 or proceeding for which indemnification is sought. The indemnifying Party shall have the
 right to assume and control the defense of any third-party claim, with counsel reasonably
 acceptable to the indemnified Party, at its expense, provided it timely acknowledges its
 indemnification obligations. The indemnifying Party shall advance reasonable defenses expenses
 to the indemnified Party upon request, subject to repayment if indemnification is not ultimately
 owed. The indemnified Party shall cooperate in good faith but shall not be required to admit
 liability or settle any matter without its written consent (not to be unreasonably withheld).

&nbsp;&nbsp;&nbsp;&nbsp;7.6. <u>Remedies Not Exclusive</u>. The
 rights and remedies provided in this Section are cumulative and in addition to any other
 rights or remedies that may be available at Law or in equity.

**8.** Termination

This Agreement may be terminated at any time prior to the Closing by mutual written consent of Buyer and Seller.

It may also be terminated by either Party if the Closing has not occurred on or before December 31, 2025 (the "Outside Date"); provided, however, that the right to terminate under this clause shall not be available to any Party whose failure to fulfill any material obligation under this Agreement has been the primary cause of, or resulted in, the failure of the Closing to occur by such date.

Buyer may terminate this Agreement in the event of a material breach by Seller of any representation, warranty, covenant, or agreement contained herein, which breach is not cured within ten (10) days following written notice thereof.

Likewise, Seller may terminate this Agreement in the event of a material breach by Buyer of any representation, warranty, covenant, or agreement contained herein, which breach is not cured within ten (10) days following written notice thereof.

In the event of any such termination, this Agreement shall become null and void and of no further force or effect, except that the provisions of Section 7 (Indemnification), if applicable, shall survive termination. Nothing in this Section shall relieve either Party from liability for any willful breach of this Agreement occurring prior to such termination. Sections 7 (Indemnification), and Section 9 (Miscellaneous) shall survive any termination; and Section 7 shall apply to any pre-termination breaches regardless of termination cause.

**9.** Governing
 Law; Dispute Resolution

This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict of law principles. Any dispute, controversy, or claim arising out of or relating to this Agreement, or the breach, termination, or validity thereof, shall be resolved by final and binding arbitration administered by the American Arbitration Association in accordance with its Commercial Arbitration Rules then in effect. The arbitration shall be conducted before a single arbitrator seated in Los Angeles County, California. Judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. Notwithstanding the foregoing, either Party may apply to the state or federal courts located in Los Angeles County, California, or New Castle County, Delaware (for entity-specific matters) for equitable relief, including injunctive relief or specific performance, to enforce the terms of this Agreement, including without limitation Sections 7.

In any such arbitration or court proceeding, the prevailing Party shall be entitled to recover its reasonable attorneys' fees and costs from the non-prevailing Party, in addition to any other relief to which it may be entitled.

**10.** Notices.

All notices, requests, consents, claims, demands, waivers, and other communications under this Agreement shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when sent by email (with confirmation of transmission); (c) one (1) business day after being sent by a nationally recognized overnight courier (with tracking); or (d) three (3) business days after being mailed by certified or registered mail, return receipt requested, postage prepaid. Notices must be sent to the respective addresses set forth below (or to such other address as may be designated by notice in accordance with this Section):

**If to Buyer:**

Earth Sciences Fund I LLC

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

Email: legal@earthsciencesfund.com

Attention: Brent Nelson

**If to Seller:**

Manufacturing 360, LLC

8 The Green, Suite R

Dover, DE 19901

Email: richard@rh2equitypartners.com

Attention: Richard Hawkins

**11.** Post-Closing
 Covenants

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.1. <u>Further Assurances</u>. Following
 the Closing, each Party shall execute and deliver such additional documents, instruments,
 and assurances, and take such further actions, as may reasonably be requested by the other
 Party to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.2. <u>Record Retention</u>. Each Party
 shall retain all material records relating to RNWF or the transactions contemplated herein
 for at least six (6) years after the Closing Date (or such longer period as required by applicable
 Law), and shall make such records available to the other Party upon reasonable request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.3. <u>Cooperation on Tax and Legal Matters</u>. The Parties shall cooperate in good faith following the Closing to respond to
 any inquiries, audits, or other proceedings initiated by any Governmental Authority with
 respect to this Agreement, including making available documents, witnesses, and relevant
 information.

**12.** Miscellaneous.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.1. <u>Entire Agreement</u>. This Agreement,
 including all exhibits and schedules hereto, constitutes the entire agreement among the Parties
 with respect to the subject matter hereof and supersedes all prior and contemporaneous understandings,
 agreements, term sheets, letters of intent, negotiations, representations, and warranties,
 both written and oral, with respect to such subject matter. No Party shall be liable or bound
 to the other Party in any manner by any warranties, representations, or covenants except
 as specifically set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.2. <u>Amendments</u>. This Agreement
 may not be amended, modified, or supplemented except by an instrument in writing signed by
 each of the Parties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.3. <u>Waiver</u>. No waiver by any
 Party of any of the provisions hereof shall be effective unless explicitly set forth in writing
 and signed by the Party so waiving. No waiver shall operate or be construed as a waiver in
 respect of any failure, breach, or default not expressly identified by such written waiver,
 whether of a similar or different character, and whether occurring before or after that waiver.
 No failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising
 from this Agreement shall operate or be construed as a waiver thereof; nor shall any single
 or partial exercise of any right, remedy, power, or privilege hereunder preclude any other
 or further exercise thereof or the exercise of any other right, remedy, power, or privilege.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.4. <u>Severability</u>. If any term
 or provision of this Agreement is determined to be invalid, illegal, or unenforceable in
 any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other
 term or provision of this Agreement or invalidate or render unenforceable such term or provision
 in any other jurisdiction. Upon such determination, the Parties shall negotiate in good faith
 to modify this Agreement so as to effect the original intent of the Parties as closely as
 possible in a mutually acceptable manner in order that the transactions contemplated hereby
 be consummated as originally contemplated to the greatest extent possible.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.5. <u>Assignment</u>. No Party may
 assign any of its rights or delegate any of its obligations hereunder without the prior written
 consent of the other Parties; provided, however, that Buyer may assign this Agreement or
 any of its rights hereunder to any of its Affiliates or to any successor entity by merger,
 consolidation, or purchase of all or substantially all of its assets or equity, provided
 such successor assumes Buyer's obligations without Seller's consent. Any attempted
 assignment in violation of this provision shall be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.6. <u>Successors and Assigns</u>. This
 Agreement shall be binding upon and shall inure to the benefit of the Parties hereto and
 their respective successors and permitted assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.7. <u>No Third-Party Beneficiaries</u>.
 Except as expressly provided herein, this Agreement is for the sole benefit of the Parties
 hereto and their respective successors and permitted assigns and nothing herein, express
 or implied, is intended to or shall confer upon any other person or entity any legal or equitable
 right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.8. <u>Remedies Cumulative</u>. Except
 as otherwise expressly provided herein, any and all remedies expressly conferred upon a Party
 will be cumulative with, and not exclusive of, any other remedy contained herein or available
 at law or in equity, and the exercise by a Party of any one remedy will not preclude the
 exercise of any other remedy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.9. <u>Further Assurances</u>. Each
 of the Parties shall execute such documents and take such further actions as may be reasonably
 required or desirable to carry out the provisions of this Agreement and the transactions
 contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.10. <u>Headings</u>. The headings and
 subheadings contained in this Agreement are for reference purposes only and shall not affect
 the meaning or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12.11. <u>Counterparts; Electronic Signatures</u>.
 This Agreement may be executed in counterparts, each of which shall be deemed an original,
 but all of which shall constitute one and the same instrument. Signatures delivered electronically
 (including by email of a PDF signature page or by DocuSign or similar e-signature service)
 shall be deemed original signatures for all purposes. This Agreement, the other Transaction
 Documents, and any amendments hereto are intended to be valid, binding, and enforceable in
 accordance with their terms under the Electronic Signatures in Global and National Commerce
 Act (15 U.S.C. §§ 7001 et seq.) and the Uniform Electronic Transactions Act as
 codified in 6 Del. C. § 12A-101 et seq.

{Signature Page Follows}

**IN WITNESS WHEREOF**, the parties have executed this Stock Purchase Agreement as of the date first written above.

**SELLER:**

Manufacturing 360, LLC

By: <u>/s/ Richard Hawkins</u>

Name: Richard Hawkins

Title: Sole Member

**BUYER:**

Earth Sciences Fund I LLC

By: <u>/s/ Brent Nelson</u>

Name: Brent Nelson

Title: CEO

EXHIBIT A

Wiring Instructions

**<u>Beneficiary</u>**

Beneficiary Name: RH2 Equity Partners

Account Number: 202505096461

Beneficiary Address: 8 The Green, Suite R, Dover, DE 19901

**<u>Receiving Bank Details</u>**

ABA Routing Number: 091311229

Bank Name: Choice Financial Group

*Mercury uses Choice Financial Group as a banking partner.*

Bank Address: 4501 23rd Avenue S, Fargo, ND 58104

## Exhibit 10.4

**Exhibit 10.4**

**CONSULTING SERVICES AGREEMENT**

This Consulting Services Agreement (the "Agreement") is made and entered into as of January 1, 2025 (the "Effective Date"), by and between Renewal Fuels, Inc., a Delaware corporation (the "Company"), and Richard Hawkins ("Consultant"). The Company and Consultant are sometimes referred to herein individually as a "Party" and collectively as the "Parties."

**RECITALS**

**WHEREAS**, Renewal Fuels, Inc., a Delaware corporation (the "Company"), desires to retain Richard Hawkins (the "Consultant") to provide strategic corporate, financial, and capital markets consulting services for the 2025 calendar year;

**WHEREAS**, Consultant has previously provided similar services to the Company and continues to serve as its Chief Executive Officer in an unpaid capacity;

**WHEREAS**, the Company acknowledges and agrees that Consultant is not acting as an employee or officer for purposes of compensation under this Agreement, and that this Agreement reflects a distinct arm's-length consulting relationship on a 1099 basis;

**WHEREAS**, the Company wishes to memorialize and compensate Consultant for such services to be rendered during the 2025 calendar year under the terms set forth herein; and

**WHEREAS**, the parties desire to set forth the terms and conditions of such engagement in writing, including the Consultant's right to elect conversion of unpaid fees in the event of default;

**NOW, THEREFORE**, in consideration of the mutual covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **<u>APPOINTMENT OF CONSULTANT</u>.** The Company grants to Consultant for the term of this Agreement, the authority to provide to the Company, on a non-exclusive basis, financial and corporate consulting services described herein upon the terms and conditions set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **<u>CONSULTANT SERVICES</u>.** Consultant, in his capacity as an independent contractor, will provide Services to the Company (the "Advisees") during the term of this Agreement when and as reasonably requested by the Company. Said Services shall include, but not be limited to (as the need for other, not herein articulated services may, with the passage of time, be required to properly advance the Services described herein), the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Advise and consult with respect to the creation of the Advisees business
plan and investor presentation, deal structure, equity and debt financing, including but not limited to review and modification of the
Advisees investment and presentation documents and develop new material as deemed necessary to communicate the business plan and investment
potential of the Advisees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Introduce concerns and advise, consult and assist with the retention of
potential officers, outside directors, specialized legal counsel, investment bankers, qualified potential investors, auditors, broker
dealers, trading firms, financial and/or securities analysts, investor relations and public relations and other professional service providers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Provide the Advisees with non-legal aspects of conducting a private placement
or registered offering of equity or debt securities while RNWF remains listed on the OTC Market as a reporting company and thereafter
further assist the Advisees in raising capital in the form of equity, convertible debt or straight debt, as the case may be, introduce
the Advisees to investment firms of all types, and advise the Advisees on structuring capital raises Advisees hereby specifically acknowledge
that they understand the Consultant is not an attorney and is not providing legal to RNWF of the Advisees.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Advise and consult with the Advisees regarding any possible or proposed
M&A transactions ('Transactions"). Consultant shall be authorized, on a case by case basis, to introduce parties and prospective
merger candidates to the Advisees, and to assist the Advisees to negotiate term sheets, definitive agreements, and perform and provide
customary due diligence. Except for such communications as are necessary or incidental to making such introductions, Consultant shall
not provide any representations regarding the Advisees without the Advisees prior written consent, and all such representations shall
be provided to such candidates exclusively by the Advisees. Any agreement for a Transaction shall be subject to approval of RNWF's
Board of Directors and stockholders and satisfactory completion by the Advisees of mutual due diligence. Advisees and Consultant may negotiate
terms of additional Compensation to Consultant in the case of a successful Transaction. Advisees hereby acknowledge that they understand
that Consultant is not a broker/dealer nor affiliated with a broker/dealer and no compensation will be paid to Consultant in connection
with sale of securities in connection with this Section2(d).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Advise the Advisees with strategic planning and relationships with other
non-financial Companies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Advise the Advisees with his personal evaluation of the performance of accounting,
legal, investment banking, securities clearing, financial public relations and other U.S. securities professionals engaged by the Advisees.

The Advisees acknowledge that Consultant will limit his role under this Agreement to that of an Consultant, and that Consultant is not, and will not become, engaged in the business of (i) effecting securities transactions for or on the account of the Advisees, (ii) providing investment Consulting services as defined in the Investment Consultants Act of 1940, or (iii) providing any tax, legal, accounting, lobbying or other services except as specifically set forth in this or any other Agreement. This is a consulting-only position and is separate from any officer role the Consultant may hold in a non-salaried capacity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **<u>COMPENSATION TO CONSULTANT</u>.** As compensation for providing the services, the Advisees agree to pay Consultant a total of $50,000.00 for the 2025 calendar year (the "Consulting Fee"). This amount shall be treated as a payable obligation of the Company and shall accrue without interest through December 31, 2025. In the event of non-payment for more than thirty (30) days following written demand by Consultant, the Consulting Fee shall accrue interest at twelve percent (12%) per annum from the original due date. Consultant shall have the option, but not the obligation, to convert the unpaid Consulting Fee (together with any accrued interest) into Common Stock of the Company at a price per share equal to $0.0002, subject to a 9.99% ownership blocker, as set forth in Section 3.1 below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Conversion Option Upon Default**. In the event of non-payment constituting
a default under this Agreement, Consultant shall have the right, but not the obligation, to convert all or a portion of the unpaid Consulting
Fee, together with any accrued interest and reasonable fees or costs, into the number of shares of Common Stock of the Company equal to
the unpaid amount divided by $0.0002 (the "Default Conversion Shares"). Such conversion shall not exceed 9.99% of the Company's
issued and outstanding shares of Common Stock immediately prior to the issuance, unless otherwise waived in writing by the Company. Shares
shall be issued free of restrictions to the fullest extent permitted under Rule 144 or any applicable registration rights.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Consulting Compensation shall accrue without interest until December
31, 2025 (the "Maturity Date"), after which any unpaid balance shall bear interest at the rate of 12% per annum until paid in
full. If the Consulting Compensation is not paid in full by the Maturity Date, such non-payment shall constitute an Event of Default.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Upon an Event of Default, Consultant shall have the right, but not the obligation,
to convert all or any portion of the unpaid Consulting Compensation (including accrued default interest) into shares of the Company's
common stock at a conversion price equal to $0.0002 per share (the "Default Conversion"), subject to a 9.99% beneficial ownership
cap.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Any shares issued pursuant to a Default Conversion shall have piggyback
registration rights in the Company's next registration statement (Form S-1 or Regulation A), subject to any limitations imposed by a lead
underwriter in a firmly committed offering. The Company shall furnish all documentation reasonably required to enable Consultant to deposit
such shares with a FINRA-registered broker-dealer, including removing any restrictive legend after any applicable holding period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **<u>CONSULTANT'S OPINIONS, ADVICE AND CONFIDENTIALITY</u>.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company acknowledges that all financial and corporate Consulting Services
(written or oral) given by Consultant to the Company in connection with Consultant's engagement are intended solely for the benefit
and use of the Company, and the Company agrees that no person or entity other than the Company shall be entitled to make use of or rely
upon the advice of Consultant given specifically and exclusively to the Company pursuant to this Agreement, and no such opinion or advice
shall be used in any other manner or for any other purpose, nor may the Company make any public references to Consultant, or use the Consultant's
name in any annual reports or any reports or releases of the Company, without the Consultant's prior written consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Consultant acknowledges that Consultant shall keep in confidence any
information that the Company provides to Consultant pursuant to this Agreement. Notwithstanding the foregoing, Consultant shall not be
required to maintain confidentiality with respect to information (i) which is or becomes part of the public domain not due to the breach
of this Agreement by Consultant; (ii) of which it had independent knowledge prior to disclosure; (iii) which comes into the possession
of Consultant in the normal and routine course of his own business from and through independent non-confidential sources; or (iv) which
is required to be disclosed by Consultant by laws, rule or regulators. If Consultant is requested or required to disclose any information
supplied to it by the Company, Consultant shall, unless prohibited by law, promptly notify the Company of such request(s) so that the
Company may seek an appropriate protective order.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. **<u>TERM OF AGREEMENT; TERMINATION: EFFECT THEREOF</u>.** The term of this Agreement shall be for twelve months commencing on the date hereof, and shall automatically renew for successive six month periods or longer subject to mutual agreement unless terminated by either party by written notice as provided for herein 30 days prior to the end of the initial or any successive term, subject to this paragraph 5. Either party may terminate the Agreement for Cause during any term by providing the other party with 30 days written notice of termination for Cause. Cause shall be defined as either Consultant or any officer, director or control person of the Company being, subsequent to execution of this Agreement, indicted, arrested or convicted by any court of any U.S. state or The United States of America or censured, barred or otherwise formally disciplined by the SEC, FINRA or any U.S. state securities commissioner. If the Agreement is terminated for Cause by either party prior to the six-month anniversary of this Agreement, the Consultant shall retain a prorated portion of the fully earned compensation for services rendered up to the date of termination, calculated on a 365-day year. If termination for Cause occurs after the six-month anniversary, the Consultant shall retain the entire Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. **<u>EXPENSES</u>.** Each of the parties hereto shall be solely responsible for any and all of its own and costs and expenses related to the negotiation and preparation of this Agreement. It is agreed and acknowledged by the Company that the Consultant may incur out of pocket costs and expenses in connection with the provision of services to the Company hereunder. The Company hereby agrees to advance such costs or expenses or to repay any such costs or expenses incurred by Consultant within fifteen days of Consultant presenting an invoice for such expenses, as long as such expenses are approved by the Company in advance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. **<u>INDEPENDENT CONTRACTOR</u>.** Consultant shall act at all times hereunder as an independent contractor as that term is defined in the Internal Revenue Code of 1986, as amended, with respect to the Company, and not as an employee, partner, agent or co-venturer of or with the Company. Except as set forth herein, the Company shall neither have nor exercise control or direction whatsoever over the operations of Consultant and Consultant shall neither have nor exercise any control or direction whatsoever over the employees, agents or subcontractors hired by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. **<u>INDEMNIFICATION</u>. See Exhibit "A".**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. **<u>NOTICES</u>.** Any notice required or permitted to be given pursuant to this Agreement shall be in writing (unless otherwise specified herein) and shall be deemed effectively given upon personal delivery or upon receipt by the addressee by courier or by telefacsimile addressed to each of the other Parties thereunto entitled at the respective address listed below, with a copy by email, or at such other addresses as a Party may designate by ten days advance written notice:

If to the Company:

Renewal Fuels, Inc.

30 N. Gould St.

Sheridan, WY 53202

If to the Consultant:

Richard Hawkins

1511 E Pebblestone Way

Hayden, ID 83835richhawkins@me.com

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **<u>ASSIGNMENT</u>.** This Agreement shall not be assigned, pledged or transferred in any way by either party hereto without the prior written consent of the other party. Any attempted assignment, pledge, transfer or other disposition of this Agreement or any rights, interests or benefits herein contrary to the foregoing provisions shall be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **<u>CONFLICTING AGREEMENTS</u>.** Consultant and the Company represent and warrant to each other that the entry into this Agreement and the obligations and duties undertaken hereunder will not conflict with, constitute a breach of or otherwise violate the terms of any agreement or court order to which either party is a party, and that each party is not required to obtain the consent of any person, firm, corporation or other entity in order to enter into this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. **<u>NO WAIVER</u>.** No terms or conditions of this Agreement shall be deemed to have been waived, nor shall any party hereto be stopped from enforcing any provisions of the Agreement, except by written instrument of the party charged with such waiver or estoppel. Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived, and shall not constitute a waiver of such term or condition for the future or as to any act other than specifically waived.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. **<u>GOVERNING LAW</u>.** This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. **<u>ENTIRE AGREEMENT</u>.** This Agreement contains the entire agreement of the parties hereto in regard to the subject matter hereof and may not be changed orally but only by written document signed by the party against whom enforcement of the waiver, change, modification, extension or discharge is sought. This Agreement supersedes all prior written or oral agreements by and among the Company or any of its subsidiaries or affiliates and Consultant or any of its affiliates with respect to the subject matter of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. **<u>PARAGRAPH HEADINGS</u>.** Headings contained herein are for convenient reference only. They are not a part of this Agreement and are not to affect in any way the substance or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. **<u>SURVIVAL OF PROVISIONS</u>.** In case any one or more of the provisions or any portion of any provision set forth in this Agreement should be found to be invalid, illegal or unenforceable in any respect, such provision(s) or portion(s) thereof shall be modified or deleted in such manner as to afford the parties the fullest protection commensurate with making this Agreement, as modified, legal and enforceable under applicable laws. The validity, legality and enforceability of any such provisions shall not in any way be affected or impaired thereby and such remaining provisions shall be construed as severable and independent thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. **<u>BINDING EFFECT</u>.** This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and assigns, subject to the restriction on assignment contained in paragraph 11 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. **<u>ATTORNEY'S FEES</u>.** The prevailing party in any legal proceeding arising out of or resulting from this Agreement shall be entitled to recover its costs and fees, including, but not limited to, reasonable attorneys' fees and post judgment costs, from the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. **<u>AUTHORIZED AGENT</u>.** The persons executing this Agreement on behalf of the Company and Consultant hereby represent and warrant to each other that they are the duly authorized representatives of their respective entities and that each has taken all necessary corporate or partnership action to ratify and approve the execution of this Agreement in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21. **<u>ADDITIONAL DOCUMENTS</u>.** Each of the parties to this Agreement agrees to provide such additional duly executed (in recordable form, where appropriate) agreements, documents and instruments as may be reasonably requested by the other party in order to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22. **<u>COUNTERPARTS,</u>** **<u>TELEFACSIMILE, OR ELECTRONIC SCAN.</u>** This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which shall constitute one agreement. A telefacsimile or electronic scan of this Agreement may be relied upon as full and sufficient evidence as an original.

{Signature Page Follows}

**IN WITNESS WHEREOF**, the parties hereto have executed this Agreement on the date first written above.

Renewal Fuels, Inc. (RNWF), a Delaware Corporation:

By: <u>/s/ Richard Hawkins</u>

Richard Hawkins, CEO

Consultant:

By: <u>/s/ Richard Hawkins</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Richard Hawkins<br>

**EXHIBIT A**

**Indemnification**

The Company agrees that it shall indemnify and hold harmless, Consultant, its members, managers, officers, employees, agents, affiliates and controlling persons within the meaning of Section 20 of the Securities Exchange Act of 1934 and Section 15 of the Securities Act of 1933, each as amended (any and all of whom are referred to as an "Indemnified Party"), from and against any and all losses, claims, damages, liabilities, or expenses, and all actions in respect thereof (including, but not limited to, all legal or other expenses reasonably incurred by an Indemnified Party in connection with the investigation, preparation, defense or settlement of any claim, action or proceeding, whether or not resulting in any liability), incurred by an Indemnified Party with respect to, caused by, or otherwise arising out of any Indemnified Party performing the services contemplated hereunder; provided, however, the Company will not be liable, or shall not be obligated to indemnify or hold harmless, to the extent, and only to the extent, that any loss, claim, damage, liability or expense is finally judicially determined to have resulted primarily from Consultant's gross negligence or bad faith in performing such services. If any legal or regulatory action is brought against the Consultant in an official capacity, the Company shall engage a Tier 1 law firm to provide defense. The Consultant, acting in an executive or control capacity, shall also be protected from personal financial harm, cyberattacks, or physical threats arising from actions taken in the course of fulfilling such official duties.

If the indemnification provided for herein is conclusively determined (by an entry of final judgment by a court of competent jurisdiction and the expiration of the time or denial of the right to appeal) to be unavailable or insufficient to hold any Indemnified Party harmless in respect to any losses, claims, damages, liabilities or expenses referred to herein, then the Company shall contribute to the amounts paid or payable by such Indemnified Party in such proportion as is appropriate and equitable under all circumstances taking into account the relative benefits received by the Company on the one hand and Consultant on the other, from the transaction or proposed transaction under the Agreement or, if allocation on that basis is not permitted under applicable law, in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one hand and Consultant on the other, but also the relative fault of the Company and Consultant; provided, however, in no event shall the aggregate contribution of Consultant and/or any Indemnified Party be in excess of the net compensation actually received by Consultant and/or such Indemnified Party pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company shall not settle or compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened action, claim, suit or proceeding in which any Indemnified Party is or could be a party and as to which indemnification or contribution could have been sought by such Indemnified Party hereunder (whether or not such Indemnified Party is a party thereto), unless such consent or termination includes an express unconditional release of such Indemnified Party, reasonably satisfactory in form and substance to such Indemnified Party, from all losses, claims, damages, liabilities or expenses arising out of such action, claim, suit or proceeding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event any Indemnified Party shall incur any expenses covered by this Exhibit A, the Company shall reimburse the Indemnified Party for such covered expenses within ten (10) business days of the Indemnified Party's delivery to the Company of an invoice therefor, with receipts attached. Such obligation of the Company to so advance funds may be conditioned upon the Company's receipt of a written undertaking from the Indemnified Party to repay such amounts within ten (10) business days after a final, non-appealable judicial determination that such Indemnified Party was not entitled to indemnification hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The foregoing indemnification and contribution provisions are not in lieu of, but in addition to, any rights which any Indemnified Party may have at common law hereunder or otherwise, and shall remain in full force and effect following the expiration or termination of Consultant's engagement and shall be binding on any successors or assigns of the Company and successors or assigns to all or substantially all of the Company's business or assets. These indemnification provisions shall survive any termination of the Agreement for a period of two (2) years.

Renewal Fuels, Inc. (RNWF), a Delaware Corporation:

By: <u>/s/ Richard Hawkins</u>

Richard Hawkins, CEO

Consultant:

By: <u>/s/ Richard Hawkins</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Richard Hawkins<br>

## Exhibit 10.5

Exhibit 10.5

**CONSULTING SERVICES AGREEMENT**

This Consulting Services Agreement (the "Agreement") is made and entered into as of January 30 2026 (the "Effective Date"), by and between American Fusion Inc., a Delaware corporation that is in the process of domestication to the State of Texas (the "Company"), and Michael G. Smith, Esq. (the "Consultant"). The Company and the Consultant may be referred to herein individually as a "Party" and collectively as the "Parties."

**RECITALS**

**WHEREAS**, the Company desires to retain Michael G. Smith, Esq. (the "Consultant") to provide legal, strategic, corporate governance, and related advisory and consulting services to the Company on a consulting basis;

**WHEREAS**, the Company desires to appoint Consultant to serve as the Company's Chief Legal Officer and as a member of the Company's Board of Directors, and Consultant is willing to serve in such capacities;

**WHEREAS,** the parties acknowledge and agree that Consultant is not being engaged as an employee of the Company, and that this Agreement reflects an independent contractor relationship on a 1099 basis, separate and apart from any employment arrangement;

**WHEREAS,** the Company desires to compensate Consultant for services to be rendered during the Term through an equity-based compensation arrangement with a one-year valuation true-up and a hard minimum value backstop as set forth in this Agreement; and;

**WHEREAS**, for purposes of this Agreement, a "Restructuring Event" means any reverse stock split, forward stock split, recapitalization, reclassification of shares, exchange of outstanding equity securities, or other transaction or series of related transactions that materially alters the Company's outstanding capitalization or per-share trading price;

**WHEREAS,** the parties desire to set forth the terms and conditions of such engagement in writing, including confidentiality, indemnification, and the Company's commitment to use commercially reasonable efforts to obtain directors' and officers' liability insurance coverage as soon as commercially practicable.

**NOW, THEREFORE**, in consideration of the mutual covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **<u>APPOINTMENT OF CONSULTANT</u>.** The Company hereby appoints Consultant, and Consultant hereby accepts such appointment, to provide consulting and advisory services to the Company on a non-exclusive basis during the Term of this Agreement, subject to the terms and conditions set forth herein.

In connection with such engagement, the Company hereby appoints Consultant to serve as the Company's Chief Legal Officer and as a member of the Company's Board of Directors for the duration of the Term, or until earlier resignation or removal in accordance with applicable law and the Company's governing documents.

The parties acknowledge and agree that Consultant's service as Chief Legal Officer and as a director of the Company is undertaken in a consulting capacity and does not create an employment relationship. Consultant shall not be deemed an independent director for any purpose due to his service as an officer of the Company.

Except as expressly set forth herein, Consultant shall have no authority to bind the Company without appropriate authorization and shall perform services in coordination with the Company's management and Board of Directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **<u>CONSULTANT SERVICES</u>.** Consultant, in his capacity as an independent contractor, will provide Services to the Company (the "Advisees") during the term of this Agreement when and as reasonably requested by the Company. Said Services shall include, but not be limited to (as the need for other, not herein articulated services may, with the passage of time, be required to properly advance the Services described herein), the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Advise and consult with respect to the creation of the Advisees business
plan and investor presentation, deal structure, equity and debt financing, including but not limited to review and modification of the
Advisees investment and presentation documents and develop new material as deemed necessary to communicate the business plan and investment
potential of the Advisees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Introduce concerns and advise, consult and assist with the retention of
potential officers, outside directors, specialized legal counsel, investment bankers, qualified potential investors, auditors, broker
dealers, trading firms, financial and/or securities analysts, investor relations and public relations and other professional service providers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Provide the Advisees with aspects of conducting a private placement or registered
offering of equity or debt securities while RNWF remains listed on the OTC Market as a reporting company and thereafter further assist
the Advisees in raising capital in the form of equity, convertible debt or straight debt, as the case may be, introduce the Advisees to
investment firms of all types, and advise the Advisees on structuring capital raises.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Advise and consult with the Advisees regarding any possible or proposed
M&A transactions ('Transactions"). Consultant shall be authorized, on a case by case basis, to introduce parties and prospective
merger candidates to the Advisees, and to assist the Advisees to negotiate term sheets, definitive agreements, and perform and provide
customary due diligence. Except for such communications as are necessary or incidental to making such introductions, Consultant shall
not provide any representations regarding the Advisees without the Advisees prior written consent, and all such representations shall
be provided to such candidates exclusively by the Advisees. Any agreement for a Transaction shall be subject to approval of RNWF's
Board of Directors and stockholders and satisfactory completion by the Advisees of mutual due diligence. Advisees and Consultant may negotiate
terms of additional Compensation to Consultant in the case of a successful Transaction. Advisees hereby acknowledge that they understand
that Consultant is not a broker/dealer nor affiliated with a broker/dealer and no compensation will be paid to Consultant in connection
with sale of securities in connection with this Section2(d).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Advise the Advisees with strategic planning and relationships with other
non-financial Companies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Advise the Advisees with his personal evaluation of the performance of accounting,
legal, investment banking, securities clearing, financial public relations and other U.S. securities professionals engaged by the Advisees.

The Advisees acknowledge that Consultant will limit his role under this Agreement to that of an Consultant, and that Consultant is not, and will not become, engaged in the business of (i) effecting securities transactions for or on the account of the Advisees, (ii) providing investment Consulting services as defined in the Investment Consultants Act of 1940, or (iii) providing any tax, legal, accounting, lobbying or other services except as specifically set forth in this or any other Agreement. This is a consulting-only position and is separate from any officer role the Consultant may hold in a non-salaried capacity.

Notwithstanding anything herein to the contrary, Consultant shall provide legal services to the Company in his capacity as Chief Legal Officer, including oversight of legal, regulatory, intellectual property, litigation, and corporate governance matters, and coordination with outside counsel. Consultant's provision of legal services shall not alter his status as an independent contractor for compensation and tax purposes under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **<u>COMPENSATION TO CONSULTANT</u>.** As full and complete consideration for the consulting and advisory services to be rendered by Consultant during the Term, the Company shall issue to Consultant shares of the Company's common stock having an aggregate fair market value of Two Hundred Forty Thousand Dollars ($240,000).

The number of shares to be issued shall be determined by dividing $240,000 by the closing price of the Company's common stock on the first trading day following the completion of any Restructuring Event (the "Initial Valuation Price"), or, if no Restructuring Event occurs, the closing price of the Company's common stock on the Effective Date. Such shares shall be issued promptly following the Effective Date pursuant to a duly authorized issuance resolution of the Board of Directors.

On the one-year anniversary of the date on which the Initial Valuation Price is determined (the "Valuation Date"), the Company shall determine the lowest closing price of the Company's common stock during the ten (10) trading days immediately preceding the Valuation Date (the "Anniversary Price").

If the Anniversary Price is less than the Initial Valuation Price, the Company shall issue to Consultant such additional number of shares as are necessary so that the aggregate fair market value of all shares issued pursuant to this Section 3, calculated using the Anniversary Price, equals Two Hundred Forty Thousand Dollars ($240,000). This adjustment shall operate as a hard minimum value backstop and shall apply automatically without the need for further action by Consultant.

In the event the trading price of the Company's common stock increases following the Effective Date, no reduction, clawback, or forfeiture shall apply.

All shares issued pursuant to this Agreement shall include piggyback registration rights in the Company's next registration statement on Form S-1 or Form 1-A, subject to customary underwriter limitations, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **<u>CONSULTANT'S OPINIONS, ADVICE AND CONFIDENTIALITY</u>.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company acknowledges that all financial and corporate Consulting Services
(written or oral) given by Consultant to the Company in connection with Consultant's engagement are intended solely for the benefit
and use of the Company, and the Company agrees that no person or entity other than the Company shall be entitled to make use of or rely
upon the advice of Consultant given specifically and exclusively to the Company pursuant to this Agreement, and no such opinion or advice
shall be used in any other manner or for any other purpose, nor may the Company make any public references to Consultant, or use the Consultant's
name in any annual reports or any reports or releases of the Company, without the Consultant's prior written consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Consultant acknowledges that Consultant shall keep in confidence any
information that the Company provides to Consultant pursuant to this Agreement. Notwithstanding the foregoing, Consultant shall not be
required to maintain confidentiality with respect to information (i) which is or becomes part of the public domain not due to the breach
of this Agreement by Consultant; (ii) of which it had independent knowledge prior to disclosure; (iii) which comes into the possession
of Consultant in the normal and routine course of his own business from and through independent non-confidential sources; or (iv) which
is required to be disclosed by Consultant by laws, rule or regulators. If Consultant is requested or required to disclose any information
supplied to it by the Company, Consultant shall, unless prohibited by law, promptly notify the Company of such request(s) so that the
Company may seek an appropriate protective order.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. **<u>TERM OF AGREEMENT; TERMINATION: EFFECT THEREOF</u>.** The term of this Agreement shall be for twelve months commencing on the date hereof, and shall automatically renew for successive six month periods or longer subject to mutual agreement unless terminated by either party by written notice as provided for herein 30 days prior to the end of the initial or any successive term, subject to this paragraph 5. Either party may terminate the Agreement for Cause during any term by providing the other party with 30 days written notice of termination for Cause. Cause shall be defined as either Consultant or any officer, director or control person of the Company being, subsequent to execution of this Agreement, indicted, arrested or convicted by any court of any U.S. state or The United States of America or censured, barred or otherwise formally disciplined by the SEC, FINRA or any U.S. state securities commissioner. If the Agreement is terminated for Cause by either party prior to the six-month anniversary of this Agreement, the Consultant shall retain a prorated portion of the fully earned compensation for services rendered up to the date of termination, calculated on a 365-day year. If termination for Cause occurs after the six-month anniversary, the Consultant shall retain the entire Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. **<u>EXPENSES</u>.** Each of the parties hereto shall be solely responsible for any and all of its own and costs and expenses related to the negotiation and preparation of this Agreement. It is agreed and acknowledged by the Company that the Consultant may incur out of pocket costs and expenses in connection with the provision of services to the Company hereunder. The Company hereby agrees to advance such costs or expenses or to repay any such costs or expenses incurred by Consultant within fifteen days of Consultant presenting an invoice for such expenses, as long as such expenses are approved by the Company in advance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. **<u>INDEPENDENT CONTRACTOR</u>.** Consultant shall act at all times hereunder as an independent contractor as that term is defined in the Internal Revenue Code of 1986, as amended, with respect to the Company, and not as an employee, partner, agent or co-venturer of or with the Company. Except as set forth herein, the Company shall neither have nor exercise control or direction whatsoever over the operations of Consultant and Consultant shall neither have nor exercise any control or direction whatsoever over the employees, agents or subcontractors hired by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. **<u>INDEMNIFICATION AND DIRECTORS' & OFFICERS' INSURANCE</u>.** The Company shall indemnify and hold harmless Consultant to the fullest extent permitted by applicable law for all losses, claims, damages, liabilities, costs, and expenses, including reasonable attorneys' fees, arising out of or relating to Consultant's service to the Company in any capacity contemplated by this Agreement, including as a consultant, Chief Legal Officer, director, or officer of the Company, provided that such indemnification shall not apply to the extent such losses are finally determined by a court of competent jurisdiction to have resulted from Consultant's gross negligence or willful misconduct.

The Company shall advance expenses incurred by Consultant in connection with any threatened, pending, or completed action, suit, or proceeding arising out of such service, upon receipt of an undertaking by Consultant to repay such amounts if it is ultimately determined that Consultant is not entitled to indemnification under applicable law.

The indemnification and advancement rights provided under this Section 9 shall survive the termination or expiration of this Agreement and Consultant's service to the Company for any reason and shall inure to the benefit of Consultant's heirs, executors, and legal representatives.

The Company shall use commercially reasonable efforts to obtain and maintain directors' and officers' liability insurance covering Consultant in his capacities as a consultant, officer, and director of the Company as soon as commercially practicable following the Effective Date, on terms no less favorable than those provided to similarly situated officers and directors of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. **<u>NOTICES</u>.** Any notice required or permitted to be given pursuant to this Agreement shall be in writing (unless otherwise specified herein) and shall be deemed effectively given upon personal delivery or upon receipt by the addressee by courier or by telefacsimile addressed to each of the other Parties thereunto entitled at the respective address listed below, with a copy by email, or at such other addresses as a Party may designate by ten days advance written notice:

If to the Company:

American Fusion Inc.

30 N. Gould St.

Sheridan, WY 53202

If to the Consultant:

Michael G. Smith

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **<u>ASSIGNMENT</u>.** This Agreement shall not be assigned, pledged or transferred in any way by either party hereto without the prior written consent of the other party. Any attempted assignment, pledge, transfer or other disposition of this Agreement or any rights, interests or benefits herein contrary to the foregoing provisions shall be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **<u>CONFLICTING AGREEMENTS</u>.** Consultant and the Company represent and warrant to each other that the entry into this Agreement and the obligations and duties undertaken hereunder will not conflict with, constitute a breach of or otherwise violate the terms of any agreement or court order to which either party is a party, and that each party is not required to obtain the consent of any person, firm, corporation or other entity in order to enter into this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. **<u>NO WAIVER</u>.** No terms or conditions of this Agreement shall be deemed to have been waived, nor shall any party hereto be stopped from enforcing any provisions of the Agreement, except by written instrument of the party charged with such waiver or estoppel. Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived, and shall not constitute a waiver of such term or condition for the future or as to any act other than specifically waived.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. **<u>GOVERNING LAW</u>.** This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. **<u>ENTIRE AGREEMENT</u>.** This Agreement contains the entire agreement of the parties hereto in regard to the subject matter hereof and may not be changed orally but only by written document signed by the party against whom enforcement of the waiver, change, modification, extension or discharge is sought. This Agreement supersedes all prior written or oral agreements by and among the Company or any of its subsidiaries or affiliates and Consultant or any of its affiliates with respect to the subject matter of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. **<u>PARAGRAPH HEADINGS</u>.** Headings contained herein are for convenient reference only. They are not a part of this Agreement and are not to affect in any way the substance or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. **<u>SURVIVAL OF PROVISIONS</u>.** In case any one or more of the provisions or any portion of any provision set forth in this Agreement should be found to be invalid, illegal or unenforceable in any respect, such provision(s) or portion(s) thereof shall be modified or deleted in such manner as to afford the parties the fullest protection commensurate with making this Agreement, as modified, legal and enforceable under applicable laws. The validity, legality and enforceability of any such provisions shall not in any way be affected or impaired thereby and such remaining provisions shall be construed as severable and independent thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. **<u>BINDING EFFECT</u>.** This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and assigns, subject to the restriction on assignment contained in paragraph 11 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. **<u>ATTORNEY'S FEES</u>.** The prevailing party in any legal proceeding arising out of or resulting from this Agreement shall be entitled to recover its costs and fees, including, but not limited to, reasonable attorneys' fees and post judgment costs, from the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. **<u>AUTHORIZED AGENT</u>.** The persons executing this Agreement on behalf of the Company and Consultant hereby represent and warrant to each other that they are the duly authorized representatives of their respective entities and that each has taken all necessary corporate or partnership action to ratify and approve the execution of this Agreement in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21. **<u>ADDITIONAL DOCUMENTS</u>.** Each of the parties to this Agreement agrees to provide such additional duly executed (in recordable form, where appropriate) agreements, documents and instruments as may be reasonably requested by the other party in order to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22. **<u>COUNTERPARTS,</u>** **<u>TELEFACSIMILE, OR ELECTRONIC SCAN.</u>** This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which shall constitute one agreement. A telefacsimile or electronic scan of this Agreement may be relied upon as full and sufficient evidence as an original.

{Signature Page Follows}

**IN WITNESS WHEREOF**, the parties hereto have executed this Agreement on the date first written above.

American Fusion Inc. (RNWF), a Delaware Corporation:

By: <u>/s/ Richard Hawkins</u>

Richard Hawkins, CEO

Consultant:

By: <u>/s/ Michael G. Smith</u>

Michael G. Smith, Esq.<br>

## Exhibit 10.6

Exhibit 10.6

**CONSULTING SERVICES AGREEMENT**

This Consulting Services Agreement (the "Agreement") is made and entered into as of February 11, 2026 (the "Effective Date"), by and between American Fusion Inc., a Texas corporation (the "Company"), and Dewight L. Cartwright (the "Consultant"). The Company and the Consultant may be referred to herein individually as a "Party" and collectively as the "Parties."

**RECITALS**

**WHEREAS**, the Company desires to retain Dewight L. Cartwright (the "Consultant") to provide operational, infrastructure, execution, and related advisory and consulting services to the Company on a consulting basis;

**WHEREAS**, the Company desires to appoint Consultant to serve as the Company's Chief Operating Officer, and Consultant is willing to serve in such capacity;

**WHEREAS,** the parties acknowledge and agree that Consultant is not being engaged as an employee of the Company, and that this Agreement reflects an independent contractor relationship on a 1099 basis, separate and apart from any employment arrangement;

**WHEREAS**, for purposes of this Agreement, a "Restructuring Event" means any reverse stock split, forward stock split, recapitalization, reclassification of shares, exchange of outstanding equity securities, or other transaction or series of related transactions that materially alters the Company's outstanding capitalization or per-share trading price;

**WHEREAS,** the Company desires to compensate Consultant for services to be rendered during the Term through an equity-based compensation arrangement with a one-year valuation true-up and a hard minimum value backstop as set forth in this Agreement;

**WHEREAS,** the parties desire to set forth the terms and conditions of such engagement in writing, including confidentiality, indemnification, and the Company's commitment to use commercially reasonable efforts to obtain directors' and officers' liability insurance coverage as soon as commercially practicable.

**NOW, THEREFORE**, in consideration of the mutual covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **<u>APPOINTMENT OF CONSULTANT</u>.** The Company hereby appoints Consultant, and Consultant hereby accepts such appointment, to provide consulting and advisory services to the Company on a non-exclusive basis during the Term of this Agreement, subject to the terms and conditions set forth herein.

In connection with such engagement, the Company hereby appoints Consultant to serve as the Company's Chief Operating Officer for the duration of the Term, or until earlier resignation or removal in accordance with applicable law and the Company's governing documents.

The parties acknowledge and agree that Consultant's service as Chief Operating Officer of the Company is undertaken in a consulting capacity and does not create an employment relationship.

Except as expressly set forth herein, Consultant shall have no authority to bind the Company without appropriate authorization and shall perform services in coordination with the Company's management and, as appropriate, the Board of Directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **<u>CONSULTANT SERVICES</u>.** Consultant, in his capacity as an independent contractor, will provide Services to the Company during the term of this Agreement when and as reasonably requested by the Company. Said Services shall include, but not be limited to (as the need for other, not herein articulated services may, with the passage of time, be required to properly advance the Services described herein), the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Oversight of day-to-day operational execution across facilities development,
manufacturing readiness, testing infrastructure, and deployment planning for the Company's fusion and energy systems;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Leadership of supply chain coordination, vendor qualification, fabrication
workflows, and production scalability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Governance of safety systems, testing protocols, quality control, and operational
compliance across Company facilities and deployment sites;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Coordination between engineering, executive leadership, and external partners
to translate technical development into deployable, revenue-generating infrastructure;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Oversight of construction, installation, commissioning, and operational
readiness for pilot and commercial systems;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Support of commercialization strategy through disciplined execution, cost
control, scheduling, and infrastructure readiness.

The Company acknowledges that Consultant will serve primarily in an operational and execution leadership capacity, and that Consultant is not engaged in the business of (i) effecting securities transactions for or on the account of the Company, (ii) providing investment advisory services as defined in the Investment Advisers Act of 1940, or (iii) providing any tax, legal, or accounting services. Consultant's service as an officer is undertaken in a consulting capacity as set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **<u>COMPENSATION TO CONSULTANT</u>.** As full and complete consideration for the consulting and advisory services to be rendered by Consultant during the Term, the Company shall issue to Consultant shares of the Company's common stock having an aggregate fair market value of Two Hundred Forty Thousand Dollars ($240,000).

The number of shares to be issued shall be determined by dividing $240,000 by the closing price of the Company's common stock on the first trading day following the completion of any Restructuring Event (the "Initial Valuation Price"), or, if no Restructuring Event occurs, the closing price of the Company's common stock on the Effective Date. Such shares shall be issued promptly following the Effective Date pursuant to a duly authorized issuance resolution of the Board of Directors.

On the one-year anniversary of the date on which the Initial Valuation Price is determined (the "Valuation Date"), the Company shall determine the lowest closing price of the Company's common stock during the ten (10) trading days immediately preceding the Valuation Date (the "Anniversary Price").

If the Anniversary Price is less than the Initial Valuation Price, the Company shall issue to Consultant such additional number of shares as are necessary so that the aggregate fair market value of all shares issued pursuant to this Section 3, calculated using the Anniversary Price, equals Two Hundred Forty Thousand Dollars ($240,000). This adjustment shall operate as a hard minimum value backstop and shall apply automatically without the need for further action by Consultant.

In the event the trading price of the Company's common stock increases following the Effective Date, no reduction, clawback, or forfeiture shall apply.

All shares issued pursuant to this Agreement shall include piggyback registration rights in the Company's next registration statement on Form S-1 or Form 1-A, subject to customary underwriter limitations, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **<u>CONSULTANT'S OPINIONS, ADVICE AND CONFIDENTIALITY</u>.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company acknowledges that all financial and corporate Consulting Services
(written or oral) given by Consultant to the Company in connection with Consultant's engagement are intended solely for the benefit
and use of the Company, and the Company agrees that no person or entity other than the Company shall be entitled to make use of or rely
upon the advice of Consultant given specifically and exclusively to the Company pursuant to this Agreement, and no such opinion or advice
shall be used in any other manner or for any other purpose, nor may the Company make any public references to Consultant, or use the Consultant's
name in any annual reports or any reports or releases of the Company, without the Consultant's prior written consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Consultant acknowledges that Consultant shall keep in confidence any
information that the Company provides to Consultant pursuant to this Agreement. Notwithstanding the foregoing, Consultant shall not be
required to maintain confidentiality with respect to information (i) which is or becomes part of the public domain not due to the breach
of this Agreement by Consultant; (ii) of which it had independent knowledge prior to disclosure; (iii) which comes into the possession
of Consultant in the normal and routine course of his own business from and through independent non-confidential sources; or (iv) which
is required to be disclosed by Consultant by laws, rule or regulators. If Consultant is requested or required to disclose any information
supplied to it by the Company, Consultant shall, unless prohibited by law, promptly notify the Company of such request(s) so that the
Company may seek an appropriate protective order.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. **<u>TERM OF AGREEMENT; TERMINATION: EFFECT THEREOF</u>.** The term of this Agreement shall be for twelve months commencing on the date hereof, and shall automatically renew for successive six month periods or longer subject to mutual agreement unless terminated by either party by written notice as provided for herein 30 days prior to the end of the initial or any successive term, subject to this paragraph 5. Either party may terminate the Agreement for Cause during any term by providing the other party with 30 days written notice of termination for Cause. Cause shall be defined as either Consultant or any officer, director or control person of the Company being, subsequent to execution of this Agreement, indicted, arrested or convicted by any court of any U.S. state or The United States of America or censured, barred or otherwise formally disciplined by the SEC, FINRA or any U.S. state securities commissioner. If the Agreement is terminated for Cause by either party prior to the six-month anniversary of this Agreement, the Consultant shall retain a prorated portion of the fully earned compensation for services rendered up to the date of termination, calculated on a 365-day year. If termination for Cause occurs after the six-month anniversary, the Consultant shall retain the entire Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. **<u>EXPENSES</u>.** Each of the parties hereto shall be solely responsible for any and all of its own and costs and expenses related to the negotiation and preparation of this Agreement. It is agreed and acknowledged by the Company that the Consultant may incur out of pocket costs and expenses in connection with the provision of services to the Company hereunder. The Company hereby agrees to advance such costs or expenses or to repay any such costs or expenses incurred by Consultant within fifteen days of Consultant presenting an invoice for such expenses, as long as such expenses are approved by the Company in advance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. **<u>INDEPENDENT CONTRACTOR</u>.** Consultant shall act at all times hereunder as an independent contractor as that term is defined in the Internal Revenue Code of 1986, as amended, with respect to the Company, and not as an employee, partner, agent or co-venturer of or with the Company. Except as set forth herein, the Company shall neither have nor exercise control or direction whatsoever over the operations of Consultant and Consultant shall neither have nor exercise any control or direction whatsoever over the employees, agents or subcontractors hired by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. **<u>INDEMNIFICATION AND DIRECTORS' & OFFICERS' INSURANCE</u>.** The Company shall indemnify and hold harmless Consultant to the fullest extent permitted by applicable law for all losses, claims, damages, liabilities, costs, and expenses, including reasonable attorneys' fees, arising out of or relating to Consultant's service to the Company in any capacity contemplated by this Agreement, including as a consultant, Chief Operating Officer, or officer of the Company, provided that such indemnification shall not apply to the extent such losses are finally determined by a court of competent jurisdiction to have resulted from Consultant's gross negligence or willful misconduct.

The Company shall advance expenses incurred by Consultant in connection with any threatened, pending, or completed action, suit, or proceeding arising out of such service, upon receipt of an undertaking by Consultant to repay such amounts if it is ultimately determined that Consultant is not entitled to indemnification under applicable law.

The indemnification and advancement rights provided under this Section 9 shall survive the termination or expiration of this Agreement and Consultant's service to the Company for any reason and shall inure to the benefit of Consultant's heirs, executors, and legal representatives.

The Company shall use commercially reasonable efforts to obtain and maintain directors' and officers' liability insurance covering Consultant in his capacities as a consultant and officer, as soon as commercially practicable following the Effective Date, on terms no less favorable than those provided to similarly situated officers of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. **<u>NOTICES</u>.** Any notice required or permitted to be given pursuant to this Agreement shall be in writing (unless otherwise specified herein) and shall be deemed effectively given upon personal delivery or upon receipt by the addressee by courier or by telefacsimile addressed to each of the other Parties thereunto entitled at the respective address listed below, or at such other addresses as a Party may designate by ten days advance written notice:

If to the Company:

American Fusion Inc.

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

If to the Consultant:

Dewight L. Cartwright

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **<u>ASSIGNMENT</u>.** This Agreement shall not be assigned, pledged or transferred in any way by either party hereto without the prior written consent of the other party. Any attempted assignment, pledge, transfer or other disposition of this Agreement or any rights, interests or benefits herein contrary to the foregoing provisions shall be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **<u>CONFLICTING AGREEMENTS</u>.** Consultant and the Company represent and warrant to each other that the entry into this Agreement and the obligations and duties undertaken hereunder will not conflict with, constitute a breach of or otherwise violate the terms of any agreement or court order to which either party is a party, and that each party is not required to obtain the consent of any person, firm, corporation or other entity in order to enter into this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. **<u>NO WAIVER</u>.** No terms or conditions of this Agreement shall be deemed to have been waived, nor shall any party hereto be stopped from enforcing any provisions of the Agreement, except by written instrument of the party charged with such waiver or estoppel. Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived, and shall not constitute a waiver of such term or condition for the future or as to any act other than specifically waived.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. **<u>GOVERNING LAW</u>.** This Agreement shall be governed by and construed in accordance with the laws of the state of Texas.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. **<u>ENTIRE AGREEMENT</u>.** This Agreement contains the entire agreement of the parties hereto in regard to the subject matter hereof and may not be changed orally but only by written document signed by the party against whom enforcement of the waiver, change, modification, extension or discharge is sought. This Agreement supersedes all prior written or oral agreements by and among the Company or any of its subsidiaries or affiliates and Consultant or any of its affiliates with respect to the subject matter of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. **<u>PARAGRAPH HEADINGS</u>.** Headings contained herein are for convenient reference only. They are not a part of this Agreement and are not to affect in any way the substance or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. **<u>SURVIVAL OF PROVISIONS</u>.** In case any one or more of the provisions or any portion of any provision set forth in this Agreement should be found to be invalid, illegal or unenforceable in any respect, such provision(s) or portion(s) thereof shall be modified or deleted in such manner as to afford the parties the fullest protection commensurate with making this Agreement, as modified, legal and enforceable under applicable laws. The validity, legality and enforceability of any such provisions shall not in any way be affected or impaired thereby and such remaining provisions shall be construed as severable and independent thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. **<u>BINDING EFFECT</u>.** This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and assigns, subject to the restriction on assignment contained in paragraph 11 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. **<u>ATTORNEY'S FEES</u>.** The prevailing party in any legal proceeding arising out of or resulting from this Agreement shall be entitled to recover its costs and fees, including, but not limited to, reasonable attorneys' fees and post judgment costs, from the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. **<u>AUTHORIZED AGENT</u>.** The persons executing this Agreement on behalf of the Company and Consultant hereby represent and warrant to each other that they are the duly authorized representatives of their respective entities and that each has taken all necessary corporate or partnership action to ratify and approve the execution of this Agreement in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21. **<u>ADDITIONAL DOCUMENTS</u>.** Each of the parties to this Agreement agrees to provide such additional duly executed (in recordable form, where appropriate) agreements, documents and instruments as may be reasonably requested by the other party in order to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22. **<u>COUNTERPARTS,</u>** **<u>TELEFACSIMILE, OR ELECTRONIC SCAN.</u>** This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which shall constitute one agreement. A telefacsimile or electronic scan of this Agreement may be relied upon as full and sufficient evidence as an original.

{Signature Page Follows}

**IN WITNESS WHEREOF**, the parties hereto have executed this Agreement on the date first written above.

American Fusion Inc., a Texas Corporation:

By: <u>/s/ Richard Hawkins</u>

Richard Hawkins, CEO

Consultant:

By: <u>/s/ Dewight L. Cartwright</u>

Dewight L. Cartwright<br>

## Exhibit 10.7

Exhibit 10.7

**INDEPENDENT DIRECTOR ADVISORY AGREEMENT**

This Independent Director Advisory Agreement (the "Agreement") is made and entered into as of February 23, 2026 (the "Effective Date"), by and between American Fusion Inc., a Texas corporation (the "Company"), and Fabrice David (the "Director"). The Company and the Director may be referred to herein individually as a "Party" and collectively as the "Parties."

**RECITALS**

**WHEREAS,** the Company desires to appoint Director to serve as an independent member of its Board of Directors;

**WHEREAS,** Director possesses significant scientific, technical, and strategic expertise in fusion-adjacent energy systems, advanced nuclear phenomena, intellectual property development, and commercialization pathways relevant to the Company's business;

**WHEREAS,** Director is willing to serve as an independent member of the Board subject to the terms and conditions set forth herein;

**WHEREAS,** for purposes of this Agreement, a "Restructuring Event" means any reverse stock split, forward stock split, recapitalization, reclassification of shares, exchange of outstanding equity securities, or other transaction or series of related transactions that materially alters the Company's outstanding capitalization or per-share trading price;

**WHEREAS,** the parties desire to set forth the terms governing Director's service, compensation, confidentiality obligations, indemnification, and the Company's commitment to maintain directors' and officers' liability insurance;

**NOW, THEREFORE**, in consideration of the mutual covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **<u>APPOINTMENT OF DIRECTOR</u>.** The Company hereby appoints Director, and Director hereby accepts such appointment, to serve as an independent member of the Company's Board of Directors effective as of the Effective Date, subject to the Company's Certificate of Formation, Bylaws, and applicable Texas law.

Director's authority shall be limited to that exercised collectively through duly authorized action of the Board of Directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **<u>BOARD RESPONSIBILITIES AND ADVISORY SERVICES</u>.** Director shall perform customary board-level duties consistent with fiduciary obligations under Texas law and the Company's governing documents. Without limiting the generality of the foregoing, Director's responsibilities shall include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Participating in meetings of the Board of Directors and any committees to
which Director is duly appointed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Reviewing materials provided in advance of meetings and exercising independent
judgment in the best interests of the Company and its shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Providing independent scientific and technical oversight of the Company's
fusion energy development strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Advising the Board regarding intellectual property strategy, innovation
governance, research validation frameworks, and long-term technology risk;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Contributing long-horizon perspective regarding commercialization pathways
and competitive positioning in advanced energy markets; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Supporting disciplined governance aligned with infrastructure-scale energy
deployment.

Director shall not participate in day-to-day management or operational execution except as expressly authorized by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **<u>COMPENSATION TO DIRECTOR</u>.** As full and complete consideration for Director's service as an independent member of the Board to be rendered by Director during the Term, the Company shall issue to Director shares of the Company's common stock having an aggregate fair market value of Two Hundred Forty Thousand Dollars ($240,000).

The number of shares to be issued shall be determined by dividing $240,000 by the closing price of the Company's common stock on the first trading day following the completion of any Restructuring Event (the "Initial Valuation Price"), or, if no Restructuring Event occurs, the closing price of the Company's common stock on the Effective Date. Such shares shall be issued promptly following the Effective Date pursuant to a duly authorized issuance resolution of the Board of Directors.

On the one-year anniversary of the date on which the Initial Valuation Price is determined (the "Valuation Date"), the Company shall determine the lowest closing price of the Company's common stock during the ten (10) trading days immediately preceding the Valuation Date (the "Anniversary Price").

If the Anniversary Price is less than the Initial Valuation Price, the Company shall issue to Director such additional number of shares as are necessary so that the aggregate fair market value of all shares issued pursuant to this Section 3, calculated using the Anniversary Price, equals Two Hundred Forty Thousand Dollars ($240,000). This adjustment shall operate as a hard minimum value backstop and shall apply automatically without the need for further action by Director.

In the event the trading price of the Company's common stock increases following the Effective Date, no reduction, clawback, or forfeiture shall apply.

All shares issued pursuant to this Agreement shall include piggyback registration rights in the Company's next registration statement on Form S-1 or Form 1-A, subject to customary underwriter limitations, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **<u>CONFIDENTIALITY</u>.** Director agrees to maintain the confidentiality of all non-public information received in connection with Board service and shall not disclose such information except as required by law or authorized by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. **<u>TERM OF AGREEMENT; TERMINATION: EFFECT THEREOF</u>.** Director's service shall commence on the Effective Date and shall continue until resignation, removal, death, incapacity, or until Director no longer serves on the Board in accordance with the Company's governing documents. Either party may terminate the Agreement for Cause during any term by providing the other party with 30 days written notice of termination for Cause. Cause shall be defined as either Director or any officer, director or control person of the Company being, subsequent to execution of this Agreement, indicted, arrested or convicted by any court of any U.S. state or The United States of America or censured, barred or otherwise formally disciplined by the SEC, FINRA or any U.S. state securities commissioner. If the Agreement is terminated for Cause by either party prior to the six-month anniversary of this Agreement, the Director shall retain a prorated portion of the fully earned compensation for services rendered up to the date of termination, calculated on a 365-day year. If termination for Cause occurs after the six-month anniversary, the Director shall retain the entire Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. **<u>EXPENSES</u>.** Each of the parties hereto shall be solely responsible for any and all of its own and costs and expenses related to the negotiation and preparation of this Agreement. It is agreed and acknowledged by the Company that the Director may incur out of pocket costs and expenses in connection with the provision of services to the Company hereunder. The Company hereby agrees to advance such costs or expenses or to repay any such costs or expenses incurred by Director within fifteen days of Director presenting an invoice for such expenses, as long as such expenses are approved by the Company in advance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. **<u>INDEMNIFICATION AND DIRECTORS' & OFFICERS' INSURANCE.</u>** The Company shall indemnify and hold harmless Director to the fullest extent permitted by applicable Texas law and the Company's Certificate of Formation and Bylaws from and against any and all losses, claims, damages, liabilities, costs, and expenses, including reasonable attorneys' fees, arising out of or relating to Director's service as a member of the Board of Directors of the Company; provided, however, that such indemnification shall not apply to the extent such losses are finally determined by a court of competent jurisdiction to have resulted from Director's gross negligence, willful misconduct, or knowing violation of law.

The Company shall advance expenses incurred by Director in connection with any threatened, pending, or completed action, suit, or proceeding arising out of such Board service upon receipt of an undertaking by Director to repay such amounts if it is ultimately determined that Director is not entitled to indemnification under applicable law.

The indemnification and advancement rights provided under this Section 7 shall survive the termination or expiration of this Agreement and Director's service to the Company for any reason and shall inure to the benefit of Director's heirs, executors, and legal representatives.

The Company shall use commercially reasonable efforts to obtain and maintain directors' and officers' liability insurance covering Director in his capacity as a member of the Board of Directors as soon as commercially practicable following the Effective Date, on terms no less favorable than those provided to similarly situated directors of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. **<u>NOTICES</u>.** Any notice required or permitted to be given pursuant to this Agreement shall be in writing (unless otherwise specified herein) and shall be deemed effectively given upon personal delivery or upon receipt by the addressee by courier or by telefacsimile addressed to each of the other Parties thereunto entitled at the respective address listed below, with a copy by email, or at such other addresses as a Party may designate by ten days advance written notice:

If to the Company:

American Fusion Inc.

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

If to the Director:

Fabrice David

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. **<u>ASSIGNMENT</u>.** This Agreement shall not be assigned, pledged or transferred in any way by either party hereto without the prior written consent of the other party. Any attempted assignment, pledge, transfer or other disposition of this Agreement or any rights, interests or benefits herein contrary to the foregoing provisions shall be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. **<u>CONFLICTING AGREEMENTS</u>.** Director and the Company represent and warrant to each other that the entry into this Agreement and the obligations and duties undertaken hereunder will not conflict with, constitute a breach of or otherwise violate the terms of any agreement or court order to which either party is a party, and that each party is not required to obtain the consent of any person, firm, corporation or other entity in order to enter into this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **<u>NO WAIVER</u>.** No terms or conditions of this Agreement shall be deemed to have been waived, nor shall any party hereto be stopped from enforcing any provisions of the Agreement, except by written instrument of the party charged with such waiver or estoppel. Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived, and shall not constitute a waiver of such term or condition for the future or as to any act other than specifically waived.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **<u>GOVERNING LAW</u>.** This Agreement shall be governed by and construed in accordance with the laws of the state of Texas.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. **<u>ENTIRE AGREEMENT</u>.** This Agreement contains the entire agreement of the parties hereto in regard to the subject matter hereof and may not be changed orally but only by written document signed by the party against whom enforcement of the waiver, change, modification, extension or discharge is sought. This Agreement supersedes all prior written or oral agreements by and among the Company or any of its subsidiaries or affiliates and Director or any of its affiliates with respect to the subject matter of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. **<u>PARAGRAPH HEADINGS</u>.** Headings contained herein are for convenient reference only. They are not a part of this Agreement and are not to affect in any way the substance or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. **<u>SURVIVAL OF PROVISIONS</u>.** In case any one or more of the provisions or any portion of any provision set forth in this Agreement should be found to be invalid, illegal or unenforceable in any respect, such provision(s) or portion(s) thereof shall be modified or deleted in such manner as to afford the parties the fullest protection commensurate with making this Agreement, as modified, legal and enforceable under applicable laws. The validity, legality and enforceability of any such provisions shall not in any way be affected or impaired thereby and such remaining provisions shall be construed as severable and independent thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. **<u>BINDING EFFECT</u>.** This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and assigns, subject to the restriction on assignment contained in paragraph 11 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. **<u>ATTORNEY'S FEES</u>.** The prevailing party in any legal proceeding arising out of or resulting from this Agreement shall be entitled to recover its costs and fees, including, but not limited to, reasonable attorneys' fees and post judgment costs, from the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. **<u>AUTHORIZED AGENT</u>.** The persons executing this Agreement on behalf of the Company and Director hereby represent and warrant to each other that they are the duly authorized representatives of their respective entities and that each has taken all necessary corporate or partnership action to ratify and approve the execution of this Agreement in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. **<u>ADDITIONAL DOCUMENTS</u>.** Each of the parties to this Agreement agrees to provide such additional duly executed (in recordable form, where appropriate) agreements, documents and instruments as may be reasonably requested by the other party in order to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. **<u>COUNTERPARTS,</u>** **<u>TELEFACSIMILE, OR ELECTRONIC SCAN.</u>** This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which shall constitute one agreement. A telefacsimile or electronic scan of this Agreement may be relied upon as full and sufficient evidence as an original.

{Signature Page Follows}

**IN WITNESS WHEREOF**, the parties hereto have executed this Agreement on the date first written above.

American Fusion Inc. (RNWF), a Texas Corporation:

By: <u>/s/ Richard Hawkins</u>

Richard Hawkins, CEO

Director:

By: <u>/s/ Fabrice David</u>

Fabrice David<br>

## Exhibit 10.9

Exhibit 10.8

**INDEPENDENT DIRECTOR ADVISORY AGREEMENT**

This Independent Director Advisory Agreement (the "Agreement") is made and entered into as of March 6, 2026 (the "Effective Date"), by and between American Fusion Inc., a Texas corporation (the "Company"), and Andrew S. Mikulski (the "Director"). The Company and the Director may be referred to herein individually as a "Party" and collectively as the "Parties."

**RECITALS**

**WHEREAS,** the Company desires to appoint Director to serve as an independent member of its Board of Directors;

**WHEREAS,** Director possesses significant expertise in electrical engineering, power electronics, advanced electronic systems, and high-reliability energy infrastructure technologies relevant to the Company's fusion energy platform;

**WHEREAS,** Director is willing to serve as an independent member of the Board subject to the terms and conditions set forth herein;

**WHEREAS,** for purposes of this Agreement, a "Restructuring Event" means any reverse stock split, forward stock split, recapitalization, reclassification of shares, exchange of outstanding equity securities, or other transaction or series of related transactions that materially alters the Company's outstanding capitalization or per-share trading price;

**WHEREAS,** the parties desire to set forth the terms governing Director's service, compensation, confidentiality obligations, indemnification, and the Company's commitment to maintain directors' and officers' liability insurance;

**NOW, THEREFORE**, in consideration of the mutual covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **<u>APPOINTMENT OF DIRECTOR</u>.** The Company hereby appoints Director, and Director hereby accepts such appointment, to serve as an independent member of the Company's Board of Directors effective as of the Effective Date, subject to the Company's Certificate of Formation, Bylaws, and applicable Texas law.

Director's authority shall be limited to that exercised collectively through duly authorized action of the Board of Directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **<u>BOARD RESPONSIBILITIES AND ADVISORY SERVICES</u>.** Director shall perform customary board-level duties consistent with fiduciary obligations under Texas law and the Company's governing documents. Without limiting the generality of the foregoing, Director's responsibilities shall include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Participating in meetings of the Board of Directors and any committees to
which Director is duly appointed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Reviewing materials provided in advance of meetings and exercising independent
judgment in the best interests of the Company and its shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Providing independent scientific and technical oversight of the Company's
fusion energy development strategy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Advising the Board regarding intellectual property strategy, innovation
governance, research validation frameworks, and long-term technology risk;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Contributing long-horizon perspective regarding commercialization pathways
and competitive positioning in advanced energy markets; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Supporting disciplined governance aligned with infrastructure-scale energy
deployment.

Director shall not participate in day-to-day management or operational execution except as expressly authorized by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **<u>COMPENSATION TO DIRECTOR</u>.** As full and complete consideration for Director's service as an independent member of the Board to be rendered by Director during the Term, the Company shall issue to Director shares of the Company's common stock having an aggregate fair market value of Two Hundred Forty Thousand Dollars ($240,000).

The number of shares to be issued shall be determined by dividing $240,000 by the closing price of the Company's common stock on the first trading day following the completion of any Restructuring Event (the "Initial Valuation Price"), or, if no Restructuring Event occurs, the closing price of the Company's common stock on the Effective Date. Such shares shall be issued promptly following the Effective Date pursuant to a duly authorized issuance resolution of the Board of Directors.

On the one-year anniversary of the date on which the Initial Valuation Price is determined (the "Valuation Date"), the Company shall determine the lowest closing price of the Company's common stock during the ten (10) trading days immediately preceding the Valuation Date (the "Anniversary Price").

If the Anniversary Price is less than the Initial Valuation Price, the Company shall issue to Director such additional number of shares as are necessary so that the aggregate fair market value of all shares issued pursuant to this Section 3, calculated using the Anniversary Price, equals Two Hundred Forty Thousand Dollars ($240,000). This adjustment shall operate as a hard minimum value backstop and shall apply automatically without the need for further action by Director.

In the event the trading price of the Company's common stock increases following the Effective Date, no reduction, clawback, or forfeiture shall apply.

All shares issued pursuant to this Agreement shall include piggyback registration rights in the Company's next registration statement on Form S-1 or Form 1-A, subject to customary underwriter limitations, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **<u>CONFIDENTIALITY</u>.** Director agrees to maintain the confidentiality of all non-public information received in connection with Board service and shall not disclose such information except as required by law or authorized by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. **<u>TERM OF AGREEMENT; TERMINATION: EFFECT THEREOF</u>.** Director's service shall commence on the Effective Date and shall continue until resignation, removal, death, incapacity, or until Director no longer serves on the Board in accordance with the Company's governing documents. Either party may terminate the Agreement for Cause during any term by providing the other party with 30 days written notice of termination for Cause. Cause shall be defined as either Director or any officer, director or control person of the Company being, subsequent to execution of this Agreement, indicted, arrested or convicted by any court of any U.S. state or The United States of America or censured, barred or otherwise formally disciplined by the SEC, FINRA or any U.S. state securities commissioner. If the Agreement is terminated for Cause by either party prior to the six-month anniversary of this Agreement, the Director shall retain a prorated portion of the fully earned compensation for services rendered up to the date of termination, calculated on a 365-day year. If termination for Cause occurs after the six-month anniversary, the Director shall retain the entire Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. **<u>EXPENSES</u>.** Each of the parties hereto shall be solely responsible for any and all of its own and costs and expenses related to the negotiation and preparation of this Agreement. It is agreed and acknowledged by the Company that the Director may incur out of pocket costs and expenses in connection with the provision of services to the Company hereunder. The Company hereby agrees to advance such costs or expenses or to repay any such costs or expenses incurred by Director within fifteen days of Director presenting an invoice for such expenses, as long as such expenses are approved by the Company in advance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. **<u>INDEMNIFICATION AND DIRECTORS' & OFFICERS' INSURANCE.</u>** The Company shall indemnify and hold harmless Director to the fullest extent permitted by applicable Texas law and the Company's Certificate of Formation and Bylaws from and against any and all losses, claims, damages, liabilities, costs, and expenses, including reasonable attorneys' fees, arising out of or relating to Director's service as a member of the Board of Directors of the Company; provided, however, that such indemnification shall not apply to the extent such losses are finally determined by a court of competent jurisdiction to have resulted from Director's gross negligence, willful misconduct, or knowing violation of law.

The Company shall advance expenses incurred by Director in connection with any threatened, pending, or completed action, suit, or proceeding arising out of such Board service upon receipt of an undertaking by Director to repay such amounts if it is ultimately determined that Director is not entitled to indemnification under applicable law.

The indemnification and advancement rights provided under this Section 7 shall survive the termination or expiration of this Agreement and Director's service to the Company for any reason and shall inure to the benefit of Director's heirs, executors, and legal representatives.

The Company shall use commercially reasonable efforts to obtain and maintain directors' and officers' liability insurance covering Director in his capacity as a member of the Board of Directors as soon as commercially practicable following the Effective Date, on terms no less favorable than those provided to similarly situated directors of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. **<u>NOTICES</u>.** Any notice required or permitted to be given pursuant to this Agreement shall be in writing (unless otherwise specified herein) and shall be deemed effectively given upon personal delivery or upon receipt by the addressee by courier or by telefacsimile addressed to each of the other Parties thereunto entitled at the respective address listed below, with a copy by email, or at such other addresses as a Party may designate by ten days advance written notice:

If to the Company:

American Fusion Inc.

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

If to the Director:

Andrew S. Mikulski

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. **<u>ASSIGNMENT</u>.** This Agreement shall not be assigned, pledged or transferred in any way by either party hereto without the prior written consent of the other party. Any attempted assignment, pledge, transfer or other disposition of this Agreement or any rights, interests or benefits herein contrary to the foregoing provisions shall be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. **<u>CONFLICTING AGREEMENTS</u>.** Director and the Company represent and warrant to each other that the entry into this Agreement and the obligations and duties undertaken hereunder will not conflict with, constitute a breach of or otherwise violate the terms of any agreement or court order to which either party is a party, and that each party is not required to obtain the consent of any person, firm, corporation or other entity in order to enter into this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **<u>NO WAIVER</u>.** No terms or conditions of this Agreement shall be deemed to have been waived, nor shall any party hereto be stopped from enforcing any provisions of the Agreement, except by written instrument of the party charged with such waiver or estoppel. Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived, and shall not constitute a waiver of such term or condition for the future or as to any act other than specifically waived.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **<u>GOVERNING LAW</u>.** This Agreement shall be governed by and construed in accordance with the laws of the state of Texas.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. **<u>ENTIRE AGREEMENT</u>.** This Agreement contains the entire agreement of the parties hereto in regard to the subject matter hereof and may not be changed orally but only by written document signed by the party against whom enforcement of the waiver, change, modification, extension or discharge is sought. This Agreement supersedes all prior written or oral agreements by and among the Company or any of its subsidiaries or affiliates and Director or any of its affiliates with respect to the subject matter of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. **<u>PARAGRAPH HEADINGS</u>.** Headings contained herein are for convenient reference only. They are not a part of this Agreement and are not to affect in any way the substance or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. **<u>SURVIVAL OF PROVISIONS</u>.** In case any one or more of the provisions or any portion of any provision set forth in this Agreement should be found to be invalid, illegal or unenforceable in any respect, such provision(s) or portion(s) thereof shall be modified or deleted in such manner as to afford the parties the fullest protection commensurate with making this Agreement, as modified, legal and enforceable under applicable laws. The validity, legality and enforceability of any such provisions shall not in any way be affected or impaired thereby and such remaining provisions shall be construed as severable and independent thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. **<u>BINDING EFFECT</u>.** This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and assigns, subject to the restriction on assignment contained in paragraph 11 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. **<u>ATTORNEY'S FEES</u>.** The prevailing party in any legal proceeding arising out of or resulting from this Agreement shall be entitled to recover its costs and fees, including, but not limited to, reasonable attorneys' fees and post judgment costs, from the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. **<u>AUTHORIZED AGENT</u>.** The persons executing this Agreement on behalf of the Company and Director hereby represent and warrant to each other that they are the duly authorized representatives of their respective entities and that each has taken all necessary corporate or partnership action to ratify and approve the execution of this Agreement in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. **<u>ADDITIONAL DOCUMENTS</u>.** Each of the parties to this Agreement agrees to provide such additional duly executed (in recordable form, where appropriate) agreements, documents and instruments as may be reasonably requested by the other party in order to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. **<u>COUNTERPARTS,</u>** **<u>TELEFACSIMILE, OR ELECTRONIC SCAN.</u>** This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which shall constitute one agreement. A telefacsimile or electronic scan of this Agreement may be relied upon as full and sufficient evidence as an original.

{Signature Page Follows}

**IN WITNESS WHEREOF**, the parties hereto have executed this Agreement on the date first written above.

American Fusion Inc. (RNWF), a Texas Corporation:

By: <u>/s/ Richard Hawkins</u>

Richard Hawkins, CEO

Director:

By: <u>/s/ Andrew S. Mikulski</u>

Andrew S. Mikulski<br>

## Exhibit 10.9

Exhibit 10.9

**CONSULTING SERVICES AGREEMENT**

This Consulting Services Agreement (the "Agreement") is made and entered into as of March 9, 2026 (the "Effective Date"), by and between American Fusion Inc., a Texas corporation (the "Company"), and ND Grid Energy Solutions LLC (the "Consultant"). The Company and the Consultant may be referred to herein individually as a "Party" and collectively as the "Parties."

**RECITALS**

**WHEREAS**, the Company desires to retain Sebastian E. Hoyos (the "Consultant") to provide revenue strategy, energy commercialization, power purchase agreement origination, customer acquisition, and related advisory and consulting services to the Company on a consulting basis;

**WHEREAS**, the Company desires to appoint Consultant to serve as the Company's Chief Revenue Officer, and Consultant is willing to serve in such capacity;

**WHEREAS,** the parties acknowledge and agree that Consultant is not being engaged as an employee of the Company, and that this Agreement reflects an independent contractor relationship on a 1099 basis, separate and apart from any employment arrangement;

**WHEREAS**, for purposes of this Agreement, a "Restructuring Event" means any reverse stock split, forward stock split, recapitalization, reclassification of shares, exchange of outstanding equity securities, or other transaction or series of related transactions that materially alters the Company's outstanding capitalization or per-share trading price;

**WHEREAS,** the Company desires to compensate Consultant for services to be rendered during the Term through an equity-based compensation arrangement with a one-year valuation true-up and a hard minimum value backstop as set forth in this Agreement;

**WHEREAS,** the parties desire to set forth the terms and conditions of such engagement in writing, including confidentiality, indemnification, and the Company's commitment to use commercially reasonable efforts to obtain directors' and officers' liability insurance coverage as soon as commercially practicable.

**NOW, THEREFORE**, in consideration of the mutual covenants and promises contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. **<u>APPOINTMENT OF CONSULTANT</u>.** The Company hereby appoints Consultant, and Consultant hereby accepts such appointment, to provide consulting and advisory services to the Company on a non-exclusive basis during the Term of this Agreement, subject to the terms and conditions set forth herein.

In connection with such engagement, the Company hereby appoints Consultant to serve as the Company's Chief Revenue Officer for the duration of the Term, or until earlier resignation or removal in accordance with applicable law and the Company's governing documents.

The parties acknowledge and agree that Consultant's service as Chief Revenue Officer of the Company is undertaken in a consulting capacity and does not create an employment relationship.

Except as expressly set forth herein, Consultant shall have no authority to bind the Company without appropriate authorization and shall perform services in coordination with the Company's management and, as appropriate, the Board of Directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. **<u>CONSULTANT SERVICES</u>.** Consultant, in his capacity as an independent contractor, will provide Services to the Company during the term of this Agreement when and as reasonably requested by the Company. Said Services shall include, but not be limited to (as the need for other, not herein articulated services may, with the passage of time, be required to properly advance the Services described herein), the following:

&nbsp;&nbsp;&nbsp;&nbsp;a) Development and execution of the Company's global revenue strategy
for commercialization of the Texatron™ fusion energy platform;

&nbsp;&nbsp;&nbsp;&nbsp;b) Origination, negotiation, and structuring of long-term power purchase agreements
(PPAs), virtual PPAs (VPPAs), and other offtake agreements with corporate, industrial, utility, hyperscale, and governmental customers;

&nbsp;&nbsp;&nbsp;&nbsp;c) Creation and management of a contracted revenue pipeline supporting the
Company's Power-as-a-Service business model;

&nbsp;&nbsp;&nbsp;&nbsp;d) Development of strategic relationships with corporate energy buyers, utilities,
data center operators, industrial energy consumers, and infrastructure investors;

&nbsp;&nbsp;&nbsp;&nbsp;e) Structuring commercial frameworks that enable project finance, infrastructure
deployment, and capital markets participation;

&nbsp;&nbsp;&nbsp;&nbsp;f) Leadership in customer acquisition strategy, revenue forecasting, and long-term
contracted revenue backlog development;

&nbsp;&nbsp;&nbsp;&nbsp;g) Collaboration with engineering, operations, and executive leadership to
align technology deployment timelines with customer demand and contracted energy delivery;

&nbsp;&nbsp;&nbsp;&nbsp;h) Representation of the Company in commercial negotiations, industry conferences,
and executive-level energy infrastructure discussions;

&nbsp;&nbsp;&nbsp;&nbsp;i) Support of strategic partnerships, joint ventures, and commercial alliances
necessary to accelerate global deployment of the Company's energy systems.

The Company acknowledges that Consultant will serve primarily in an operational and execution leadership capacity, and that Consultant is not engaged in the business of (i) effecting securities transactions for or on the account of the Company, (ii) providing investment advisory services as defined in the Investment Advisers Act of 1940, or (iii) providing any tax, legal, or accounting services. Consultant's service as an officer is undertaken in a consulting capacity as set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. **<u>COMPENSATION TO CONSULTANT</u>.** As full and complete consideration for the consulting and advisory services to be rendered by Consultant during the Term, the Company shall issue to Consultant shares of the Company's common stock having an aggregate fair market value of Two Hundred Fifty Thousand Dollars ($250,000).

The number of shares to be issued shall be determined by dividing $250,000 by the closing price of the Company's common stock on the first trading day following the completion of any Restructuring Event (the "Initial Valuation Price"), or, if no Restructuring Event occurs, the closing price of the Company's common stock on the Effective Date. Such shares shall be issued promptly following the Effective Date pursuant to a duly authorized issuance resolution of the Board of Directors.

On the one-year anniversary of the date on which the Initial Valuation Price is determined (the "Valuation Date"), the Company shall determine the lowest closing price of the Company's common stock during the ten (10) trading days immediately preceding the Valuation Date (the "Anniversary Price").

If the Anniversary Price is less than the Initial Valuation Price, the Company shall issue to Consultant such additional number of shares as are necessary so that the aggregate fair market value of all shares issued pursuant to this Section 3, calculated using the Anniversary Price, equals Two Hundred Fifty Thousand Dollars ($250,000). This adjustment shall operate as a hard minimum value backstop and shall apply automatically without the need for further action by Consultant.

In the event the trading price of the Company's common stock increases following the Effective Date, no reduction, clawback, or forfeiture shall apply.

All shares issued pursuant to this Agreement shall include piggyback registration rights in the Company's next registration statement on Form S-1 or Form 1-A, subject to customary underwriter limitations, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. **<u>CONSULTANT'S OPINIONS, ADVICE AND CONFIDENTIALITY</u>.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company acknowledges that all financial and corporate Consulting Services
(written or oral) given by Consultant to the Company in connection with Consultant's engagement are intended solely for the benefit
and use of the Company, and the Company agrees that no person or entity other than the Company shall be entitled to make use of or rely
upon the advice of Consultant given specifically and exclusively to the Company pursuant to this Agreement, and no such opinion or advice
shall be used in any other manner or for any other purpose, nor may the Company make any public references to Consultant, or use the Consultant's
name in any annual reports or any reports or releases of the Company, without the Consultant's prior written consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The Consultant acknowledges that Consultant shall keep in confidence any
information that the Company provides to Consultant pursuant to this Agreement. Notwithstanding the foregoing, Consultant shall not be
required to maintain confidentiality with respect to information (i) which is or becomes part of the public domain not due to the breach
of this Agreement by Consultant; (ii) of which it had independent knowledge prior to disclosure; (iii) which comes into the possession
of Consultant in the normal and routine course of his own business from and through independent non-confidential sources; or (iv) which
is required to be disclosed by Consultant by laws, rule or regulators. If Consultant is requested or required to disclose any information
supplied to it by the Company, Consultant shall, unless prohibited by law, promptly notify the Company of such request(s) so that the
Company may seek an appropriate protective order.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. **<u>TERM OF AGREEMENT; TERMINATION: EFFECT THEREOF</u>.** The term of this Agreement shall be for twelve months commencing on the date hereof, and shall automatically renew for successive six month periods or longer subject to mutual agreement unless terminated by either party by written notice as provided for herein 30 days prior to the end of the initial or any successive term, subject to this paragraph 5. Either party may terminate the Agreement for Cause during any term by providing the other party with 30 days written notice of termination for Cause. Cause shall be defined as either Consultant or any officer, director or control person of the Company being, subsequent to execution of this Agreement, indicted, arrested or convicted by any court of any U.S. state or The United States of America or censured, barred or otherwise formally disciplined by the SEC, FINRA or any U.S. state securities commissioner. If the Agreement is terminated for Cause by either party prior to the six-month anniversary of this Agreement, the Consultant shall retain a prorated portion of the fully earned compensation for services rendered up to the date of termination, calculated on a 365-day year. If termination for Cause occurs after the six-month anniversary, the Consultant shall retain the entire Compensation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. **<u>EXPENSES</u>.** Each of the parties hereto shall be solely responsible for any and all of its own and costs and expenses related to the negotiation and preparation of this Agreement. It is agreed and acknowledged by the Company that the Consultant may incur out of pocket costs and expenses in connection with the provision of services to the Company hereunder. The Company hereby agrees to advance such costs or expenses or to repay any such costs or expenses incurred by Consultant within fifteen days of Consultant presenting an invoice for such expenses, as long as such expenses are approved by the Company in advance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. **<u>INDEPENDENT CONTRACTOR</u>.** Consultant shall act at all times hereunder as an independent contractor as that term is defined in the Internal Revenue Code of 1986, as amended, with respect to the Company, and not as an employee, partner, agent or co-venturer of or with the Company. Except as set forth herein, the Company shall neither have nor exercise control or direction whatsoever over the operations of Consultant and Consultant shall neither have nor exercise any control or direction whatsoever over the employees, agents or subcontractors hired by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. **<u>INDEMNIFICATION AND DIRECTORS' & OFFICERS' INSURANCE</u>.** The Company shall indemnify and hold harmless Consultant to the fullest extent permitted by applicable law for all losses, claims, damages, liabilities, costs, and expenses, including reasonable attorneys' fees, arising out of or relating to Consultant's service to the Company in any capacity contemplated by this Agreement, including as a consultant, Chief Revenue Officer, or officer of the Company, provided that such indemnification shall not apply to the extent such losses are finally determined by a court of competent jurisdiction to have resulted from Consultant's gross negligence or willful misconduct.

The Company shall advance expenses incurred by Consultant in connection with any threatened, pending, or completed action, suit, or proceeding arising out of such service, upon receipt of an undertaking by Consultant to repay such amounts if it is ultimately determined that Consultant is not entitled to indemnification under applicable law.

The indemnification and advancement rights provided under this Section 9 shall survive the termination or expiration of this Agreement and Consultant's service to the Company for any reason and shall inure to the benefit of Consultant's heirs, executors, and legal representatives.

The Company shall use commercially reasonable efforts to obtain and maintain directors' and officers' liability insurance covering Consultant in his capacities as a consultant and officer, as soon as commercially practicable following the Effective Date, on terms no less favorable than those provided to similarly situated officers of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. **<u>NOTICES</u>.** Any notice required or permitted to be given pursuant to this Agreement shall be in writing (unless otherwise specified herein) and shall be deemed effectively given upon personal delivery or upon receipt by the addressee by courier or by telefacsimile addressed to each of the other Parties thereunto entitled at the respective address listed below, or at such other addresses as a Party may designate by ten days advance written notice:

If to the Company:

American Fusion Inc.

401 N Carroll Ave., Ste. 192

Southlake, TX 76092

If to the Consultant:

ND Grid Energy Solutions LLC

Sebastian E. Hoyos

7005 Wilkinson BLVD Suite D

Belmont, NC, 28012

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. **<u>ASSIGNMENT</u>.** This Agreement shall not be assigned, pledged or transferred in any way by either party hereto without the prior written consent of the other party. Any attempted assignment, pledge, transfer or other disposition of this Agreement or any rights, interests or benefits herein contrary to the foregoing provisions shall be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. **<u>CONFLICTING AGREEMENTS</u>.** Consultant and the Company represent and warrant to each other that the entry into this Agreement and the obligations and duties undertaken hereunder will not conflict with, constitute a breach of or otherwise violate the terms of any agreement or court order to which either party is a party, and that each party is not required to obtain the consent of any person, firm, corporation or other entity in order to enter into this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. **<u>NO WAIVER</u>.** No terms or conditions of this Agreement shall be deemed to have been waived, nor shall any party hereto be stopped from enforcing any provisions of the Agreement, except by written instrument of the party charged with such waiver or estoppel. Any written waiver shall not be deemed a continuing waiver unless specifically stated, shall operate only as to the specific term or condition waived, and shall not constitute a waiver of such term or condition for the future or as to any act other than specifically waived.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. **<u>GOVERNING LAW</u>.** This Agreement shall be governed by and construed in accordance with the laws of the state of Texas.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15. **<u>ENTIRE AGREEMENT</u>.** This Agreement contains the entire agreement of the parties hereto in regard to the subject matter hereof and may not be changed orally but only by written document signed by the party against whom enforcement of the waiver, change, modification, extension or discharge is sought. This Agreement supersedes all prior written or oral agreements by and among the Company or any of its subsidiaries or affiliates and Consultant or any of its affiliates with respect to the subject matter of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16. **<u>PARAGRAPH HEADINGS</u>.** Headings contained herein are for convenient reference only. They are not a part of this Agreement and are not to affect in any way the substance or interpretation of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17. **<u>SURVIVAL OF PROVISIONS</u>.** In case any one or more of the provisions or any portion of any provision set forth in this Agreement should be found to be invalid, illegal or unenforceable in any respect, such provision(s) or portion(s) thereof shall be modified or deleted in such manner as to afford the parties the fullest protection commensurate with making this Agreement, as modified, legal and enforceable under applicable laws. The validity, legality and enforceability of any such provisions shall not in any way be affected or impaired thereby and such remaining provisions shall be construed as severable and independent thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18. **<u>BINDING EFFECT</u>.** This Agreement is binding upon and inures to the benefit of the parties hereto and their respective successors and assigns, subject to the restriction on assignment contained in paragraph 11 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19. **<u>ATTORNEY'S FEES</u>.** The prevailing party in any legal proceeding arising out of or resulting from this Agreement shall be entitled to recover its costs and fees, including, but not limited to, reasonable attorneys' fees and post judgment costs, from the other party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20. **<u>AUTHORIZED AGENT</u>.** The persons executing this Agreement on behalf of the Company and Consultant hereby represent and warrant to each other that they are the duly authorized representatives of their respective entities and that each has taken all necessary corporate or partnership action to ratify and approve the execution of this Agreement in accordance with its terms.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21. **<u>ADDITIONAL DOCUMENTS</u>.** Each of the parties to this Agreement agrees to provide such additional duly executed (in recordable form, where appropriate) agreements, documents and instruments as may be reasonably requested by the other party in order to carry out the purposes and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22. **<u>COUNTERPARTS,</u>** **<u>TELEFACSIMILE, OR ELECTRONIC SCAN.</u>** This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original and all of which shall constitute one agreement. A telefacsimile or electronic scan of this Agreement may be relied upon as full and sufficient evidence as an original.

{Signature Page Follows}

**IN WITNESS WHEREOF**, the parties hereto have executed this Agreement on the date first written above.

American Fusion Inc., a Texas Corporation:

By: <u>/s/ Richard Hawkins</u>

Richard Hawkins, CEO

Consultant:

ND Grid Energy Solutions LLC

By: <u>/s/ Sebastian E. Hoyos</u>

Sebastian E. Hoyos, CEO<br>

## Exhibit 21.1

Exhibit 21.1

List of Subsidiaries

Name State of Incorporation <br> Kepler Technologies, Inc. Texas

## Exhibit 23.1

Exhibit 23.1

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We hereby consent to the use in this Registration Statement on Form 10 of Renewal Fuel Inc. of our report dated 16<sup>th</sup> March 2026 relating to the Financial Statements of Renewal Fuel Inc. for the year ended December 31, 2025, and December 31, 2024, which appears in this Registration Statement.

We also consent to the reference to us under the heading "Experts" in such Registration Statement.

*/s/ JV CPA INC.*

*820 Gessner Road Suite 300 Houston, Texas 77024*

Date: March 16, 2026

Houston, Texas

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO RULE 13a-14(a) OF THE<br> SECURITIES EXCHANGE ACT OF 1934**

I, Richard Hawkins, hereby certify that:

1. I
 have reviewed this Registration Statement on Form 10 of Renewal Fuels, Inc.;

2. Based
 on my knowledge, this Registration Statement on Form 10 does not contain any untrue statement of a material fact or omit to state
 a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading
 with respect to the period covered by this Registration Statement;

3. Based
 on my knowledge, the financial statements, and other financial information included in this Registration Statement on Form 10, fairly
 present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for,
 the periods presented in this Registration Statement;

4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
 (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
 Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the period in which this Registration Statement is being prepared;

(b) designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
 supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with generally accepted accounting principles;

(c) evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this Registration Statement our conclusions
 about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Registration Statement
 based on such evaluation; and

(d) disclosed
 in this Registration Statement any change in the registrant's internal control over financial reporting that occurred during
 the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report)
 that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial
 reporting; and

5. The
 registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
 reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
 the equivalent functions):

(a) all
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

(b) any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| March 16, 2026 |  | */s/ Richard Hawkins* |
|  | Name: | Richard Hawkins |
|  | Title: | Chief Executive Officer |
|  |  | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION PURSUANT TO RULE 13a-14(a) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

I, Richard Hawkins, hereby certify that:

1. I
 have reviewed this Registration Statement on Form 10 of Renewal Fuels, Inc.;

2. Based
 on my knowledge, this registration statement does not contain any untrue statement of a material fact or omit to state a material
 fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
 respect to the period covered by this registration statement;

3. Based
 on my knowledge, the financial statements, and other financial information included in this registration statement, fairly present
 in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
 presented in this registration statement;

4. The
 registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
 (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
 Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the period in which this Registration Statement is being prepared;

(b) designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
 supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with generally accepted accounting principles;

(c) evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this Registration Statement our conclusions
 about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Registration Statement
 based on such evaluation; and

(d) disclosed
 in this registration statement any change in the registrant's internal control over financial reporting that occurred during
 the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report)
 that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial
 reporting; and

5. The
 registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
 reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
 the equivalent functions):

(a) all
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

(b) any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| March 16, 2026 |  | */s/ Richard Hawkins* |
|  | Name: | Richard Hawkins |
|  | Title: | Chief Financial Officer |
|  |  | (Principal Financial Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. §1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the registration statement on Form 10 of Renewal Fuels, Inc. (the "Company") as filed with the Securities and Exchange Commission on the date hereof (the "Registration Statement"), Richard Hawkins, as Chief Executive Officer and principal executive officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of the undersigned's knowledge and belief, that:

1. the
 Registration Statement fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange
 Act of 1934, as amended; and

2. the
 information contained in the Registration Statement fairly presents, in all material respects, the financial condition and results
 of operations of the Company as of the dates and for the periods expressed in the Registration Statement.

---

| |
|:---|
| */s/ Richard Hawkins* |
| Richard Hawkins |
| Chief Executive Officer and Principal Executive Officer |
| Dated: March 16, 2026 |

---

This certification accompanies this Registration Statement pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. §1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the registration statement on Form 10 of Renewal Fuels, Inc. (the "Company"), as filed with the Securities and Exchange Commission on the date hereof (the "Registration Statement"), Richard Hawkins, as Chief Financial Officer and principal financial officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of the undersigned's knowledge and belief, that:

1. the
 Registration Statement fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange
 Act of 1934, as amended; and

2. the
 information contained in the Registration Statement fairly presents, in all material respects, the financial condition and results
 of operations of the Company as of the dates and for the periods expressed in the Registration Statement.

---

| |
|:---|
| */s/ Richard Hawkins* |
| Richard Hawkins |
| Chief Financial Officer and Principal Financial Officer |
| Dated: March 16, 2026 |

---

This certification accompanies this Registration Statement pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

<br>